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“Ist	  das	  verwendete	  Blut	  frisch,	  hat	  man	  sich	  vor	  Misshandlung	  des	  Herzens	  gehütet,	  
ist	   sorgfältig	   auf	   Fernhalten	   von	   Verunreinigungen,	   von	   Gerinnseln	   und	   besonders	  
von	  Luftblasen	  geachtet,	  so	  bleibt	  der	  Erfolg	  der	  Blutspeisung	  kaum	  jemals	  aus,	  und	  
bei	  passender	  Regelung	  des	  Druckes	  und	  der	  Temperatur	  des	  einströmenden	  Blutes	  
genießt	  man	  dann	  viele	  Stunden	  lang	  das	  Vergnügen,	  das	  Herz	  kräftig	  und	  in	  voller	  
Regelmäßigkeit	  arbeiten	  zu	  sehen.“	  	  	  	  	  	  	  	  	  	  	  	  	  Oscar	  Langendorff,	  Rostock,	  Germany	  1895	  	  	  	  	  	  	  	  
	   	   	  
Abstract	  Cardiovascular	  magnetic	   resonance	   (CMR)	   perfusion	   imaging	   has	   been	   shown	   to	  accurately	   detect	   significant	   coronary	   artery	   stenoses	   and	   is	   of	   potential	   use	   to	  detect	  patients	  for	  early	  treatment	  and	  to	  improve	  prognosis.	  New	  techniques	  yield	  a	  superb	  spatial	  resolution	  and	  may	  allow	  for	  full	  quantification	  of	  perfusion.	  	  Novel	  CMR	  techniques	  and	  imaging	  biomarkers	  are	  often	  validated	  in	  small	  animal	  models	  or	  empirically	  in	  patients.	  The	  direct	  translation	  of	  small	  animal	  magnetic	  resonance	  (MR)	  imaging	  protocols	  to	  humans	  is	  rarely	  possible,	  while	  validation	  in	  humans	   is	   often	   difficult,	   slow	   and	   occasionally	   not	   possible	   due	   to	   ethical	  considerations.	  	  The	  aim	  of	  the	  thesis	  was	  to	  develop	  an	  MR-­‐compatible	  isolated	  blood-­‐perfused	  pig	  heart	  model,	  which	  closely	  resembles	  human	  physiology,	  anatomy	  and	  size	  and	  to	  utilize	   it	   for	   controlled	   validation	   of	   quantitative	   perfusion	   at	   the	   segmental	   and	  voxel	  level	  using	  standard	  clinical	  sequences	  and	  MR	  scanners.	  To	  enable	  accurate	  quantification	   a	   universal	   dual-­‐bolus	   method	   was	   developed.	   The	   design	   of	   the	  heart	   allowed	   exquisite	   control	   regarding	   overall	   and	   regional	   blood-­‐flow	   and	  imaging	  by	   identical	  equipment	  used	   for	  humans.	  Quantitative	  perfusion	   imaging	  showed	   a	   good	   correlation	   with	   microspheres,	   which	   was	   most	   apparent	   with	  Fermi	  function	  constrained	  deconvolution	  regardless	  of	  sequence	  or	  field	  strength.	  Fermi	   deconvolution	   based	   voxel-­‐wise	   quantitative	   perfusion	   values	   also	  correlated	  well	  with	  microspheres	  throughout	   the	  myocardial	  wall.	  The	  validated	  sequences	  proved	  useful	  for	  the	  detection	  of	  significant	  coronary	  artery	  disease	  in	  a	   small	   feasibility	   study	   in	  patients	  analysing	  perfusion	  at	   the	  segmental	   level.	   In	  conclusion	   this	   work	   has	   resulted	   in	   an	   accurate	   validation	   of	   quantitative	  perfusion	  CMR	  at	   a	   segmental	   and	  voxel	   level	   at	   common	  clinical	   field	   strengths.	  The	  dual-­‐bolus	  method	  used	  can	  be	  easily	  applied	  to	  any	  clinical	  environment	  and	  should	  facilitate	  quantification	  of	  perfusion	  in	  clinical	  practice.	  Lastly	  this	  work	  has	  resulted	   in	   an	   isolated	   heart	  model	   that	   is	   useful	   to	   evaluate	   and	   validate	   novel	  imaging	  methodology	  particularly	  for	  perfusion	  quantification.	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  Coronary	  Artery	  Disease	   (CAD),	   subsequent	  myocardial	   infarction	   (MI)	  and	  heart	  failure	   constitute	  a	   leading	   cause	  of	  death	   in	   the	  UK	   (1).	  Myocardial	   ischaemia	   is	  the	  major	   component	   underlying	   these	   cardiovascular	   diseases.	   It	   is	   known	   that	  patients	   with	   extensive	   myocardial	   infarction	   are	   at	   risk	   of	   post-­‐infarction	  remodelling	  and	  heart	  failure	  (2).	  	  Cardiovascular	  magnetic	  resonance	  imaging	  (CMR)	  is	  a	  non-­‐invasive,	  tomographic	  medical	   imaging	   technology	   that	   enables	   the	   study	   of	   cardiac	   function	   and	  structure	  without	   harmful	   ionising	   radiation.	   It	   is	   being	   increasingly	   used	   in	   the	  diagnosis	  and	  assessment	  of	  CAD	  as	  it	  is	  a	  unique	  application	  capable	  of	  assessing	  myocardial	   function,	   viability	   and	   perfusion	   in	   one	   session	   (3).	   It	   compares	  favourably	   to	   other	   non-­‐invasive	   methods	   (4-­‐8).	   Recent	   advances	   of	   this	   high-­‐resolution	   technique,	   with	   development	   of	   new	   hardware,	   contrast	   agents,	  acquisition	  sequences	  and	  new	  post-­‐processing	   tools,	  bring	   the	  promise	  of	  better	  diagnostic	  accuracy,	  better	  understanding	  of	  the	  pathophysiology	  and	  most	  of	  all,	  a	  better	   management	   of	   the	   disease	   (9,10).	   However	   these	   methods	   have	   to	   be	  developed,	  validated	  and	  finally	  translated	  to	  patients.	  	  Novel	   magnetic	   resonance	   (MR)	   techniques	   and	   imaging	   biomarkers	   are	   often	  validated	  in	  small	  animal	  models	  or	  empirically	  in	  patients.	  The	  direct	  translation	  of	  small	  animal	  cardiac	  MR	  imaging	  protocols	  to	  humans	  is	  rarely	  possible.	  On	  the	  other	   hand,	   validation	   of	   novel	   imaging	   techniques	   in	   humans,	   for	   example	  quantitative	   perfusion,	   novel	   sequences,	   optimized	   contrast	   agent	   injection	  schemes	   or	   responses	   to	   alterations	   of	   blood	   flow	   requires	   large	   patient	  populations	  and	  is	  occasionally	  not	  possible	  due	  to	  ethical	  considerations.	  	  In	  order	  to	  observe	  cardiovascular	  physiology	  and	  pathophysiology	  in	  a	  controlled	  fashion,	  complex	  experimental	  models	  are	  necessary	  to	  mimic	  the	  human	  situation	  as	  closely	  as	  possible.	  Since	  the	  porcine	  heart	  to	  a	  large	  extent	  resembles	  the	  human	  heart	  in	  respect	  to	  size,	  anatomy	  and	  physiology	  pigs	  are	  frequently	  used	  for	  cardiovascular	  research	  in	   vivo.	   While	   studies	   in	   whole	   animals	   resemble	   a	   more	   realistic	   physiological	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scenario	  isolated	  perfused	  hearts	  offer	  much	  greater	  control	  of	  perfusion	  and	  many	  other	  parameters.	  A	  key	  component	  of	  this	  PhD	  was	  the	  development	  of	  a	  novel	  MR	  compatible	   explanted	   pig	   heart	   model	   that	   allows	   excellent	   control	   of	   regional	  blood	  flow	  and	  therefore	  represents	  an	  ideal	  vehicle	  for	  validation	  of	  quantitative	  perfusion	  methodology.	   Another	   direction	   of	   the	  work	  was	   the	   utilization	   of	   the	  novel	  model	  for	  validation	  of	  quantitative	  perfusion	  imaging	  at	  the	  segmental	  and	  at	   the	   voxel	   level	   against	   the	   gold	   standard	   of	   fluorescent-­‐labelled	  microspheres	  using	  standard	  clinical	  perfusion	  acquisitions	  and	  MR	  scanners.	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1.1 Thesis	  Overview	  Myocardial	   ischaemia	  as	  a	  consequence	  of	  CAD	   is	  a	  major	  cause	  of	  mortality	  and	  morbidity.	  Therefore	  a	  better	  understanding	  of	  the	  early	  steps	  within	  the	  ischaemic	  cascade	  and	  the	  associated	  underlying	  physiology	  has	  the	  potential	  to	  facilitate	  the	  management	   of	   patients	   with	   known	   or	   suspected	   CAD.	   The	   ability	   to	   non-­‐invasively	   and	   quantitatively	  measure	  myocardial	   perfusion	  with	   CMR	   brings	   us	  closer	   to	   this	  ambitious	  goal	  and	  may	  ultimately	  enhance	  patient	  care.	  This	  work	  has	  been	  divided	  into	  the	  following	  chapters.	  	  
Chapter	  2	   introduces	  the	  use	  of	  CMR	  in	  clinical	  routine,	  with	  a	  specific	  focus	  on	  myocardial	   perfusion	   imaging	   and	   its	   use	   for	   the	   assessment	   of	  ischaemia.	  	  	  
Chapter	  3	  	   introduces	   the	   principles	   of	   quantitative	   CMR	   myocardial	   perfusion	  imaging	  and	  its	  study	  using	  advanced	  animal	  models.	  	  
Chapter	  4	  	   introduces	   a	   practical	   dual-­‐bolus	   injection	   scheme	   for	   universal,	  clinical	   use	   in	   order	   to	   allow	   accurate	   quantification	   of	   myocardial	  perfusion.	   	  Setup,	  feasibility	  and	  timing	  along	  with	  practical	  guidance	  are	  provided.	  	  	  
Chapter	  5	   describes	  a	  novel	  explanted	  blood	  perfused	  pig	  heart	  system	  that	  has	  been	  developed	  to	  be	  used	  within	  a	  clinical	  MR	  scanner.	  The	  chapter	  is	  divided	  into	  three	  phases	  that	  focus	  on	  validation	  of	  the	  model	  outside	  the	   MR	   environment,	   its	   use	   within	   regular	   1.5	   Tesla	   and	   3	   Tesla	  imaging	   suites	   and	   its	   use	  within	   a	   state	   of	   the	   art	   hybrid	   3	   T	   XMR	  fluoroscopy	  laboratory.	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Chapter	  6	   describes	  the	  validation	  of	  quantitative	  perfusion	  imaging	  in	  standard	  myocardial	   segments	   using	   k-­‐space	   and	   time	   (k-­‐t)	   accelerated	  balanced	   TFE	   at	   1.5	   Tesla	   and	   k-­‐t	   accelerated	   TFE	   at	   3	   Tesla.	   Blood	  flow	   quantification	   is	   based	   on	   different	   algorithms,	   namely	   Fermi	  function	   constrained	   deconvolution,	   autoregressive	   moving	   average	  modeling,	   deconvolution	   using	   exponential	   basis	   and	   deconvolution	  using	   B-­‐spline	   basis.	   The	   individual	   correlations	   with	   the	   gold	  standard	  of	  fluorescent-­‐labelled	  coloured	  microspheres	  are	  presented	  for	   each	   algorithm,	   sequence	   and	   field	   strength	   in	   this	   chapter.	  Another	  direction	  focuses	  on	  a	  small	  feasibility	  study	  in	  patients	  with	  quantification	   based	   on	   Fermi	   function	   constrained	   deconvolution.	  The	  translation	  from	  the	  pigs	  to	  patients	  using	  identical	  sequences	  and	  hardware	  is	  described.	  	  
Chapter	  7	   describes	  the	  validation	  of	  voxel-­‐wise	  quantitative	  perfusion	   imaging	  against	   the	   gold	   standard	   of	   fluorescent-­‐labelled	   coloured	  microspheres.	  CMR	  perfusion	  quantification	  described	  in	  this	  chapter	  is	   based	   on	   Fermi	   function	   constrained	   deconvolution	   using	   k-­‐space	  and	   time	   (k-­‐t)	   accelerated	   balanced	   TFE	   and	   k-­‐t	   accelerated	   TFE	  sequences	  at	  1.5	  Tesla	  and	  at	  3	  Tesla,	  respectively.	  	  
	  
Chapter	  8	   summarises	   the	   findings	  made	   in	   this	  work	   and	   gives	   an	  outlook	  on	  future	  projects.	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2.1 Summary	  Coronary	   artery	   disease	   represents	   one	   of	   the	   major	   threats	   to	   health	   in	   the	  western	   world.	   The	   pathophysiological	   substrate	   of	   coronary	   artery	   disease	   is	  heterogeneous,	   varying	   from	   ischaemia	   and	   hibernating	   myocardium	   to	  irreversible	   scarring.	   There	   is	   evidence	   to	   suggest	   that	   patients	   with	   significant	  ischaemia	   benefit	   most	   from	   revascularization,	   whereas	   medical	   therapy	   is	  associated	   with	   an	   adverse	   prognosis.	   Therefore,	   non-­‐invasive	   testing	   is	  recommended	   by	   relevant	   guidelines	   to	   guide	   optimal	   management	   in	   these	  patients.	   Cardiovascular	   magnetic	   resonance	   has	   evolved	   into	   a	   comprehensive,	  clinical	  modality	  that	  provides	  high	  quality	  accurate	  determination	  of	  the	  presence	  and	   degree	   of	   myocardial	   ischaemia,	   the	   amount	   of	   hibernating	   myocardium	   as	  well	   as	   the	   extent	   and	   spatial	   location	   of	   myocardial	   scarring.	   Consequently,	  cardiovascular	   magnetic	   resonance	   has	   a	   broad	   range	   of	   clinical	   applications,	  including	  measurements	  of	  global	  and	  regional	  myocardial	  function,	  perfusion	  and	  flow	   reserve,	   as	   well	   as	   myocardial	   viability.	   It	   is	   a	   safe	   approach,	   which	   in	   the	  absence	  of	  ionizing	  radiation	  is	  being	  increasingly	  used	  to	  diagnose,	  follow-­‐up	  and	  guide	   therapy	  of	   patients	  with	  different	   cardiac	  diseases	   and	   especially	   coronary	  artery	  disease.	  This	   chapter	   focuses	   on	   the	   indications,	   accuracy,	   and	   clinical	   utility	   of	  cardiovascular	   magnetic	   resonance,	   with	   a	   special	   focus	   on	   cardiovascular	  magnetic	  resonance	  ischaemia	  testing	  in	  coronary	  artery	  disease.	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2.2 Introduction	  Despite	   many	   advances	   in	   the	   prevention,	   detection	   and	   treatment	   of	   coronary	  artery	   disease	   (CAD)	   subsequent	  myocardial	   infarction	   (MI)	   and	   heart	   failure	   of	  ischemic	  origin	  constitute	  a	  leading	  cause	  of	  death	  in	  the	  industrialized	  world	  (1).	  Myocardial	   ischaemia	   is	   the	   major	   component	   underlying	   these	   cardiovascular	  diseases	  (2).	  	  Coronary	  intervention	  aimed	  at	  the	  restoration	  of	  blood	  flow	  and	  medical	  therapy	  are	  important	  in	  the	  management	  of	  patients	  with	  stable	  CAD.	  However	  in	  clinical	  routine	   appropriate	   selection	   of	   patients	   and	   stenoses	   for	   revascularisation	   is	  difficult.	  Patients	  with	  complex	  CAD	  such	  as	  multivessel	  disease,	  previous	  coronary	  artery	  bypass	  grafting	  (CABG),	  complex	  anatomy	  and	  reduced	  left	  ventricular	  (LV)	  function	  are	  at	  higher	  risk	  of	  procedural	  complications	  but	  also	  potentially	  benefit	  the	   most	   from	   revascularisation.	   Information	   regarding	   associated	   risks	   and	  potential	  benefits	  of	  a	  given	  procedure	  is	  crucial	  for	  appropriate	  patient	  selection.	  	  Clinical	  decision-­‐making	  regarding	  revascularisation	  is	  however	  often	  made	  on	  the	  basis	  of	  coronary	  anatomy	  and	  the	  pure	  presence	  of	  a	  lesion	  rather	  than	  taking	  its	  functional	   significance	   into	   account.	   Guiding	   patient	   management	   based	   on	  anatomical	   appearance	   of	   a	   coronary	   artery	   narrowing	   alone	   fails	   to	   assess	  coronary	  blood	   flow,	  myocardial	  perfusion	  and	  viability,	  which	  are	   central	   to	   the	  pathophysiology	   of	   CAD	   (11).	   In	   fact	   anatomic	   assessment	   of	   the	   severity	   of	   a	  coronary	  artery	  stenosis	  has	  been	  repeatedly	   shown	   to	  correlate	  poorly	  with	   the	  hemodynamic	  effects	  a	  stenosis	  may	  have	  (12,13).	  It	  is	  important	  to	  realize	  that	  the	  evidence	   supporting	   coronary	   revascularisation	   related	   to	   angiographic	  appearances	   comes	   from	   animal	   experiments	   showing	   a	   reduction	   in	   blood	   flow	  below	  a	  threshold	  of	  50-­‐70%	  coronary	  artery	  narrowing	  induced	  with	  mechanical	  constrictors	   (14).	  This	  however	  oversimplifies	   the	   situation	   in	  patients	  with	  CAD	  that	   may	   have	   collateral	   vessels	   and	   calcification	   and	   dynamic	   changes	   in	  vasomotor	  tone.	  It	  is	  sometimes	  also	  difficult	  for	  the	  interventionalist	  to	  identify	  a	  truly	  normal	  vessel	  segment	  as	  a	  reference	  diameter.	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These	  considerations	  are	  widely	  accepted	  and	  the	  importance	  of	  functional	  testing	  prior	   to	   revascularisation	   is	   outlined	   in	   guidelines	   for	   percutaneous	   coronary	  intervention	  (PCI)	  in	  stable	  CAD	  (15).	  	  There	   are	   several	   invasive	   and	   non-­‐invasive	   modalities	   available	   to	   assess	   the	  physiological	   relevance	   of	   a	   given	   coronary	   artery	   stenosis	   that	   can	   be	   used	   to	  guide	   clinical	   decision	   making	   (16).	   Cardiovascular	   magnetic	   resonance	   imaging	  (CMR)	  has	  rapidly	  evolved	  over	  the	  past	  decade	  and	  is	  increasingly	  used	  in	  clinical	  routine.	  There	  are	  several	  reasons	  to	  explain	  the	  increased	  usage.	  CMR	  has	  become	  more	   available	   and	   there	   are	   increasing	  numbers	   of	   physicians	   that	   can	  perform	  high	   quality	   examinations.	   	   In	   addition	   CMR	   has	   many	   advantages	   over	   other	  cardiac	   imaging	   techniques	   such	   as	   echocardiography	   or	   nuclear	   medicine.	   It	   is	  non-­‐invasive,	   uses	   no	   ionizing	   radiation,	   and	   produces	   high-­‐resolution	   images	   of	  the	   heart	   to	   assess	   myocardial	   function,	   tissue-­‐characteristics	   (e.g.	   scar)	   and	  perfusion	  within	  a	  single	  examination.	  	  
2.3 Ischaemia	  Even	   though	   the	   exact	   pathophysiological	   definition	  of	  myocardial	   ischaemia	  has	  been	   subjected	   to	   extensive	   debate	   the	   most	   accepted	   clinical	   definition	   is	   an	  inadequate	   blood	   supply	   that	   occurs	   when	   blood	   flow	   to	   the	   myocardium	   is	  obstructed	  by	  a	  partial	  or	  complete	  blockage	  of	  a	  coronary	  artery	  (17).	  	  
2.3.1 The	  pathophysiology	  of	  ischaemia	  Coronary	  artery	   flow	  can	  be	  derived	   form	  the	  arterial	  pressure	  and	   the	  coronary	  resistance	  in	  a	  given	  coronary	  artery.	  The	  physiology	  of	  the	  coronary	  circulation	  is	  dependent	   on	   many	   regulatory	   factors	   including	   nervous	   control,	   metabolic	  control,	  mechanical	  factors	  including	  aortic	  pressure,	  extravascular	  systolic	  forces,	  cardiac	  frequency	  and	  the	  coronary	  autoregulation.	  Coronary	  autoregulation	  plays	  an	   important	   role	   by	   adaption	   of	   the	   vessel	   diameter	   through	   vasodilation	   in	  response	   to	   increased	   or	   decreased	   oxygen	   demand	   of	   the	   myocardium.	   The	  
Chapter	  2	  –	  Coronary	  artery	  disease	  and	  cardiovascular	  magnetic	  resonance	   17	  
difference	  of	   the	  maximum	  blood	   flow,	  which	  can	  be	  achieved	  by	  vasodilation,	  as	  opposed	   to	   the	   resting	   value	   is	   called	   the	   coronary	   flow	   reserve	   (CFR).	   In	   the	  presence	   of	   a	   physiologically	   significant	   coronary	   artery	   stenosis	   the	   arterioles	  vasodilate	   at	   rest	   to	   achieve	   sufficient	  blood	   supply	   through	   the	   stenosis.	  This	   in	  turn	  leads	  to	  reduced	  CFR	  because	  there	  is	  already	  vasodilation	  of	  the	  arterioles	  at	  rest	   which	   cannot	   be	   further	   increased	   with	   stress	   leading	   to	   stress	   induced	  myocardial	  ischaemia	  (Figure	  2.1).	  	  
	  
Figure	  2.1:	  The	  figure	  shows	  a	  schematic	  diagram	  of	  the	  coronary	  artery	  circulation	  and	  the	  
myocardium	   in	   the	   normal	   situation	   (left	   part	   of	   the	   diagram)	   and	   in	   the	   presence	   of	   an	  
epicardial	  coronary	  artery	  stenosis	  (right	  part	  of	  the	  diagram).	  There	  are	  three	  resistances	  
(R1,	  R2,	  R3)	  contributing	  to	  the	  average	  coronary	  resistance.	  R1	  represents	  the	  resistance	  in	  
the	  epicardial	  vessel,	  R2	  the	  autoregulatory	  resistance	  in	  the	  arterioles	  and	  R	  3	  represents	  
the	   compressive	   forces	   on	   the	  myocardial	   wall.	   In	   the	   normal	   situation	   the	   arterioles	   are	  
constricted	   representing	   the	  major	   component	   of	   the	   coronary	   resistance	   whereas	   in	   the	  
presence	  of	  an	  epicardial	  stenosis	  the	  arterioles	  are	  vasodilated	  to	  achieve	  sufficient	  blood	  
supply	   through	   the	   stenosis	   at	   rest.	   This	   leads	   to	   reduced	   coronary	   flow	   reserve	   (CFR)	   at	  
stress	  due	  to	  reduced	  vasodilatory	  capacity.	  Please	  note	  that	  for	  the	  purposes	  of	  this	  figure	  
only,	  R2	  is	  displayed	  as	  a	  sphincter	  like	  resistance,	  which	  does	  not	  reflect	  the	  physiological	  
situation	  in	  the	  arterioles.	  Adapted	  from	  (18).	  	  Figure	  2.2	  shows	  the	  relationship	  between	  CFR	  and	  percent	  diameter	  stenosis	  in	  an	  experimental	   canine	  model.	  Essentially	  with	  an	   increase	   in	  percent	  diameter	  of	  a	  coronary	   artery	   stenosis,	   the	   maximum	   coronary	   flow	   measured	   during	   full	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vasodilatation	  decreases,	  which	   is	  paralleled	  by	  a	  decrease	   in	   resting	   flow	  with	  a	  high	   degree	   coronary	   stenosis.	   However	   CFR	   values	   seem	   to	   be	   relatively	  preserved	  between	  50	  and	  70	  percent	  diameter	  stenosis	  with	  significant	  variability	  in	   the	   individual	   case.	   With	   a	   higher	   degree	   stenosis	   CFR	   is	   more	   significantly	  reduced.	  	  
	  
Figure	  2.2:	  The	  figure	  shows	  the	  coronary	  flow	  reserve	  (CFR)	  in	  relation	  to	  the	  angiographic	  
percent	  diameter	  narrowing	  in	  a	  dog	  experimental	  model.	  An	  increase	  in	  percent	  diameter	  
coronary	  artery	  stenosis	  relates	  to	  a	  reduced	  maximum	  coronary	  flow	  measured	  during	  full	  
vasodilatation.	   However	   CFR	   values	   are	   relatively	   preserved	   between	   50	   and	   70	   percent	  
diameter	  stenosis	  with	  significant	  variability	   in	   the	   individual	  case	  (grey	  shading	   indicates	  
95	  %	   confidence	   intervals-­‐	   CI).	   There	   is	   a	   significant	   decrease	   in	   CFR	   thereafter.	   Adapted	  
from	  (14).	  
	  This	   can	   be	   also	   very	   elegantly	   appreciated	   from	   a	   previous	   study	   by	   Uren	   and	  colleagues	  looking	  at	  the	  relationship	  between	  the	  degree	  of	  stenosis	  and	  coronary	  blood	  flow	  in	  35	  patients	  with	  CAD	  and	  21	  healthy	  control	  subjects	  (19).	  Regional	  coronary	  blood	  flow	  to	  the	  myocardium	  subtended	  by	  the	  diseased	  coronary	  artery	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was	  measured	  using	  positron	  emission	  tomography	  (PET)	  with	  oxygen-­‐15-­‐labelled	  water.	   The	   authors	   were	   able	   to	   demonstrate	   that	   a	   progressive	   decline	   in	   CFR	  significantly	  correlates	  with	  the	  degree	  of	  the	  coronary	  artery	  stenosis.	  Demer	  et	  al.	  demonstrated	  a	  similar	   finding	   in	   their	  study	  using	  quantitative	  angiography	  and	  PET	  (Figure	  2.3).	  	  
	  
Figure	  2.3:	  Relationship	  between	  the	  coronary	  flow	  reserve	  (CFR)	  and	  the	  percent	  diameter	  
narrowing	  of	  the	  stenosis.	  There	  is	  a	  significant	  variability	  in	  the	  individual	  patient	  ranging	  
from	  normal	   to	  highly	  reduced	  CFR	   for	  a	  given	  coronary	  artery	  stenosis	  narrowing.	  This	   is	  
especially	   important	   for	   intermediate	   stenosis	   levels	   (50-­‐70%,	   red	   box)	   where	   functional	  
significance	   of	   a	   given	   lesion	   cannot	   be	   extrapolated	   from	   the	   anatomical	   stenosis	   degree.	  
Adapted	  from	  (20).	  	  However	   similar	   to	   the	   animal	   work	   by	   Gould	   et	   al.	   (14)	   in	   humans	   there	   is	   a	  significant	   variability	   in	   the	   individual	   patient	   ranging	   from	   normal	   to	   highly	  reduced	   CFR	   for	   a	   given	   coronary	   artery	   stenosis	   narrowing	   which	   is	   most	  pronounced	  at	   intermediate	   stenosis	   levels	   (50-­‐70%)	   (19,20).	  This	   indicates	   that	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the	  physiology	  of	  the	  coronary	  artery	  circulation	  cannot	  be	  oversimplified	  to	  solely	  consider	  the	  anatomy	  of	  a	  coronary	  lesion	  and	  that	  some	  functional	  physiological	  assessment	  is	  needed	  to	  identify	  whether	  or	  not	  a	  given	  anatomical	  lesion	  results	  in	  significant	  stress	  induced	  ischaemia.	  	  
2.3.2 Clinical	  implications	  The	  presence	  of	  myocardial	  ischaemia	  in	  stable	  CAD	  is	  associated	  with	  an	  adverse	  prognosis	   whether	   detected	   by	   exercise	   testing	   (21),	   single	   photon	   emission	  computed	   tomography	   (SPECT)	   (22),	   stress	  echocardiography	   (23),	  or	  CMR	  (24).	  However	  there	  is	  only	  limited	  evidence	  that	  myocardial	  revascularisation	  improves	  outcome	  in	  these	  patients.	  Hachamovitch	  et	  al.	  (25)	  assessed	  survival	  in	  10,627	  patients	  who	  had	  undergone	  clinical	   SPECT	   studies	   in	   a	   single	   US	   centre.	   Patients	   with	   no	   or	   mild	   baseline	  ischaemia	   had	   an	   improved	   prognosis	   with	   medical	   therapy	   compared	   to	  revascularisation	  whilst	  conversely	   those	  with	  moderate	   to	  severe	   ischaemia	  had	  an	  improved	  prognosis	  with	  revascularisation.	  An	  ischaemic	  threshold	  of	  10-­‐12.5%	  of	  myocardium	  differentiated	  patients	  who	  benefited	  from	  revascularisation	  from	  those	  who	  did	  not.	   Even	   though	   these	  data	   are	   from	  a	   very	   large	   cohort	   and	   the	  conclusions	   are	   interesting,	   the	   non-­‐randomised,	   retrospective	   observational	  nature	  of	  the	  study	  and	  the	  fact	  that	  a	  propensity	  score	  was	  used	  to	  adjust	  for	  non-­‐randomisation	  need	  to	  be	  considered.	  In	  the	  Asymptomatic	  Cardiac	  Ischaemia	  Pilot	  study,	  that	  included	  558	  patients	  with	  asymptomatic	  ischaemia,	  those	  who	  were	  randomised	  to	  revascularisation	  (PCI	  or	  CABG)	   had	   significantly	   lower	   rates	   of	   death	   or	   MI	   than	   those	   randomised	   to	  medical	  therapy	  (26).	  There	  were	  however	  relatively	  few	  events	  (31	  in	  total)	  and	  the	  medical	  therapy	  used	  reflected	  practice	  at	  the	  time	  rather	  than	  current	  routine	  aggressive	  therapy.	  In	  the	  SWISSI	  II	  trial	  patients	  post	  MI	  with	  silent	  ischaemia	  had	  a	  significantly	  reduced	  rate	  of	  major	  adverse	  cardiac	  events	  with	  PCI	  compared	  to	  medical	  therapy	  (27).	  
Chapter	  2	  –	  Coronary	  artery	  disease	  and	  cardiovascular	  magnetic	  resonance	   21	  
The	   landmark	   randomised	   controlled	   COURAGE	   trial	   (28)	   on	   the	   other	   hand	  concluded	   that	   PCI	   does	   not	   confer	   a	   prognostic	   benefit	   as	   opposed	   to	   optimal	  medical	   therapy	   alone	   in	   patients	   with	   stable	   CAD.	   Considering	   the	   majority	   of	  participants	   had	   objective	   evidence	   of	   ischaemia	   at	   baseline	   including	   54%	   of	  patients	   with	   reversible	   defects	   on	   nuclear	   imaging	   these	   data	   generated	  considerable	   controversy	   and	   led	  many	   to	   entirely	   re-­‐evaluate	   the	   role	   of	   PCI	   in	  stable	  CAD.	   It	   seems	  paradoxical	   that	   there	  was	  no	   incremental	  benefit	   from	  PCI	  given	   that	   the	   presence	   of	   demonstrable	   ischaemia	   confers	   a	   worse	   prognosis.	  Although	   there	   are	   a	   number	   of	   possible	   explanations	   for	   this	   the	   most	   likely	  explanation	  is	  the	  study	  design	  that	  favoured	  inclusion	  of	  lower	  risk	  patients	  with	  a	  lower	  burden	  of	  pre	  treatment	  myocardial	  ischaemia.	  For	  example	  patients	  with	  an	  exercise	  test	  positive	  in	  the	  first	  stage	  were	  excluded	  and	  only	  a	  third	  of	  patients	  in	  the	  PCI	  arm	  had	  a	  significant	  reduction	  of	  ischaemia	  following	  PCI.	  	  	  Indeed	   the	  nuclear	   sub	  study	  of	   the	  same	   trial	   suggested	   that	  PCI	  might	   confer	  a	  prognostic	   benefit	   especially	   in	   patients	   with	   moderate	   to	   severe	   baseline	  ischaemia	   (29).	   This	   suggests	   that	   revascularisation	   may	   confer	   a	   prognostic	  benefit	   in	   patients	   with	   a	   significant	   ischemic	   burden	   and	   improved	   patient	  selection	   may	   allow	   this	   benefit	   to	   be	   realised.	   In	   fact	   the	   DEFER	   study	   (30)	  demonstrated	   that	   in	   single	   vessel	   disease	   it	   is	   safe	   to	   defer	   treatment	   of	  angiographically	  moderate	  stenoses	  that	  do	  not	  cause	  ischaemia	  as	  determined	  by	  fractional	  flow	  reserve	  (FFR).	  FFR	  is	  defined	  as	  the	  distal	  pressure	  after	  a	  stenosis	  relative	   to	   the	   pressure	   before	   the	   stenosis	   during	   pharmacological	   maximal	  vasodilation.	  FFR	  values	  of	  ≤0.8	  mean	  that	  a	  given	  stenosis	  causes	  a	  20%	  drop	  in	  blood	  pressure.	  The	  recent	  FAME	  study	  demonstrated	  the	  utility	  of	  extending	  this	  approach	   to	   a	   multivessel	   setting	   (31).	   This	   large	   multicentre,	   randomised,	  controlled	   trial	   demonstrated	   that	   ischaemia-­‐guided	   PCI	   confers	   a	   prognostic	  benefit	  (reduced	  rate	  of	  death,	  nonfatal	  MI	  and	  repeat	  revascularization)	  over	  PCI	  guided	  by	  angiographic	  appearances	  alone.	  At	  present	  FFR	  is	  considered	  the	  gold	  standard	   for	   clinical	   invasive	   assessment	   of	   the	   functional	   severity	   of	   a	   given	  coronary	  artery	  stenosis.	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2.4 Non-­‐invasive	  imaging	  of	  ischaemia	  On	   the	   basis	   of	   this	   evidence	   most	   clinicians	   accept	   that	   combining	   anatomical	  information	   with	   a	   functional	   assessment	   pre	   revascularisation	   in	   patients	   with	  CAD	  is	  important.	  A	  number	  of	  non-­‐invasive	  imaging	  modalities	  are	  available	  each	  with	   its	  own	   inherent	  advantages	  and	  disadvantages.	  Clinicians	  can	  decide	  which	  method	   is	   most	   appropriate	   according	   to	   the	   clinical	   situation	   and	   availability.	  SPECT	  and	  PET	  are	  well	  established	  and	  effective.	  Most	  evidence	  today	  supporting	  the	   concept	   of	   ischaemia	   imaging	   as	   an	   essential	   part	   of	   the	   workup	   of	   these	  patients	   comes	   from	   SPECT	   imaging.	   However	   both	   require	   the	   use	   of	   ionising	  radiation,	  have	  inferior	  spatial	  resolution	  compared	  to	  CMR	  and	  the	  availability	  of	  PET	  remains	  very	  limited.	  This	  is	  of	  particular	  importance	  as	  many	  coronary	  artery	  lesions	   lead	   to	   subendocardial	   rather	   than	   transmural	   ischaemia	   and	   a	   certain	  resolution	   is	   required	   to	   distinguish	   subendocardial	   ischaemia	   from	   normal	  subendocardial	   flow	   (Figure	   2.4).	   This	   information	   however	   might	   be	   lost	   with	  SPECT	  leading	  to	  less	  diagnostic	  accuracy	  as	  compared	  with	  CMR	  (32).	  
	  
Figure	   2.4:	   The	   figure	   shows	   an	   adapted	   version	   of	   Figure	   1.1	   (see	   above)	   indicating	   the	  
current	   standard	   spatial	   resolutions	   of	   clinical	   imaging	   modalities	   to	   assess	   myocardial	  
ischaemia.	   CMR	   has	   the	   particular	   advantage	   over	   its	   competitors	   to	   offer	   higher	   spatial	  
resolution	  allowing	  subendocardial	  ischaemia	  to	  be	  depicted.	  Adapted	  from	  (18).	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Echocardiography	   is	   well	   validated	   and	   widely	   available.	   It	   remains	   a	   valuable,	  non-­‐ionising	   technique	   often	   used	   first	   line,	   but	   can	   be	   limited	   by	   poor	   acoustic	  windows	  and	  endocardial	  border	  definition.	  CT	  can	  potentially	  assess	  LV	  function	  (33),	  perfusion	  and	  viability	  (34)	  however	  currently	  this	  is	  not	  well	  established	  and	  its	   main	   strength	   at	   present	   is	   coronary	   artery	   imaging.	   Non-­‐invasive	   coronary	  artery	  imaging	  is	  of	  limited	  value	  in	  these	  patients	  as	  it	  is	  not	  capable	  of	  assessing	  functional	  severity	  of	  a	  lesion	  (35).	  Furthermore	  anatomic	  assessment	  is	  hampered	  by	   high	   prevalence	   of	   calcification	   in	   patients	   with	   CAD,	   limiting	   image	  interpretation.	   Therefore	   the	   main	   strength	   of	   CT	   angiography	   is	   its	   specificity	  rather	   than	   its	   limited	   sensitivity	   (36).	   The	   major	   disadvantage	   of	   CT	   is	   its	  significant	   radiation	   exposure	   particularly	   if	   coronary	   angiography,	   function,	  perfusion	  and	  viability	  are	  studied	  within	  one	  examination.	  CMR	  has	  emerged	  as	  a	  highly	   accurate	   and	   versatile	   tool	   for	   making	   these	   assessments	   and	   guiding	  clinical	  management.	  Advantages	  of	  CMR	  include	  freedom	  from	  ionising	  radiation,	  generation	   of	   high	   quality	   images	   and	   most	   importantly,	   the	   generation	   of	   a	  complete	  workup	  incorporating	  LV	  volumes	  and	  function,	  myocardial	  viability	  and	  scar,	  as	  well	  as	  ischaemia	  within	  a	  single	  study	  lasting	  approximately	  one	  hour.	  The	  main	   disadvantages	   are	   that	   imaging	   is	   contraindicated	   in	   patients	   with	   certain	  implants	   e.g.	   pacemakers,	   still	   limited	   availability	   as	   compared	   to	   other	  methodologies	   and	   rarely	   reduction	   of	   imaging	   quality	   due	   to	   patient	  claustrophobia,	  poor	  gating	  or	  patient	  motion.	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2.5 Cardiovascular	  magnetic	  resonance	  	  
2.5.1 Cardiovascular	  magnetic	  resonance	  imaging	  of	  ischaemia	  The	  two	  main	  CMR	  methods	  for	  the	  assessment	  of	  myocardial	   ischaemia	  are	  high	  dose	   dobutamine	   stress	   with	   wall	   motion	   assessment	   and	   first-­‐pass	   myocardial	  perfusion	  during	  adenosine	  infusion.	  	  Dobutamine	  stress	  involves	  the	  administration	  of	  a	  standard	  dobutamine/atropine	  protocol	   to	   achieve	   a	   target	   heart	   rate.	   The	   occurrence	   of	   new	   wall	   motion	  abnormalities	   during	   increasing	   doses	   of	   dobutamine	   is	   considered	   diagnostic	   of	  ischaemia.	   Nagel	   et	   al.	   (4)	   were	   the	   first	   to	   validate	   dobutamine	   CMR	   for	   the	  detection	  of	  CAD.	  Dobutamine	  CMR	  performed	  better	  than	  stress	  echocardiography	  in	  the	  identification	  of	  CAD	  using	  at	  least	  50%	  stenosis	  on	  coronary	  angiography	  as	  the	  gold	  standard.	  CMR	  sensitivity	  and	  specificity	  in	  this	  study	  of	  208	  patients	  were	  88.7%	  and	  85.7%	  respectively.	  Many	  validation	  studies	  have	  been	  performed	  and	  reported	   similar	   results	   since.	   However	   as	   the	   studies	   are	   relatively	   small	   the	  confidence	   intervals	  are	  often	  wide.	  Nandalur	  et	  al.	   (37)	  pooled	  the	  data	   from	  14	  studies	   and	  724	  patients	   and	   confirmed	  good	   sensitivity	   (83%;	  95%	  CI	   79-­‐88%)	  and	  specificity	  (86%;	  95%	  CI	  81-­‐91%)	  of	  stress	  induced	  wall	  motion	  abnormalities	  against	  X-­‐ray	  coronary	  angiography	  for	  the	  detection	  of	  CAD.	  It	  is	  noteworthy	  that	  there	  was	  a	  high	  prevalence	  of	  CAD	  (70.5%)	  in	  the	  735	  participants	  included	  from	  the	  combined	  13	  studies	  that	  were	  used	  in	  the	  final	  analysis.	  High	  dose	  dobutamine-­‐atropine	  stress	  CMR	  is	  safe	  in	  addition	  to	  being	  effective.	  In	  a	  series	  of	  1000	  patients	  (38)	  adverse	  events	  included	  one	  case	  (0.1%)	  of	  sustained	  and	  four	  cases	  (0.4%)	  of	  non-­‐sustained	  ventricular	  tachycardia,	  16	  cases	  (1.6%)	  of	  atrial	  ﬁbrillation,	  and	  two	  cases	  (0.2%)	  of	  transient	  second	  degree	  AV	  block.	  	  Exercise	   stress	   CMR	   is	   also	   technically	   possible	   using	   a	   specific	   MRI-­‐compatible	  cycle	  ergometer.	  Recent	  work	  suggests	  that	  it	  may	  be	  possible	  to	  overcome	  some	  of	  the	  technical	  limitations,	  such	  as	  motion	  and	  difficulties	  in	  breath	  holding	  by	  using	  real	  time	  exercise	  stress	  CMR	  images	  (39).	  However	  at	  present	  real	  time	  imaging	  is	  not	  in	  routine	  clinical	  use	  despite	  good	  preliminary	  clinical	  results	  (40).	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First-­‐pass	   myocardial	   perfusion	   during	   pharmacologically	   induced	   maximal	  coronary	   vasodilation	   (usually	   with	   adenosine)	   involves	   imaging	   of	   the	   first	  passage	   of	   a	   contrast	   bolus	   into	   the	  myocardium.	   Perfusion	   of	   contrast	   into	   the	  myocardium	  subtended	  by	  vessels	  with	   flow-­‐limiting	  CAD	  does	  not	   increase	  with	  stress	  (because	  of	  reduced	  CFR)	  as	  much	  as	  perfusion	  of	  contrast	  into	  myocardium	  supplied	  by	  normal	  vessels	  (with	  normal	  CFR).	  In	  the	  clinical	  setting	  this	  is	  usually	  analysed	  qualitatively	  as	  a	  defect	  in	  the	  contrast	  perfusion	  into	  the	  myocardial	  wall	  visible	  during	  stress	  but	  not	  at	  rest	  (Figure	  2.5).	  	  	  
	  	  
Figure	  2.5:	  Risk	  stratification	  in	  suspected	  CAD:	  a)	  Steady-­‐state	  free	  precession	  cine	  (diastole	  
and	   systole),	   fast	   gradient	   echo	   perfusion	   (stress	   and	   rest,	   d	   and	   e),	   as	   well	   as	   late	  
gadolinium	  enhancement	  (LGE,	  b	  and	  c)	  images	  of	  a	  66-­‐year-­‐old	  male	  presenting	  for	  workup	  
of	  atypical	  chest	  pain	  and	  hypertension.	  Adenosine	  stress	  CMR	  was	  performed	  after	  a	  normal	  
rest	  echocardiography	  and	  an	  un-­‐diagnostic	  stress	  ECG.	  Adenosine	  perfusion	  CMR	  revealed	  
stress-­‐induced	  ischaemia	  in	  the	  RCA	  territory	  (d	  and	  e)	  without	  myocardial	  scarring	  or	  wall	  
motion	   abnormalities	   (a,	   b	   and	   c).	   Based	   on	   the	   CMR	   results,	   invasive	   angiography	   was	  
performed	  (f)	  demonstrating	  a	  tight	  subtotal	  mid	  RCA	  lesion,	  which	  was	  treated	  by	  PCI	  and	  
stenting.	  Adapted	  from	  (41)	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There	   are	   a	   number	   of	   single-­‐centre	   studies	   and	   a	   few	   multi-­‐centre	   trials	  comparing	  CMR	  to	  established	  methods	  of	  detecting	  myocardial	   ischaemia.	   In	  the	  above	  mentioned	  meta-­‐analysis	  (37),	  perfusion	  CMR	  was	  also	  assessed	  using	  data	  from	  24	  studies	  and	  1516	  patients	  resulting	  in	  a	  sensitivity	  of	  91%	  (95%	  CI	  88	  to	  94%)	   and	   a	   speciﬁcity	   of	   81%	   (95%	   CI	   77	   to	   85%)	   against	   X-­‐ray	   coronary	  angiography.	  Again	   there	  was	  a	   relatively	  high	  prevalence	  of	  CAD	  (57.4%)	   in	   the	  pooled	  population.	  MR-­‐IMPACT	  was	  the	  first	  perfusion	  CMR	  multi-­‐centre	  trial	  demonstrating	  that	  CMR	  perfusion	  was	  non-­‐inferior	  to	  SPECT	  for	  the	  detection	  of	  CAD	  with	  ≥50%	  stenosis	  on	   quantitative	   X-­‐ray	   coronary	   angiography	   as	   the	   reference	   standard.	   This	  was	  however	   a	   dose-­‐finding	   study	   and	   only	   42	   patients	   formed	   the	   CMR	   cohort	   on	  which	   this	  analysis	  was	  based	   (42).	  To	  actually	  compare	  diagnostic	  accuracy	   in	  a	  sufficient	  patient	  collective	  MR-­‐IMPACT	  II	  enrolled	  533	  patients	  in	  33	  international	  centres	   (43).	   In	   this	   trial	   the	   authors	   found	   a	   better	   sensitivity	   of	   CMR	   (0.67	   vs.	  059)	   but	   a	   lower	   specificity	   compared	   with	   SPECT	   (0.61	   and	   0.72).	   The	   major	  conclusion	  was	   the	   non-­‐inferiority	   of	   CMR	   in	   a	   real	   world	   clinical	   scenario	  with	  multiple	  centres	  around	  the	  world	  with	  varying	  expertise	  in	  CMR	  and	  SPECT.	  The	  CE-­‐MARC	  single	  centre	  trial	  is	  the	  largest,	  prospective	  evaluation	  of	  CMR	  including	  stress	   perfusion	   demonstrating	   superiority	   over	   SPECT	   (32).	   752	   patients	   with	  suspected	  CAD	  were	  included	  in	  this	  investigation	  and	  CMR	  had	  86.5%	  sensitivity	  and	   83.4%	   specificity	   as	   opposed	   to	   SPECT	   with	   66.5%	   sensitivity	   and	   82.6%	  specificity	  for	  the	  detection	  of	  significant	  CAD	  as	  defined	  by	  invasive	  angiography.	  It	  is	  important	  to	  note	  that	  both	  techniques	  had	  better	  diagnostic	  accuracy	  in	  this	  study	   performed	   in	   a	   highly	   experienced	   single	   centre	  with	   CMR	   being	   superior	  because	  of	  its	  better	  sensitivity.	  One	   of	   the	   difficulties	   in	   validating	   non-­‐invasive	   methods	   for	   the	   detection	   of	  myocardial	   ischaemia	  is	  the	  absence	  of	  a	  clear	  gold	  standard	  for	  comparison.	  The	  studies	  discussed	  above	  use	   coronary	  angiography	  as	   the	  gold	   standard	  with	   the	  limitations	  discussed	  previously	   in	   this	   chapter.	  For	  a	  more	  direct	   comparison	  of	  invasive	  versus	  non-­‐invasive	  physiological	  measurements,	  CMR	  has	  been	  validated	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against	  FFR.	  These	  studies	  have	  also	  revealed	  overall	  good	  correlation	  between	  the	  two	   methods	   with	   CMR	   perfusion	   sensitivities	   ranging	   from	   88%-­‐92.9%	   and	  specificities	  from	  56.7%-­‐94%	  (44-­‐47).	  	  
2.5.2 Additional	  value	  from	  CMR	  imaging	  	  CMR	   is	   the	   gold	   standard	   for	   evaluation	   of	   LV	   volumes	   and	   function,	   which	   are	  routinely	   obtained	   during	   any	   CMR	   examination.	   CMR	   viability	   assessment	   is	  achieved	   using	   low	   dose	   dobutamine	   (functional	   response),	   late	   gadolinium	  enhancement	   (LGE)	   scar	   imaging	   (morphologic	   assessment	   of	   viability),	   or	   a	  combination	  of	   both	  methods.	   CMR	  examination	  of	  patients	  being	  worked-­‐up	   for	  coronary	   revascularisation	   frequently	   provides	   the	   clinician	   with	   other	   valuable	  data	  including	  prognostic	  information	  and	  even	  alternative	  diagnoses.	  High	  spatial	  resolution	  allows	  for	  analysis	  of	  the	  distribution	  of	  the	  scar	  within	  the	  myocardial	  wall	   and	   differentiation	   of	   ischemic	   from	   dilated	   cardiomyopathy	   (48,49).	   Such	  additional	  information	  obtained	  from	  CMR	  is	  clinically	  relevant	  as	  demonstrated	  in	  the	  Euro-­‐CMR	  registry	  pilot	  phase	   including	  11,040	  patients	   in	  Germany	   (50).	   In	  this	  registry	  a	  CMR	  examination	  including	  CAD	  or	  ischaemia	  assessment	  resulted	  in	  a	  new,	  previously	  unsuspected	  diagnosis	  in	  19.6%	  of	  patients.	  Furthermore	  patient	  management	  was	   influenced	   in	   >70%	  patients.	   In	   a	   different	   study	  CMR	   showed	  evidence	  of	  a	  previous	  MI	  detected	  by	  LGE	  in	  23%	  of	  patients	  with	  suspected	  CAD	  but	  no	  history	  or	  ECG	  evidence	  of	  prior	  MI	  (51).	  This	  has	  prognostic	  implications	  as	  the	   detection	   of	   even	   a	   very	   small	   amount	   of	   scar	   is	   associated	   with	   a	   >7-­‐fold	  increase	   in	   major	   adverse	   cardiovascular	   events.	   Finally,	   there	   are	   also	   data	   to	  suggest	   that	   scar	   detected	   by	   CMR	   is	   a	   stronger	   predictor	   of	   adverse	   clinical	  outcome	  than	  LV	  ejection	  fraction	  and	  volumes	  (52).	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2.5.3 The	  CMR	  examination	  The	  clinical	  CMR	  examination	  may	  include	  assessment	  of	  volumetry,	  wall-­‐motion,	  scar,	  and	  ischaemia	  in	  a	  standardised	  way	  according	  to	  internationally	  recognised	  guidelines	   published	   on	   behalf	   of	   the	   Society	   for	   Cardiovascular	   Magnetic	  Resonance	  (SCMR)	  (53).	  The	  examination	  can	  be	  tailored	  to	  the	  individual	  patient	  depending	  on	   the	  clinical	  question.	  The	  standard	  examination	   for	   ischaemia	  at	  St	  Thomas’	   Hospital	   includes	   left	   and	   right	   ventricular	   function	   and	   volumes,	   first	  pass	  perfusion	  imaging	  with	  adenosine	  stress	  followed	  by	  rest	  perfusion	  and	  LGE.	  When	   the	   main	   clinical	   question	   concerns	   viability	   low	   dose	   dobutamine	   stress	  testing	   is	   performed	   instead	   of	   perfusion	   imaging.	   A	   combination	   of	   perfusion	  imaging	  and	  low	  dose	  dobutamine	  stress	  testing	  is	  performed	  when	  ischaemia	  and	  viability	  are	  of	  particular	  relevance.	  	  CMR	  protocols	  that	  used	  in	  our	  institution	  are	  shown	  in	  Figure	  2.6.	  If	  clinically	  indicated	  high	  dose	  dobutamine	  can	  be	  used	  rather	  than	  first	  pass	  perfusion	  imaging.	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Figure	   2.6:	   The	   figure	   shows	   the	   cardiac	   magnetic	   resonance	   protocols	   used	   in	   our	  
institution	   (with	   images	   from	   different	   patients	   for	   illustrative	   purposes)	   to	   assess	  
ischaemia	   (A)	   or	   ischaemia	   and	   viability	   (B).	  DOBUT:	   dobutamine;	   SA:	   short	   axis;	   LA:	   long	  
axis.	  Adapted	  from	  (16)	  	  If	   clinically	   indicated	   CMR	   coronary	   angiography	   can	   also	   be	   performed	   and	   the	  technique	   has	   evolved	   over	   the	   years	   (54,55).	   However	   coronary	   artery	   imaging	  with	   CMR	   is	   still	   a	   cumbersome	   method	   with	   a	   higher	   failure	   rate,	   longer	   scan	  times	  and	  lower	  positive	  predictive	  value	  in	  comparison	  to	  CT.	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3.1 Summary	  Cardiovascular	   magnetic	   resonance	   (CMR)	   imaging	   enables	   accurate	   and	  reproducible	   assessment	   of	   perfusion	   at	   rest	   and	   stress.	   CMR	   perfusion	   is	  performed	   with	   a	   T1-­‐weighted	   dynamic	   real	   time	   sequence.	   Analysis	   can	   be	  performed	  qualitatively,	   semi-­‐quantitatively	   and	   fully	   quantitatively.	  Quantitative	  assessment	   of	   myocardial	   perfusion	   and	   perfusion	   reserve	   has	   the	   potential	   to	  facilitate	   diagnosis	   and	  management	   of	   patients	  with	   coronary	   artery	   disease	   by	  monitoring	   disease	   progression	   and	   quantifying	   the	   response	   to	   therapeutic	  interventions.	  Validation	  of	  quantitative	   techniques	   is	  most	  commonly	  performed	  in	   living	   pigs	   and	   dogs.	   There	   are	   however	   alternative	   platforms	   for	   validation	  purposes	  to	  achieve	  true	  validation.	  This	  chapter	  comprises	  the	  recent	  advances	  in	  image	   acquisition	   and	   quantitative	   image	   analysis	   with	   CMR	   and	   discusses	   the	  available	  animal	  platforms	  used	  in	  perfusion	  research.	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3.2 CMR	  perfusion	  imaging	  Significant	   technical	   and	   clinical	   advances	   have	   occurred	   in	   the	   field	   of	   CMR	  perfusion	   imaging	   in	   recent	   years.	   CMR	   perfusion	   imaging	   provides	   an	   accurate	  assessment	   of	   myocardial	   ischaemia	   without	   exposing	   the	   patient	   to	   ionizing	  radiation.	  It	  is	  increasingly	  accessible	  and	  offers	  sufficiently	  high	  spatial	  resolution	  to	   allow	   analysis	   of	   transmural	   differences	   in	   myocardial	   blood	   flow.	   CMR	  perfusion	   imaging	  makes	   use	   of	   T1-­‐sensitive	   imaging	   sequences	   during	   the	   first	  pass	  of	  a	  gadolinium-­‐based	  contrast	  agent	  bolus.	  T1-­‐weighting	  can	  be	  obtained	  by	  inversion	   recovery	   or	   saturation	   recovery,	   either	   non-­‐	   slice	   selective	   or	   slice-­‐selective	   (=notched	   pulse	   saturation).	   The	   main	   issue	   in	   the	   design	   of	   CMR	  perfusion	   sequences	   is	   the	   trade-­‐off	   between	   spatial	   and	   temporal	   resolution.	   A	  sufficient	   temporal	   and	   spatial	   resolution,	   which	   is	   required	   to	   image	   several	  cardiac	   slices,	   every	  or	  at	   least	  every	  other	  heartbeat,	   and	   to	  achieve	  an	   in-­‐plane	  resolution	  of	  2–3	  mm	  to	  separately	  visualize	  the	  endocardial	  and	  epicardial	  layers,	  can	  be	   obtained	  with	   a	   fast	   data	   readout	   by	  means	  of	   gradient	   echo	   (GRE),	   echo	  planar	   imaging	   (EPI)	   or	   steady	   state	   free	   precession	   (SSFP)	   techniques	   (56).	  Typically,	  three	  to	  five	  short-­‐axis	  slices	  of	  the	  heart	  are	  acquired	  over	  5–10	  s	  prior	  to	  the	  injection	  of	  the	  intravenous	  contrast	  bolus,	  and	  about	  60	  s	  after	  the	  injection	  of	   contrast.	   Imaging	   during	   pharmacological	   vasodilatation	   with	   adenosine	   or	  dipyridamole	   is	   routinely	   performed	   to	   improve	   differentiation	   of	   normal	   from	  stenotic	   perfusion	   beds.	   The	   diagnostic	   accuracy	   of	   the	   technique	   has	   been	  validated	  against	  competing	  non-­‐invasive	  and	  invasive	  modalities	   in	  single	  centre	  and	   increasingly	   in	   multicentre	   studies	   (32,37,42,43).	   In	   addition,	   increasing	  prognostic	  data	  on	  the	  value	  of	  stress	  perfusion	  MR	  has	  become	  available	  (24).	  As	  a	  result,	   stress	   perfusion	   CMR	   has	   evolved	   from	   a	   promising	   research	   tool	   to	   an	  everyday	  clinical	  test.	  The	  ability	  to	  detect	  global	  reductions	  in	  perfusion	  reserve,	  to	   assess	   serial	   changes	   in	   flow	   with	   improved	   precision,	   and	   to	   examine	  subendocardial	  flow	  can	  provide	  important	  insights	  into	  our	  understanding	  of	  the	  pathophysiology	  of	  myocardial	  disease	  and	  aid	  in	  the	  evaluation	  of	  novel	  therapies.	  CMR	  perfusion	  imaging	  can	  quantify	  the	  absolute	  myocardial	  blood	  flow	  (MBF)	  in	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millilitres/minute/gram.	   For	   this	   purpose	   the	   regional	   image	   contrast	  enhancement	   should	   ideally	   be	   proportional	   to	   the	   contrast	   agent	   concentration.	  Such	  an	  approximate	  linear	  relationship	  between	  regional	  signal	  intensity	  (SI)	  and	  contrast	   agent	   concentration	   is	   only	   observed	   at	   lower	   contrast	   agent	   doses	  (Figure	  3.1).	  	  
	  	  
Figure	  3.1	  O(x)	   demonstrates	   the	   relationship	  between	  blood	   signal	   intensity	   (SI)	   and	  Gd-­‐
DTPA	   concentration	   determined	   in	   human	   blood	   samples	   by	   using	   a	   saturation	   recovery	  
myocardial	   perfusion	  MR	   sequence	   (balanced	   TFE,	   TR=3.0	  ms,	   TE=1.5	  ms,	   ﬂip	   angle=	   40°,	  
saturation	   recovery	   time=	   200	   ms).	   N(x)	   shows	   the	   ideal,	   theoretical	   linear	   curve	   of	   the	  
blood	   SI	   vs.	   Gd-­‐DTPA	   concentration	   without	   saturation	   effects.	   	   The	   saturation	   effect	   is	  
observed	  when	   the	   Gd-­‐DTPA	   concentration	   exceeds	   0.67mmol/L.	  When	   using	   an	   injection	  
speed	  of	  4	  ml/s	  and	  a	  contrast	  agent	  concentration	  of	  0.05	  mmol/kg	  the	  peak	  LV	  gadolinium	  
concentration	  was	  previously	  estimated	   to	  be	  3.5±1.4	  mmol/L	   (57)	  and	   is	   indicated	   in	   the	  
graph	  by	  the	  grey	  line.	  	  Adapted	  from	  Ichihara	  et	  al.	  (58).	  	  	  	  Dosage	   regimes	   for	   gadolinium	   based	   extracellular	   contrast	   agents	   have	   varied	  between	  0.025	  and	  0.15	  moll/kg	  in	  different	  studies.	  Investigators	  have	  also	  used	  a	  dual-­‐bolus	   technique	   for	   first	   pass	   CMR	   perfusion	   rather	   than	   a	   single	   bolus	   in	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order	  to	  allow	  quantitative	  analysis	  of	  perfusion	  (59).	  This	  is	  performed	  by	  initially	  giving	  a	  very	  low	  dose	  bolus	  to	  generate	  an	  arterial	  input	  function	  (AIF)	  that	  is	  still	  in	  the	  linear	  contrast	  to	  signal	  range	  (Figure	  3.1),	  followed	  by	  a	  high	  dose	  bolus	  to	  maximize	  myocardial	  enhancement.	  The	  dual-­‐bolus	  technique	  has	  been	  developed	  to	  provide	  less	  distortion	  of	  the	  left	  ventricular	  cavity	  SI,	  thereby	  allowing	  accurate	  depiction	   of	   the	   AIF.	   Quantitative	   myocardial	   perfusion	   using	   a	   dual-­‐bolus	   first	  pass	  perfusion	  has	  been	  validated	  in	  animal	  models	  against	  microspheres,	  and	  has	  been	  shown	  to	  differentiate	  hyperaemic	  blood	  flow	  in	  healthy	  human	  subjects.	  As	  a	  part	   of	   this	   PhD	   thesis	   chapter	   4	   introduces	   a	   universal	   dual-­‐bolus	   acquisition	  scheme	   that	   can	   be	   easily	   implemented	   in	   clinical	   practice	   (Chapter	   4)	   and	   this	  approach	  was	  used	  for	  validation	  of	  different	  quantification	  strategies	  (Chapters	  6-­‐8).	  To	   derive	   quantitative	   indices	   related	   to	   the	   presence	   or	   absence	   of	   myocardial	  perfusion	   deficits,	   time-­‐SI	   curves	   must	   be	   evaluated	   for	   regions	   within	   the	  myocardium.	   Endocardial	   and	   epicardial	   contours	   can	   be	  manually	   traced	   in	   the	  images	  or	  copied	  to	  other	  frames	  after	  delineating	  the	  contours	  in	  one	  image	  using	  sophisticated	   motion	   correction	   algorithms.	   Subsequently,	   time-­‐SI	   curves	   for	  particular	   myocardial	   regions	   can	   be	   easily	   generated.	   These	   curves	   can	  theoretically	  be	  determined	  at	  a	  pixel	  level	  however	  the	  noise	  level	  in	  the	  images	  is	  not	  always	  sufficient	  to	  derive	  reliable	  perfusion	  indices	  at	  this	  level	  of	  detail.	  More	  typically	  4–6	  segments	  are	  defined	  for	  each	  imaging	  section	  following	  a	  recognized	  standard	  model	   from	   the	   American	  Heart	   Association	   (AHA)	   (60).	   The	   segments	  can	  then	  be	  further	  sub-­‐divided	  into	  an	  endocardial	  and	  an	  epicardial	  layer	  (8).	  	  
3.2.1 Qualitative	  and	  Semi-­‐quantitative	  analysis	  The	  detection	  of	  the	  functional	  significance	  of	  an	  anatomical	  lesion	  is	  important	  to	  diagnose	   and	   manage	   patients	   with	   significant	   CAD.	   The	   simplest	   method	   for	  interpreting	   CMR	   perfusion	   studies	   is	   to	   view	   the	   study	   in	   cine-­‐	   loop	   format	   for	  regions	  of	  relative	  hypoperfusion.	  This	  is	  the	  most	  common	  method	  used	  in	  clinical	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practice	   and	   both	   single	   and	   multicentre	   studies	   have	   validated	   the	   diagnostic	  accuracy	   of	   the	   visual	   assessment	   of	   stress	   perfusion	   data	   against	   invasive	  angiography	  (37).	  A	  number	  of	  semi-­‐quantitative	  parameters	  can	  also	  be	  obtained	  from	  the	  time-­‐SI	  curve	  that	  can	  be	  constructed	  by	  plotting	  the	  SI	  against	  the	  time	  from	   the	   dynamic	   perfusion	   images.	   These	   parameters	   include	   the	   maximal	   SI,	  contrast	   appearance	   time,	   time	   to	   maximal	   SI,	   area	   under	   the	   SI	   curve	   and	   the	  steepness	  of	  the	  SI	  curve’s	  upslope	  determined	  by	  a	  linear	  fit	  to	  the	  initial	  part	  of	  the	  curve.	  Of	   these	  parameters	   the	  upslope	  of	   the	  SI	   curve	  has	  been	  most	  widely	  adopted	  for	  semi-­‐quantitative	  analysis	  and	  has	  been	  shown	  to	  improve	  diagnostic	  accuracy	  over	  visual	  analysis	  alone	  (61).	  A	  recent	  meta-­‐analysis	  showed	  an	  overall	  sensitivity	   of	   91%	   and	   specificity	   of	   81%	   for	   CMR	   perfusion	   imaging	   using	  qualitative	   and	   semi-­‐quantitative	   analysis	   for	   the	   diagnosis	   of	   CAD,	   compared	   to	  quantitative	  coronary	  angiography	  (37).	  	  
3.2.2 Absolute	  perfusion	  quantification	  In	  order	  to	  accurately	  calculate	  absolute	  MBF	  using	  first-­‐pass	  myocardial	  perfusion	  MR	   imaging,	   it	   is	   essential	   to	   use	   models	   that	   fit	   the	   kinetics	   of	   the	   gadolinium	  contrast	  medium.	   	   Although	   a	   detailed	  mathematical	   description	   of	  model	   based	  flow	  measurement	   techniques	   is	   beyond	   the	   scope	   of	   this	   chapter,	   the	   essential	  components	  of	  important	  equations	  are	  cited	  to	  enhance	  the	  understanding	  of	  the	  key	   concepts	   behind	   each	   model.	   	   There	   are	   essentially	   two	   main	   methods	   for	  quantification	   of	   absolute	   MBF	   namely	   the	   linear	   time-­‐invariant	   model	   and	   the	  compartment	   model.	   	   Each	   model	   has	   its	   own	   set	   of	   assumptions	   to	   produce	  meaningful	  and	  valid	  estimations	  of	   flow.	  For	   the	  purposes	  of	   this	  PhD	  thesis	   the	  linear	   time-­‐invariant	  model	  was	   used	   for	   quantification	   and	   is	   introduced	   in	   the	  following	  paragraph.	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3.2.2.1 The	  linear	  time-­‐invariant	  model	  The	  contrast	  enhancement	  can	  be	  modelled	  by	  a	  linear	  time-­‐invariant	  system,	  and	  the	   myocardial	   impulse	   response,	   calculated	   by	   deconvolution	   of	   the	   measured	  tissue	  response	  with	  an	  arterial	   input.	   	  This	  myocardial	   impulse	  response	  gives	  a	  direct	  estimate	  of	  MBF	  (62).	   	  The	  only	  assumption	  in	  this	  model	  is	  that	  the	  tissue	  response	  is	  described	  by	  a	  linear,	  stationary	  system	  with	  a	  single	  input	  and	  a	  single	  output	   (62).	   	   The	   central	   volume	  principal,	   originally	   introduced	   by	   Zierler	   (63),	  establishes	  the	  relation	  between	  the	  tracer	  concentration	  in	  a	  tissue	  region,	  and	  the	  amount	   of	   tracer	   in	   the	   arterial	   input	   to	   the	   same	   tissue	   region	   (63,64).	   	   Briefly,	  regional	   MBF	   can	   theoretically	   be	   computed	   from	   the	   arterial	   input,	   Cin(t),	   and	  tissue	  output,	  Ctis(t),	  curves	  as	  follows:	  	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  [1]	  	  where	  *	  denotes	  the	  convolution	  product,	  h(t)	   is	  the	  transfer	  function,	  and	  R(t)	   is	  the	   residue	   function.	   For	   an	   idealized	   instantaneous	   unit	   bolus	   input,	   R(t)	  represents	   the	   fraction	  of	   contrast	  medium	  still	   remaining	   in	   the	   tissue	  at	   time	   t,	  defined	  	  as:	  	  
	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  [2]	  
	  By	  defining	  r(t)	  as:	  	  
	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  [3]	  	  
equation	   [3]	   represents	   that	   the	   initial	   amplitude	  of	   the	   impulse	   response	   equals	  MBF.	  	  	  
€ 
Ctis(t) = MBF ⋅Cin (t)∗ 1− h(t')dt'0
t









r(t) = MBF ⋅ R(t);
€ 
r(0) = MBF
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To	   obtain	   the	   myocardial	   impulse	   response,	   the	   input	   and	   output	   curves	   must	  undergo	   the	   reverse	   process	   of	   convolution.	   	  Equation	   [1]	   can	   be	   solved	   by	   two	  approaches:	   analytical	   (model-­‐dependent)	   techniques	   and	   algebraic	   (model-­‐independent)	   techniques	   (65).	   	   In	   analytical	   techniques,	   a	   specific	   analytical	  expression	  of	  the	  shape	  of	  r(t)	  is	  assumed.	  	  This	  approach	  is	  used	  in	  Fermi	  function	  (Figure	  3.2)	  and	  exponential	  models	  (65).	   	  The	  analytical	  expression	  of	  the	  Fermi	  function	  is:	  	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  [4]	  
	  where	   	  is	  the	  delay	  between	  the	  measured	  LV	  signal	  time	  course	  used	  for	  Cin(t)	  and	   the	   true	   arterial	   input	   curve	   to	   the	   region	   of	   interest	   being	   analyzed.	   	  characterizes	  the	  width	  of	  the	  shoulder	  of	  the	  Fermi	  function.	  	   ,	  a	  unit	  step	  function,	  equals	  0	  for	  t	  <	   	  and	  1	  for	  t	  > 	  (62).	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Figure	   3.2:	   The	   graphs	   illustrate	   use	   of	   Fermi	   function	   deconvolution	   to	   quantify	   absolute	  
MBF	  from	  scaled	  LV	  blood	  input	  function	  and	  myocardial	  output	  function.	  Left:	  	  The	  SI	  of	  the	  
LV	  cavity	  is	  corrected	  by	  the	  dual-­‐bolus	  technique.	  Right:	  Myocardial	  enhancement	  from	  the	  
main	   contrast	   bolus	   injection.	   Convolution	   ( )	   is	   a	   mathematical	   procedure	   that	   can	   be	  
used	   to	   describe	   how	   the	   input	   in	   a	   system	   changes	   into	   the	   output.	   	   The	   deconvolution	  
process	  extracts	   the	  myocardial	   transfer	   function	  by	   iteratively	   convolving	   the	  scaled	  SI	  of	  
the	   LV	   cavity	   by	   using	   a	   three-­‐parameter	   Fermi	   transfer	   function	   until	   the	   myocardial	  
enhancement	  can	  be	  predicted.	  Adapted	  from	  Christian	  et	  al.	  (66).	  	  In	   algebraic	   techniques,	   Equation	   [1]	   is	   solved	   by	   using	   a	   discrete	   form	   of	   the	  convolution	   equation.	   	   Model-­‐independent	   deconvolution	   (e.g.	   B-­‐spline)	   and	  autoregressive	   moving	   average	   modeling	   (ARMA)	   deconvolution	   both	   use	   this	  approach	  (65).	  	  Algebraic	  techniques	  build	  a	  transfer	  function	  from	  splines	  and	  use	  a	   sophisticated	  mathematical	   technique	   to	   produce	   a	  more	   intricate	   curve	  while	  not	  overfitting	  noise	  within	  the	  data	  (67,68).	  	  	  Of	   the	   various	   mathematical	   solution	   methods,	   Fermi	   function	   deconvolution	   is	  commonly	   used.	   	   However,	   this	   method	   potentially	   has	   important	   limitations.	  	  Firstly,	   the	   Fermi	   function	   cannot	   accommodate	   leakage	   of	   gadolinium	   contrast	  agent	  from	  the	  intravascular	  to	  the	  extravascular	  compartment	  because	  the	  Fermi	  function	   is	   the	   constrained	   impulse	   response	  originally	   introduced	   to	  distinguish	  
to complement the simple plots of linear
correlations.
RESULTS
The radial heart segments had a mean
size of 1.70 g ! 0.76 (standard deviation)
and were subdivided into endocardial
(0.79 g ! 0.36) and epi ardial (0.91 g !
0.43) regions.
The microsphere-measured blood flow
values for the occlusion, control, and
adenosine zones in each heart slice were
significantly different (P " .001) and are
summarized in the Table. The sample
sizes resulted in a power of greater than
0.90, with an # of .05 for all comparisons
in the Table, except those involving en-
docardial perfusion (power of 0.75). For
the control zones, endocardial flow was
significantly higher (P " .001) than epi-
cardial flow, with a 22% gradient be-
tween these areas. The pattern was re-
versed in segments in which hyperemia
was induced with intracoronary infusion
of adenosine: The flow rate in the epicar-
dial segments was 26% higher than that
in the endocardial segments (P " .001).
The occlusion segments showed no
transmural gradient in flow.
The effect of the 0.0025 mmol/kg bo-
lus of gadopentetate dimeglumine on
myocardial enhancement was minimal.
The mean degree of myocardial enhance-
ment over the baseline level generated
with the low-concentration bolus was an
absolute increase in signal intensity of 2
signal intensity units ! 2 (standard devi-
ation) for the control zones (P " .05 for
peak signal intensity vs baseline signal
intensity). In contrast, the mean degree
of myocardial enhancement over the
baseline level after the 0.10 mmol/kg bo-
lus was an absolute change in signal in-
tensity of 53 signal intensity units ! 12
(P " .001 for comparison with enhance-
ment generated by the low-concentra-
tion bolus).
MR Imaging Analysis of First-Pass
Perfusion
CER.—The correlation between CER
and microsphere-measured MBF is shown
in Figure 4, A. For ischemic to normal
perfusion, the overall linear correlation
was significant (r $ 0.75, P " .001) when
all segments were considered. However,
there was a relative plateau in the associ-
ation between these two variables at
blood flow greater than 1.0 mL/min/g.
Use of contrast enhancement measures
alone led to underestimated hyperemic
MBF values, as evidenced by the solid
line in Figure 4, A. Findings were similar
when epicardial and endocardial regions
were analyzed separately.
Myocardial-to-LV upslope index ratio.—
The mean upslope index ratio (Fig 4, B)
increased 1.7-fold between the control
and peak hyperemia segments, whereas
the mean transmural MBF increased
2.5-fold between these same segments
(Table). Although there was a significant
linear correlation between the micro-
sphere-measured blood flow and the
myocardial-to-LV upslope index ratio
(r $ 0.69 for all segments), the use of this
index also led to systematically underes-
timated MBF values, starting at mild hy-
peremic levels (Fig 4, B).
Upslope integral.—The upslope integral
(Fig 4, C) proved to be the most linear
semiquantitative index of MBF (r $ 0.89,
P " .001 for all segments). The plateau
effect during hyperemia was least severe
with use of this measure. The linearity
between microsphere-measured MBF and
this measure was preserved at blood flow
of up to 3 mL/min/g.




Measurement* MR Measurement* P Value†
Occlusion
Transmural 0.40 ! 0.37 (0.01–0.98) 0.40 ! 0.37 (0–1.04) NS
Endocardial 0.38 ! 0.39 (0.01–1.35) 0.40 ! 0.39 (0–1.38) NS
Epicardial 0.35 ! 0.30 (0.01–1.02) 0.41 ! 0.34 (0.08–1.26) NS
Control
Transmural 0.88 ! 0.30 (0.40–1.76) 0.99 ! 0.33 (0.43–1.91) ".001
Endocardial 0.97 ! 0.35 (0.40–1.96) 1.04 ! 0.37 (0.54–2.15) .07
Epicardial 0.79 ! 0.27 (0.38–1.57) 0.94 ! 0.36 (0.43–1.92) ".001
Adenosine Infusion
Transmural 2.34 ! 1.39 (0.59–5.06) 2.27 ! 1.42 (0.66–5.50) NS
Endocardial 2.07 ! 1.24 (0.45–4.59) 1.98 ! 1.33 (0.54–5.65) NS
Epicardial 2.60 ! 1.60 (0.60–5.72) 2.32 ! 1.56 (0.85–5.74) NS
* Data are mean MBF measurements (in milliliters per minute per gram) ! standard deviations.
Numbers in parentheses are measurement ranges.
† NS $ not significant (P ! .05).
Figure 3. Graphs illustrate use of Fermi function deconvolution to quantify perfusion at dual-
bolus MR imaging. Left: After the low-concentration bolus (F), the signal intensity of the LV
cavity is magnified by a factor of 40. After the high-concentrat on bolus (E), the signal int nsity
of the LV cavity is underestimated by a factor of approximately 10. Right: Resulting myocardial
enhancement after the high-concentration bolus (Œ). The LV andmyocardial curves are functions
of time. Convolution (R) is a mathematical procedure that can be used to describe how the input
in a system changes into the output, as described by the system’s transfer function. In the case of
perfusion, the transfer function characterizes the myocardial circulation that transforms the
delivery of contrast material into the LV cavity (input) into the observed myocardial enhance-
ment (output). Middle: The deconvolution process extracts the myocardial transfer function by
iteratively convolving the scaled signal intensity of the LV cavity resulting after the low-concen-
tration bolus by using a three-parameter Fermi transfer function until the myocardial enhance-
ment can be predicted.
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between	   the	   behavior	   of	   a	   diffusible	   and	   that	   of	   an	   intravascular	   contrast	   agent	  (65).	   	   Secondly,	   the	   model-­‐constrained	   approach	   is	   susceptible	   to	   the	   delay	   of	  myocardial	  contrast	  enhancement	  (68).	  	  If	  the	  AIF	  is	  measured	  up-­‐stream	  from	  the	  myocardial	  region	  of	  interest	  (ROI),	  then	  the	  myocardial	  response	  may	  be	  delayed,	  relative	   to	   the	   AIF.	   	   To	   accommodate	   this,	   the	   Fermi	   function	  model	   builds	   in	   a	  delay	  before	  its	  upstroke	  to	  allow	  for	  passage	  of	  the	  contrast	  from	  the	  left	  ventricle	  into	  the	  coronary	  arteries	  before	  the	  tissue	  enhancement.	   	  However,	   it	  only	  gives	  accurate	  blood	  flow	  estimates	  if	  the	  delay	  is	  estimated	  correctly.	   	  For	  the	  purpose	  of	  determining	  this	  delay	  time,	  model-­‐independent	  deconvolution	  has	  been	  found	  to	  be	  more	  reliable	  (69).	  	  Thus	  far	  the	  use	  of	  model-­‐independent	  deconvolution	  has	  not	   become	   widespread	   which	   is	   likely	   to	   be	   because	   of	   its	   mathematical	  complexity.	  	  The	  use	  of	  exponential	  model	  deconvolution	  and	  ARMA	  deconvolution	  are	  also	   limited	   in	   the	   literature	  on	  quantitative	  myocardial	  perfusion	  evaluation	  by	   CMR	   (65).	   However	   recently	   both	   have	   been	   used	   along	   with	   Fermi	  deconvolution	  for	  validation	  of	  voxel-­‐wise	  quantification	  in	  patients	  (70).	  	  	  
3.3 Clinical	  implications	  First-­‐pass	   myocardial	   perfusion	   has	   become	   a	   reliable	   tool	   for	   the	   diagnosis	   of	  myocardial	  ischaemia.	  Although	  myocardial	  perfusion	  images	  are	  usually	  evaluated	  by	   visual	   assessment	   (37)	   or	   by	   semi-­‐quantitative	   approaches	   (71),	   quantitative	  analysis	   and	   absolute	   quantification	   may	   permit	   a	   more	   accurate	   assessment	   of	  patients	  with	   heart	   disease,	   particularly	   those	  with	   three-­‐vessel	   coronary	   artery	  disease	   because	   perfusion	   is	   often	   globally	   reduced	   and	   qualitative	   or	   semi-­‐	  quantitative	  measures	  are	  inadequate	  (72).	  	  Quantitative	   myocardial	   perfusion	   CMR	   studies	   have	   provided	   insights	   into	   the	  pathophysiology	  of	  epicardial	  coronary	  artery	  disease,	  microvascular	  disease	  and	  cardiomyopathy.	  The	  benefits	  of	  absolute	  blood	  flow	  quantification	  with	  CMR	  may	  improve	   clinical	   diagnosis,	   serve	   as	   a	   follow-­‐up	   after	   therapeutical	   or	  pharmacological	  interventions	  and	  have	  important	  implications	  for	  cardiovascular	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research.	  In	   healthy	   volunteers	   MBF	   measurements	   with	   CMR	   have	   been	   found	   to	   be	   in	  agreement	  with	  published	  values	  based	  on	  invasive	  and	  non-­‐invasive	  methods,	  and	  the	  magnitude	   of	   flow	   heterogeneity	   is	   similar	   to	   that	   seen	   in	   positron	   emission	  tomography	   (PET)	   (73-­‐75).	   A	   significant	   correlation	   has	   been	   shown	   for	   both	  dipyridamole-­‐induced	   flow	   (r	  =	  0.70,	   P	  =	  0.001)	  and	  MPR	  (r	  =	  0.48,	  P	  =	  0.04)	  between	   CMR	   and	   PET	   in	   healthy	   volunteers	   (76).	   Recently	  we	   have	   studied	   41	  patients	   with	   known	   or	   suspected	   CAD	   and	   demonstrated	   good	   correlation	  between	   MPR	   derived	   from	   CMR	   and	   PET	   (r=0.75,	   P	   <0.0001)	   (77).	   However,	  absolute	  perfusion	  values	  from	  PET	  and	  CMR	  were	  only	  weakly	  correlated	  at	  rest	  (r=0.32;	   p=0.002)	   and	   during	   stress	   (r=0.37;	   p=<0.0001)	   indicating	   that	   further	  refinements	  and	  more	  validation	  work	  are	  still	  required.	  Absolute	  quantitative	  CMR	  perfusion	  has	  been	  recently	  used	  in	  a	  number	  of	  clinical	  studies	   in	   both	   patients	   with	   CAD	   and	   cardiomyopathy	   (44,46,78-­‐83).	   The	  myocardial	   perfusion	   reserve	   index,	   using	   quantitative	   CMR	   perfusion,	   has	   been	  shown	   to	   be	   reduced	   in	   the	   presence	   of	   early	   myonecrosis	   after	   percutaneous	  coronary	  intervention	  (PCI),	  using	  late	  gadolinium	  enhancement	  CMR	  (LGE)	  as	  the	  reference	   standard	   (81).	   In	   hibernating	   myocardial	   segments	   quantitative	   CMR	  perfusion	  measurements	  demonstrate	  reduced	  resting	  myocardial	  blood	  flow	  (82).	  Percutaneous	   treatment	   of	   chronic	   total	   coronary	   occlusions	   improves	   regional	  hyperaemic	   myocardial	   blood	   flow	   as	   measured	   by	   quantitative	   CMR	   perfusion	  imaging	   (78).	   The	   fractional	   flow	   reserve	   (FFR),	   determined	   using	   invasive	  intracoronary	   pressure	   wires,	   is	   considered	   to	   be	   a	   reliable	   stenosis-­‐specific	  method	   for	   determining	   hemodynamically	   significant	   CAD	   (30).	   Costa	   and	  colleagues	   studied	   37	   consecutive	   patients	   and	   demonstrated	   that	   a	   perfusion	  reserve	  cut-­‐off	  of	  2.04	  yields	  92.9%	  sensitivity	  and	  56.7%	  specificity	  for	  predicting	  a	   coronary	   segment	   with	   a	   FFR	   below	   0.75	   using	   standard	   methods	   (spatial	  resolution	   2-­‐	   3	   mm)	   (46).	   In	   a	   more	   recent	   study	   high	   resolution	   perfusion	  accelerated	  with	  k-­‐t	  SENSE	  at	  3	  Tesla	  was	  performed	  in	  42	  consecutive	  patients.	  A	  perfusion	  reserve	  cut-­‐off	  of	  1.58	  was	  demonstrated	  to	  be	  80%	  sensitive	  and	  89%	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specific	   in	   predicting	   a	   significant	   coronary	   lesion	   with	   a	   FFR	   below	   0.75	   (44).	  Quantitative	   perfusion	   CMR	   is	   thus	   potentially	   a	   safe	   non-­‐invasive	   test	   that	  represents	   a	   stenosis-­‐specific	   alternative	   for	   determining	   the	   hemodynamic	  significance	   of	   CAD.	   In	   hypertrophic	   cardiomyopathy	   (HCM),	   hyperaemic	   blood	  flow,	  as	  measured	  by	  quantitative	  CMR	  perfusion,	  has	  been	  shown	  to	  be	  reduced	  in	  proportion	   to	   the	  magnitude	   of	   the	   hypertrophy	   (80).	  Microvascular	   dysfunction	  and	  subsequent	  ischaemia	  may	  be	  important	  components	  of	  the	  risk	  attributable	  to	  HCM.	  Further	   studies	   are	   underway	   in	   the	   field	   of	   CMR	   perfusion	   imaging	   acquisition.	  Most	   contemporary	   pulse	   sequences	   do	   not	   achieve	   full	   heart	   coverage	   but	   can	  acquire	  at	  least	  three	  short-­‐axis	  slices	  every	  heart	  beat	  with	  an	  acquisition	  time	  of	  approximately	  150	  ms/slice	  and	  an	   in-­‐plane	  spatial	   resolution	  of	  2–3	  mm.	  Faster	  pulse	   sequences,	   new	   acceleration	   techniques	   (5,84),	   imaging	   at	   higher	   field	  strengths	  (85),	  usage	  of	  3	  dimensional	  perfusion	  acquisition	  sequences,	  and	  the	  use	  of	   intravascular	   contrast	   agents	   are	   under	   investigation	   with	   the	   potential	   to	  enable	   full	   heart	   coverage,	   greater	   spatial	   resolution	   and	   or	   increased	   signal-­‐to-­‐noise	  ratio.	  	  
3.4 Animal	  models	  to	  study	  perfusion	  There	   are	   several	   animal	   models	   available	   that	   have	   been	   widely	   used	   in	  cardiovascular	  research.	  The	  pig	  is	  particularly	  attractive	  as	  an	  experimental	  model	  because	  of	  the	  close	  resemblance	  between	  the	  anatomy	  of	  the	  pig	  and	  the	  human	  heart.	   Pigs	   were	   used	   to	   study	   cardiac	   energetics	   in	   stunned,	   hibernating	   and	  hypertrophied	   myocardium	   (86-­‐89).	   Graded	   ischaemia	   (90),	   ischaemic	  preconditioning	  (91)	  and	  the	  coronary	  microcirculation	  (92)	  have	  all	  been	  studied	  in	  different	  porcine	  models.	  Furthermore,	  different	  imaging	  applications	  have	  been	  used	   in	  pigs	  such	  as	  coloured	  microspheres	  to	  study	  coronary	  blood-­‐flow	  (93)	  or	  computer	   tomography	  (CT)	   to	  study	  microvascular	   function	  (94).	  This	  model	  has	  also	   been	   utilized	   for	   the	   validation	   of	   novel	   perfusion	   tracers	   for	   PET	   (95).	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Advances	  in	  magnetic	  resonance	  imaging	  such	  as	  novel	  MR	  contrast	  agents	  (96)	  or	  T2	   weighted	   sequences	   for	   the	   detection	   of	   oedematous	   tissue	   have	   also	   been	  validated	   in	   a	   similar	   fashion	   (97).	   Other	   applications	   include	   validation	   of	   MR-­‐guided	   real	   time	   coronary	   catheterization	   or	   percutaneous	   transluminal	   balloon	  angioplasty	  in	  aortic	  coarctation	  (98,99).	  	  In	  CMR	  perfusion	  research	  multiple	  animal	  models	  have	  been	  used	  to	   fill	   the	  gap	  between	  phantom	  experiments	  and	  volunteer	  and	  patient	  studies.	  While	  much	  of	  the	  sequence	  development	  work	   is	  either	  performed	  using	  numerical	  simulations	  or	   more	   recently	   a	   novel	   synthetic	   hardware	   phantom	   (72,100,101)	   many	  techniques	   need	   further	   validation	   in	   a	   more	   realistic	   scenario	   before	   being	  translated	   to	   patients.	   There	   are	   several	   animal	   models	   available	   to	   study	  myocardial	   perfusion.	   Dog	   hearts	   also	   closely	   resemble	   the	   human	   heart	   and	  therefore	  most	  of	  the	  studies	  have	  been	  performed	  in	  dogs	  or	  pigs	  to	  validate	  semi-­‐quantitative	   and	   true	   quantitative	   assessments	   of	   myocardial	   perfusion	  (7,59,66,68,102,103).	  These	  studies	  either	  used	  a	  low	  dose	  of	  Gd-­‐DTPA	  (68)	  or	  the	  dual-­‐bolus	   technique	   (59,66)	   and	   validated	   their	   results	   against	   perfusion	  measurements	  with	  microspheres,	   which	   provide	   a	   pathologic	   gold	   standard	   for	  regional	   tissue	   perfusion	   (104).	   These	   animal	   models	   allow	   realistic	   and	  physiological	   generation	   of	   the	   time-­‐SI	   curves	   and	   enable	   invasive	   procedures,	  such	  as	  microsphere	   injection,	   for	  validation	  of	   the	  results.	  However	  experiments	  performed	   in	  whole	  animals	   cannot	  precisely	   control	  MBF	  and	  usually	  validation	  studies	   do	   not	   provide	   data	   obtained	   at	   various	   flow	   rates.	   In	   order	   to	  maintain	  preparation	   stability,	   data	   is	   obtained	   at	   rest	   and	   with	   adenosine	   induced	  hyperaemia	  only	   (66,68).	  Furthermore,	   logistic	  considerations	  and	   the	  associated	  high	   costs	   limit	   their	   applicability.	   Makowski	   et	   al.	   have	   described	   a	   method	   of	  performing	   first-­‐pass	   MR	   perfusion	   imaging	   in	   rodents	   (105),	   using	   the	   k-­‐t	  principal	  component	  analysis	   technique	  (106)	  and	  a	  clinical	  3T	  MR	  scanner.	  This	  model	   also	   offers	   the	   possibility	   of	   microsphere	   validation	   (107)	   that	   has	   been	  previously	   established	   in	   echocardiography	   perfusion	   studies	   (108).	   To	   study	  perfusion	   in	   mice	   benefits	   from	   the	   variety	   of	   many	   different	   mouse	   models	   of	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cardiovascular	   disease	   including	   genetic	   modifications	   that	   can	   be	   investigated.	  However	  even	  though	  this	  model	  can	  be	  used	  in	  a	  clinical	  environment	  the	  direct	  translation	  of	  results	  from	  small	  animal	  experiments	  to	  patients	  is	  rarely	  possible.	  Therefore	   even	   considering	   there	   are	   fewer	   disease	   models	   compared	   to	   small	  animal	  models	   the	  more	  realistic	  situation	   in	  pigs	  or	  dogs	  compared	  with	  patient	  studies	   combined	   with	   a	   meaningful	   variety	   of	   different	   pathological	   scenarios	  make	  this	  model	  more	  suitable	  for	  validation	  work.	  Several	  studies	  have	  evaluated	  perfusion	  in	  instrumented	  animals	  to	  compare	  non-­‐invasive	  MBF	  by	  CMR	  with	  flow	  measured	  by	  injected	  microspheres,	  which	  provide	  a	  pathological	  gold	  standard	  for	  regional	  tissue	  perfusion	  (59,66,68,109).	  The	  overall	  correlation	  between	  CMR	  and	  microsphere	  MBF	  is	  good	  to	  excellent,	  with	  the	  correlation	  coefficient	  ranging	  from	  0.79	   to	   0.95	   over	   a	   wide	   range	   of	   myocardial	   blood	   flow.	   In	   addition,	   absolute	  perfusion	   correlated	  more	   closely	  with	  microsphere	   blood	   flow	   than	   established	  semi-­‐quantitative	   CMR	   indexes	   (59).	   Schmitt	   et	   al.	   demonstrated	   correlation	  between	   experimentally	   reduced	   coronary	   perfusion	  measured	  with	   quantitative	  CMR	   and	   fluorescent-­‐labelled	   microspheres	   (110).	   Similarly	   quantitative	  myocardial	   perfusion	   imaging	   was	   studied	   at	   1.5	   and	   3	   Tesla	   and	   related	   to	  fluorescent-­‐labelled	   microspheres	   (103).	   Recently	   Hsu	   and	   co-­‐workers	   elegantly	  used	  this	  model	  to	  introduce	  a	  novel	  pixel	  based	  quantitative	  myocardial	  perfusion	  mapping	  technique	  (111).	  	  Whereas	   the	   work	   in	   living	   animals	   represents	   the	   optimal	   physiological	  environment	   isolated	   heart	   models	   have	   also	   been	   studied	   extensively	   in	  cardiovascular	   research	   as	   they	   offer	   much	   greater	   control	   and	   reproducibility.	  Previous	   work	   has	   been	   performed	   in	   hearts	   from	   the	   abattoir	   (112,113)	   or	   in	  surgically	  explanted	  hearts	  (114).	  The	  pathophysiology	  of	  cardiac	  arrhythmias	  and	  electrical	  conduction	  of	  endocardial	  pacing	  were	  studied	  in	  Langendorff	  coronary	  perfused	   pig	   hearts	   (114,115).	   This	   perfusion	   mode	   essentially	   supplies	   the	  coronary	  artery	  with	  oxygenated	  whole	  blood	  or	  buffer	  without	  ventricular	  work-­‐load.	  Langendorff	  perfused	  hearts	  were	  also	  used	  to	  study	  right	  and	  left	  ventricular	  performance	   in	   neonatal	   hearts	   (116)	   and	   to	   compare	   different	   techniques	   of	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donor	   heart	   preservation	   (117).	   Furthermore	   preclinical	   high-­‐field	   Rubidium-­‐87	  MR	   spectroscopy	   imaging	   at	   7	   Tesla	   has	   been	   used	   to	   study	   ischaemia	   and	  infarction	  in	  coronary	  blood-­‐perfused	  pig	  hearts	  (118).	  	  The	   other	   potential	   perfusion	   mode	   is	   the	   so-­‐called	   working	   heart	   mode.	  Modersohn	  and	  co-­‐workers	  studied	  transmyocardial	  laser	  revascularisation	  in	  a	  2-­‐chamber	  (left	  atrium	  and	  left	  ventricle)	  working	  heart	  (119)	  whilst	  Chinchoy	  et	  al.	  studied	   cardiac	   physiology	   in	   a	   crystalloid	   solution	   perfused	   4-­‐chamber	  working	  heart	  (120).	  Intracardiac	  digital	  imaging	  of	  valvular	  motion	  (121)	  and	  fluorimetric	  evaluation	  of	  function	  (122)	  were	  also	  investigated	  under	  working	  conditions.	  The	  visible	   heart	   project	   used	   such	   an	   ex	   vivo	   working	   heart	   set-­‐up	   for	   endoscopic	  visualisation	  of	  trans-­‐catheter	  pulmonary	  valve	  implantation	  using	  high	  resolution	  cameras	   in	  a	  human	  donor	  heart	   that	  was	  not	   suitable	   for	   transplantation	   (123).	  This	   endoscopic	   imaging	   technique	   provides	   a	   true	   gold	   standard	   and	   training	  platform	   for	   new	   device	   development	   and	   implantation.	   A	   similar	   project,	   called	  the	   Physio	   Heart,	   was	   used	   for	   trans-­‐catheter	   aortic	   valve	   implantation	   in	  slaughterhouse	  pig	  hearts	   (124).	  This	   full-­‐working	  heart	   set-­‐up	  was	  described	  as	  very	   close	   to	   human	   physiology	   with	   excellent	   performance	   for	   up	   to	   4	   hours	  (125).	   Finally	   isolated	   non-­‐beating	   porcine	   hearts	   have	   been	   previously	  investigated	  by	  MR	  myocardial	  perfusion	  imaging	  to	  compare	  kinetics	  of	  different	  contrast	   agents	   and	   to	   investigate	   the	   microcirculation	   of	   transplant	   hearts	  (126,127).	  	  Interestingly	   such	   a	   non-­‐beating	   heart	   model	   was	   used	   to	   quantify	   myocardial	  perfusion	   at	   a	   pixel	   level	   (65)	   akin	   to	   what	   has	   subsequently	   been	   validated	   in	  living	  dogs	  and	  been	   translated	   to	  patients	   (70,111).	  Explanted	  heart	  work	  has	  a	  tremendous	   advantage	   for	   validation	   of	   novel	   perfusion	   techniques	   especially	  quantitative	  perfusion	  because	  of	   the	  ability	   to	  deliver	   the	  gadolinium	  during	   the	  first	   pass	   at	   a	   precisely	   controlled	  perfusion	   rate.	  However	   studying	  non-­‐beating	  and	  essentially	  electrically	  and	  functionally	  dead	  explanted	  pig	  hearts	  do	  not	  at	  all	  resemble	   physiological	   function	   and	   can	   be	   only	   used	   as	   tissue	   phantoms.	   To	  overcome	   this	   severe	   limitation	   we	   sought	   to	   develop	   a	   fully	   functioning	   MR	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compatible	   beating	   explanted	   blood	   perfused	   pig	   heart	   model	   that	   can	   be	  exquisitely	   controlled	   in	   terms	   of	   regional	   and	   global	   perfusion	   and	   should	  resemble	   cardiac	   in	   vivo	   physiology	   ex-­‐vivo.	   In	   parallel	   with	   our	   development	  Eggen	  and	  colleagues	  developed	  a	  system	  to	  study	  human	  hearts	   in	  a	  clinical	  MR	  scanner	  (128).	  They	  studied	  pacing	  induced	  electrical	  ventricular	  asynchrony	  using	  CMR	   in	   an	   isolated	   perfused	   human	   donor	   heart	   that	   was	   not	   suitable	   for	  transplantation.	  The	  purpose	  of	  this	  PhD	  thesis	  was	  to	  develop	  an	  isolated	  beating	  heart	  model	  for	  use	   in	   a	   clinical	   MR	   scanner	   and	   utilise	   controlled	   perfusion	   rates	   to	   allow	  quantitative	   perfusion	   validation.	   For	   such	  work	   it	   is	   important	   to	   consider	   that	  isolated	  heart	  models	  have	  several	  important	  advantages	  over	  other	  experimental	  designs,	   but	   also	   some	   limitations,	   which	   need	   to	   be	   considered.	   The	   main	  advantage	   is	   the	  precision	  of	   the	  model	  allowing	  accurate	  control	  of	  regional	  and	  global	   perfusion	   and	   oxygenation,	   as	  well	   as	   controlled	   nutrient	   delivery.	  Whole	  heart	   or	   regional	   ischaemia	   can	   easily	   be	   induced	   and	   adjusting	   perfusion	   can	  control	   the	  severity	  of	   ischaemia.	  The	  model	   is	  also	   free	   from	  external	   influences	  such	  as	  neuro-­‐humoral	  activation-­‐	  the	  effects	  of	  which	  are	  difficult	  to	  quantify.	   In	  addition	   in	  contrast	   to	   in	  vivo	  preparations	   the	   isolated	  heart	  preparation	  allows	  experiments	   to	   be	   continued	   after	   fatal	   events	   (e.g.	   infarction	   induced	   cardiac	  arrest	   or	   arrhythmias),	   which	   can	   frequently	   terminate	   an	   in	   vivo	   experiment.	  Additionally	   the	   isolated	  heart	  model	  can	  be	  studied	   in	  a	  clinical	  scanner	  and	  the	  results	   can	   be	   easily	   translated	   to	   patients.	   These	   factors	   facilitate	   the	  development,	   validation	   and	   translation	   of	   new	   MR	   methods	   in	   general	   and	  particularly	   perfusion	   methods	   as	   detailed	   in	   this	   PhD	   thesis.	   The	   fact	   that	  coronary	  blood	  flow	  can	  be	  precisely	   titrated	   is	  an	  advantage	  over	   intact	  animals	  where	   the	   coronary	   artery	   flow	   cannot	   be	   easily	   obtained	   or	   controlled.	  Furthermore,	   the	   AIF	   can	   be	   constructed	   from	   the	   SI	   in	   the	   vessel	   that	   directly	  supplies	  the	  coronary	  arteries	  and	  therefore	  the	  model	  is	  free	  from	  influences	  such	  as	   contrast	   dilution	   in	   the	   left	   ventricle	   or	   changes	   in	   heart	   rate.	   From	   that	  perspective	   it	   seems	   ideally	   suited	   for	   validation	   of	   quantitative	   perfusion	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especially	   as	   image	   quality	   is	   not	   distorted	   by	  motion	   because	   of	   the	   absence	   of	  breathing.	   Moreover	   the	   use	   of	   the	   Langendorff	   perfusion	   mode	   diminishes	   the	  effect	  of	  ventricular	  loading.	  However,	  using	  a	  Langendorff	  mode	  means	  that	  there	  will	  not	  be	  systolic	  or	  diastolic	  perfusion	  variation,	  which	  is	  an	  oversimplification	  of	   a	   real	   physiological	   scenario.	   Operating	   this	   experimental	   model	   in	   a	   clinical	  scanner	  is	  also	  associated	  with	  higher	  costs	  and	  requires	  considerable	  preparation	  times,	   and	   should	   thus	   be	   restricted	   to	   the	   validation	   of	   pre-­‐developed	  methodology.	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4.1 Summary	  The	  dual-­‐bolus	  protocol	  enables	  accurate	  quantification	  of	  myocardial	  blood	   flow	  by	   first-­‐pass	   myocardial	   perfusion	   cardiovascular	   magnetic	   resonance	   (CMR)	  imaging.	   	   However,	   despite	   the	   advantages	   and	   increasing	   demand	   for	   the	   dual-­‐bolus	   method,	   thus	   far,	   it	   has	   not	   been	   widely	   used	   in	   the	   field	   of	   quantitative	  perfusion	  CMR	  imaging.	  The	  main	  reasons	  for	  this	  are	  that	  the	  setup	  is	  complex	  and	  requires	   a	   state-­‐of-­‐the-­‐art	   injector	   and	   there	   is	   also	   a	   lack	   of	   post	   processing	  software.	   	  As	  a	  solution	  to	  one	  of	   these	  problems	  a	  universal	  dual-­‐bolus	   injection	  scheme	   for	   use	   in	   a	   clinical	   setting	   is	   introduced	   in	   this	   chapter.	   Multiple	  combinations	   of	   different	   contrast	   agents,	   contrast	   agent	   doses,	   power	   injectors,	  perfusion	   sequences,	   and	   magnetic	   resonance	   (MR)	   scanners	   were	   tested.	   This	  included	  3	  different	  contrast	  agents	   (Gd-­‐DO3A-­‐butrol,	  Gd-­‐DTPA	  and	  Gd-­‐DOTA),	  4	  different	  doses	  (0.025mmol/kg,	  0.05mmol/kg,	  0.075mmol/kg	  and	  0.1mmol/kg),	  2	  different	   types	   of	   injectors	   (with	   and	   without	   “pause”	   function),	   5	   different	  sequences	   (turbo	   field	   echo	   (TFE),	   balanced	   TFE,	   k-­‐space	   and	   time	   (k-­‐t)	  accelerated	   TFE,	   k-­‐t	   accelerated	   balanced	   TFE,	   turbo	   fast	   low-­‐angle	   shot)	   and	   3	  different	  MR	   scanners	   from	  2	   different	  manufacturers.	   The	   relation	   between	   the	  time	  width	  of	  dilute	  contrast	  agent	  bolus	  curve	  and	  cardiac	  output	  was	  obtained	  to	  determine	  the	  optimal	  predefined	  pause	  duration	  between	  dilute	  and	  neat	  contrast	  agent	   injection.	   One	   hundred	   and	   sixty	   one	   dual-­‐bolus	   perfusion	   scans	   were	  performed.	   Three	   non-­‐injector-­‐related	   technical	   errors	   were	   observed	   (1.9%).	  There	  were	  no	  injector-­‐related	  errors	  observed.	  Linear	  regression	  analysis	  showed	  that	  the	  optimal	  duration	  for	  the	  predefined	  pause	  is	  25s	  to	  separate	  the	  dilute	  and	  neat	   contrast	   agent	   bolus	   curves	   if	   0.1mmol/kg	   dose	   of	   Gd-­‐DO3A-­‐butrol	   is	   used.	  The	  dual-­‐bolus	  scheme	  worked	  well	  with	  all	  the	  combinations	  of	  parameters	  using	  the	  optimal	  predefined	  pause.	  	  	  The	  methods	  described	  in	  this	  chapter	  do	  not	  require	  one	  of	  the	  latest	  double-­‐head	  power	   injectors	   to	   obtain	   reasonable	   arterial	   input	   function	   curves	   for	   absolute	  myocardial	  blood	  flow	  quantification.	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4.2 Introduction	  Quantitative	   analysis	   of	   first-­‐pass	   myocardial	   perfusion	   cardiovascular	   magnetic	  resonance	  (CMR)	  images	  allows	  the	  expression	  of	  myocardial	  blood	  flow	  (MBF)	  in	  units	   of	   ml/min/g	   and	   may	   permit	   an	   accurate,	   objective	   assessment	   of	   altered	  myocardial	   perfusion	   in	   patients	  with	   heart	   disease	   (58,62,68).	   Quantification	   of	  MBF	   with	   CMR	   relies	   on	   a	   linear	   relationship	   between	   signal	   intensity	   (SI)	   and	  gadolinium	   concentration.	   However,	   it	   is	   well	   known	   that	   with	   gadolinium	  concentrations	   currently	   in	   use	   for	   first-­‐pass	   perfusion	   imaging,	   T1-­‐saturation	  effects	   can	   cause	   substantial	   signal	   attenuation	   predominantly	   in	   the	   left	  ventricular	   (LV)	   cavity	   where	   the	   SI-­‐time	   curve	   usually	   represents	   the	   arterial	  input	  function	  (AIF)	  (57,58).	   	  To	  preserve	  an	  accurate	  AIF,	  previous	  studies	  using	  quantitative	  measures	  have	   focused	  on	   low	  doses	   (0.025mmol/kg-­‐0.05mmol/kg)	  of	   contrast	   agent	   (CA)	   in	   combination	   with	   strongly	   T1	   weighted	   sequences	  (62,129).	  Low-­‐dose	   techniques	  are	  applied	   for	  precise	  and	   reproducible	  absolute	  quantification	  of	  cardiac	  perfusion	  (62,129).	  	  However,	  this	  approach	  is	  limited	  by	  a	   low	  contrast	   to	  noise	  ratio	  (CNR)	   in	   the	  myocardial	   tissue	  as	  a	  result	  of	   limited	  myocardial	  enhancement.	  	  	  To	   overcome	   the	   limitation	   of	   T1-­‐induced	   signal	   saturation	   in	   the	   LV	  blood	  pool	  and	   low	   CNR	   in	   the	   myocardial	   tissue,	   dual-­‐bolus	   methods	   were	   introduced	   to	  allow	  the	  use	  of	  a	  high	  gadolinium	  concentration	  bolus	  for	  myocardial	  analysis,	  and	  a	   lower	   gadolinium	   concentration	   bolus	   to	  maintain	   the	   linearity	   of	   the	   LV	   SI	   to	  enable	  quantification	  of	  MBF	  (59,66,75,130,131).	  These	  techniques	  use	  a	  low	  dose	  of	  dilute	  contrast	  agent	  as	  a	  prebolus	  before	  the	  main	  bolus	  of	  neat	  contrast	  agent.	  Clinically	  it	  is	  important	  to	  consider	  that:	  1) Both	  the	  main-­‐bolus	  of	  neat	  gadolinium	  CA,	  and	  the	  pre-­‐bolus	  of	  diluted	   gadolinium	   CA	   solution,	   should	   be	   of	   equal	   volume	   and	  administered	  at	  the	  same	  flow	  rate	  (66,75).	  2) Each	   bolus	   should	   be	   equal	   in	   volume	   and	   administered	   at	   the	  same	   injection	   speed	   followed	   by	   a	   saline	   flush	   to	   maintain	   a	  compact	  CA	  bolus	  in	  the	  LV	  chamber	  (59,66,75,130).	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3) The	   time	   delay	   between	   each	   bolus	   should	   be	   controllable	   to	  minimize	   temporal	   overlap	   and	   this	   delay	   should	   be	   adjustable	  related	  to	  heart	  rate	  or	  cardiac	  output	  if	  required	  (59,66,75).	  4) The	   system	   should	  be	   easy	   to	   set	   up	   and	   the	  procedure	   easy	   to	  perform	  and	  repeat	  within	  a	  routine	  clinical	  scan.	  Because	   of	   the	   complexity	   of	   the	   aforementioned	   points,	   thus	   far,	   the	   dual-­‐bolus	  method	  has	  not	  been	  widely	  adopted	   in	  clinical	   routine.	  This	  chapter	  describes	  a	  dual-­‐bolus	  method	  that	  is	  independent	  of	  the	  local	  set-­‐up	  in	  a	  given	  CMR	  unit	  and	  less	  complex	  to	  adopt	  in	  clinical	  practice.	  	  	  
4.3 Methods	  
	  
4.3.1 Set-­‐up	  of	  the	  universal	  dual-­‐bolus	  injection	  scheme	  The	  set-­‐up	  of	  the	  universal	  dual-­‐bolus	  injection	  scheme	  is	  described	  as	  a	  step-­‐by-­‐step	  protocol	  as	  follows:	  
4.3.1.1 For	  injectors	  with	  a	  programmable	  “pause”	  functionality	  Step1	  (Preparation	  of	  gadolinium	  CA)	  (Figure	  4.1	  A)	  1. Draw	  1	  ml	  of	  gadolinium	  CA	  into	  a	  10	  ml	  syringe	  (syringe	  1)	  and	  dilute	  it	  to	  a	  10%	  solution	  by	  adding	  9	  ml	  of	  saline.	  Repeat	  this	  process	  for	  syringe	  2.	  2. Adjust	   the	  volume	  of	  syringe	  1	  and	  syringe	  2	  according	  to	  the	  weight	  of	   the	  patient	   i.e.	   if	   a	  60	  kg	  patient	  needs	  6	  ml	  of	  1.0	  mol/L	  gadolinium	  CA	   then	  discard	  4	  ml	  of	  CA	  from	  10	  ml	  syringe	  	  (syringe	  1	  and	  2	  therefore	  consist	  of	  10%	  dilute	  gadolinium	  CA).	  3. Draw	   the	   same	   volume	   of	   neat	   gadolinium	   CA	   into	   two	   additional	   10ml	  syringes	  (syringe	  3	  and	  4	  therefore	  consist	  of	  neat	  gadolinium	  CA).	  Note:	  These	   two	  pairs	  of	   syringes	  containing	  10%-­‐dilute	  and	  neat	  gadolinium	  CA	  are	  used	  for	  the	  stress	  and	  rest	  bolus	  injection	  respectively.	  	  It	  is	  possible	  to	  substitute	   larger	  or	  smaller	  syringes	  adapted	   to	   the	  dose	  of	  contrast	  medium.	  All	  syringes	  should	  be	  carefully	  labelled.	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  Figure	  4.1	  Preparation	  of	  the	  dual-­‐bolus	  injection	  scheme	  for	  injectors	  with	  programmable	  
“pause”	  functionality	  is	  illustrated.	  Please	  see	  the	  text	  for	  details.	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Step	  2	  (Preparation	  of	  injector	  and	  tubing)	  (Figure	  4.1	  B	  and	  4.2	  A)	  1. Fill	  both	  the	  first	  (A)	  and	  second	  (B)	  power	  injector	  syringes	  with	  at	  least	  60	  ml	  of	  saline.	  	  2. Connect	  the	  Y-­‐shaped	  long	  tube	  to	  injector	  syringes	  as	  per	  the	  manufacturer’s	  instructions.	  3. Connect	  a	  three-­‐way	  stopcock	  (stopcock	  A)	  to	  the	  distal	  end	  of	  the	  Y-­‐shaped	  long	  tube.	  4. Connect	  a	  high-­‐pressure	  extension	  tube	  with	  15	  ml	  volume	  to	  stopcock	  A.	  5. Flush	  these	  tubes	  with	  saline	  6. Connect	   the	   distal	   end	   of	   the	   high-­‐pressure	   extension	   tubes	   to	   a	   venous	  cannula	  in	  the	  patient’s	  antecubital	  vein.	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Figure	  4.2	  The	  dual-­‐head	  power	   injector	  and	  tubing	  set-­‐up	  for	  a	  CMR	  perfusion	  scan	  in	  the	  
case	   of	   a	   dual-­‐head	   power	   injector	   with	   and	   without	   a	   “pause”	   function	   (A	   and	   B	  
respectively).	  	  Please	  see	  the	  text	  for	  details.	  	  Step	  3	  (Programming	  the	  dual-­‐head	  power	  injector)	  (Figure	  4.3	  A).	  1. Injector	  A	  (first	  phase):	  Set	  the	  flow	  rate	  to	  4	  ml/s	  and	  the	  volume	  of	  saline	  flush	  to	  25	  ml).	  2. Injector	  A	  (second	  phase):	  To	  program	  the	  delay	  time	  between	  the	  pre-­‐bolus	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and	  the	  main-­‐bolus,	  use	  the	  “pause”	  phase	  and	  set	  the	  desired	  time	  delay.	  	  3. Injector	  B:	  Use	  the	  same	  flow	  rate	  and	  injection	  volume	  used	  for	  injector	  A.	  	  
	  
Figure	  4.3	  Programmed	  injector	  control	  in	  the	  case	  of	  the	  dual-­‐head	  power	  injector	  with	  (A)	  
and	  without	  (B)	  a	  “pause”	  function.	  	  Please	  see	  the	  text	  for	  details.	  	  Step	  4	  (Loading	  the	  gadolinium	  CA	  and	  dual-­‐bolus	  injection)	  1. 	  	  Connect	   the	   10	  ml	   syringe	   containing	   dilute	   CA	   (syringe	   1)	   to	   stopcock	   A	  without	  injecting	  the	  CA	  (Figure	  4.1	  B).	  2. 	  	  Once	  the	  set	  up	  for	  the	  perfusion	  scan	  is	  ready,	  arm	  the	  injector.	  3. 	  	  Just	   prior	   to	   the	   power	   injection	   turn	   stopcock	   A	   and	  manually	   inject	   the	  entire	  volume	  of	  dilute	  CA	  (syringe	  1)	  into	  the	  high-­‐pressure	  extension	  tube	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(Figure	  4.1	  C).	  	  4. 	  	  Disconnect	   the	   syringe	   1	   (dilute	   CA)	   and	   connect	   the	   10	   ml	   syringe	  containing	   neat	   CA	   (syringe	   3)	   to	   stopcock	   A	   without	   injecting	   the	   CA	  (Figure	  4.1	  E).	  5. 	  	  Start	  the	  perfusion	  scan	  and	  the	  power	  injection	  at	  the	  same	  time.	  6. 	  	  During	  the	  delay	  time,	  turn	  stopcock	  A	  and	  manually	  inject	  the	  entire	  volume	  of	   neat	   CA	   from	   the	   syringe	   3	   (neat	   CA)	   into	   the	   high-­‐pressure	   extension	  tube.	  	  7. 	  	  After	   the	   programmed	   delay,	   injection	   B	   (saline)	   starts.	   This	   allows	   the	  contrast	  agent	  to	  be	  flushed	  out	  of	  the	  extension	  tube	  and	  into	  the	  patient’s	  vein.	  	  
4.3.1.2 For	  injectors	  without	  programmable	  “pause”	  functionality	  (Figure	  4.1,	  4.2,	  4.3,	  4.4)	  Step1	  (Preparation	  of	  gadolinium	  CA)	  (Figure	  4.1	  A)	  1.-­‐3.	  All	  steps	  as	  described	  above.	  	  Step	  2	  (Preparation	  of	  injector	  and	  tubing)	  (Figure	  4.2	  B	  and	  4.4	  A)	  1. Fill	  both	   the	   first	   (A)	  and	  second	  (B)	  power	   injector	  syringes	  with	  at	   least	  60ml	  of	  saline.	  	  2. Connect	   a	   three-­‐way	   stopcock	   (stopcock	   B)	   to	   the	   tip	   of	   syringe	   A.	   	   This	  enables	   the	  attachment	  of	   a	   syringe	   to	  act	   as	  a	   release	  mechanism	   for	   the	  additional	  saline	   injection,	  which	   is	  programmed	  to	  allow	  a	  delay	  between	  dilute	  and	  neat	  CA.	  	  Connect	  the	  empty	  10ml	  syringe	  to	  stopcock	  B	  (Figure	  4.2	  B	  and	  4.4	  A).	  	  Connect	  one	  arm	  of	  the	  Y-­‐shaped	  long	  tube	  to	  stopcock	  B	  and	  the	  other	  arm	  of	  it	  to	  the	  tip	  of	  syringe	  B.	  	  	  3.-­‐6.	  	  Follow	  these	  steps	  as	  described	  above.	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Figure	   4.4	   Preparation	   of	   the	   dual-­‐bolus	   injection	   scheme	   for	   injectors	   without	  
programmable	  “pause”	  functionality	  is	  illustrated.	  	  Please	  see	  the	  text	  for	  details.	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Step	  3	  (Programming	  the	  dual-­‐head	  power	  injector)	  (Figure	  4.3	  B).	  1. Injector	  A	  (first	  phase):	  Set	  the	  flow	  rate	  to	  4	  ml/s	  and	  the	  volume	  of	  saline	  flush	  to	  25	  ml).	  2. Injector	  A	  (second	  phase):	  As	  this	  injector	  does	  not	  have	  a	  “pause”	  function,	  we	  need	  to	  set	   the	   flow	  rate	  and	  volume	  of	   the	  saline	   injection,	  which	  will	  allow	  a	  specific	  time	  delay.	  For	  example,	  for	  a	  10	  seconds	  delay,	  1ml	  volume	  at	  0.1	  ml/s,	  for	  a	  15	  seconds	  delay,	  3	  ml	  volume	  at	  0.2	  ml/s,	  for	  a	  20	  seconds	  delay,	  2	  ml	  volume	  at	  0.1	  ml/s	  etc.	  	  This	  additional	  saline	  will	  then	  be	  taken	  up	   into	   the	   “release”	   syringe,	   thereby	  ensuring	   that	   there	   is	  no	  dilution	  of	  contrast	   agent,	   which	   will	   be	   injected	   into	   the	   extension	   tube	   during	   the	  delay.	  	  3. Injector	  B:	  Use	  the	  same	  flow	  rate	  and	  injection	  volume	  used	  for	  injector	  A.	  	  Step	  4	  (Loading	  the	  gadolinium	  CA	  and	  dual-­‐bolus	  injection)	  1.	  -­‐6.	  These	  steps	  are	  performed	  as	  described	  above	  (Figure	  4.4	  B	  and	  4.4	  C).	  7.	  	   Just	   after	   injection	   A	   is	   completed,	   turn	   stopcock	   B	   to	   the	   empty	   10	   ml	  syringe	  in	  order	  to	  collect	  the	  volume	  injected	  to	  define	  the	  pause	  (step	  3.2).	  	  (Figure	  4.4	  D).	  8.	  -­‐9.	  These	  steps	  are	  performed	  as	  described	  above	  (Figure	  4.4	  E	  and	  4.4	  F).	  	  During	  dynamic	  MR	  image	  acquisition	  the	  patient	  is	  instructed	  to	  breath	  gently	  as	  the	  first	  bolus	  is	  delivered	  via	  the	  power	  injector	  and	  during	  the	  pause.	  The	  patient	  is	  subsequently	  instructed	  to	  hold	  their	  breath	  whilst	  the	  main	  bolus	  is	  delivered.	  	  Consequently	   each	   CA	   bolus,	   of	   equal	   volume,	   is	   delivered	   to	   the	   patient	   at	   the	  same	   flow	   rate	   with	   a	   pre-­‐programmed	   temporal	   delay	   between	   the	   dilute	   and	  neat	  bolus.	  A	  second	  dual-­‐bolus	  perfusion	  CMR	  image	  acquisition	  can	  be	  performed	  by	  repeating	  step	  3	  and	  step	  4.	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4.3.1.3 Weight-­‐adjusted	  dose	  of	  contrast	  agent	  The	  volume	  of	  CA	  required	  for	  this	  method	  depends	  on	  which	  particular	  CA	  is	  used	  (0.5	  mol/L	  or	  1.0	  mol/L)	  and	  on	  the	  desired	  dose	  of	  gadolinium	  CA.	   	  The	  dose	  of	  the	  gadolinium	  CA	  is	  adjusted	  to	  the	  patient’s	  weight.	  	  The	  current	  injection	  scheme	  has	   been	  developed	   for	   a	   0.1	  mmol/kg	  dose	   of	  Gd-­‐DO3A-­‐butrol	   (Gadovist,	   Bayer	  Healthcare,	   Leverkusen,	   Germany)	   (1.0	   mol/L).	   	   In	   this	   setting,	   the	   volume	   of	  gadolinium	   CA	   required	   is	   less	   than	   10	   ml	   for	   an	   average-­‐sized	   individual.	  Therefore,	  10	  ml	  small	  syringes	  and	  15	  ml	  extension	  tubes	  are	  used	  for	  the	  set-­‐up	  described	  in	  this	  chapter.	  	  However,	  with	  minor	  modifications	  (e.g.	  using	  shorter	  or	  longer	  extension	  tubes	  and	  smaller	  or	  larger	  syringes),	  this	  scheme	  can	  be	  applied	  to	  any	  type	  and	  dose	  of	  commonly	  used	  commercially	  available	  gadolinium	  CA.	  	  
4.3.1.4 Validation	  studies	  Adenosine	  stress	  and/or	  rest	  dual-­‐bolus	  perfusion	  CMR	  were	  performed	  mainly	  in	  patients	   with	   known	   or	   suspected	   coronary	   artery	   disease	   using	   the	   universal	  dual-­‐bolus	   injection	   scheme.	   For	   perfusion	   CMR	   imaging,	   three	   short	   axis	   slices	  were	  acquired	  every	  heart	  beat	  for	  a	  period	  lasting	  70	  heartbeats	  using	  one	  of	  the	  following	  non-­‐slice-­‐selective	  saturation-­‐recovery	  perfusion	  sequences;	   turbo	   field	  echo	  (TFE)	  /	  turbo	  fast	   low-­‐angle	  shot	  (TurboFLASH),	  balanced	  TFE,	  k-­‐space	  and	  time	  (k-­‐t)	  accelerated	  TFE	  and	  k-­‐t	  accelerated	  balanced	  TFE	  (Table	  4.1).	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Sequences	   Vendor	   Magnetic	  field	  strength	  
Delay	   between	   the	  saturation	   pulse	   and	  the	  centre	  of	  k-­‐space	  
TR	  (ms)	   TE	  (ms)	   FA	  (˚)	  
TFE	   Philips	   3.0	   105	   3.6	   1.7	   18	  k-­‐t	   accelerated	  	  TFE	   Philips	   3.0	   110	   2.7	   0.9	   20	  TFE	   Philips	   1.5	   100	   3.8	   1.8	   18	  b-­‐TFE	   Philips	   1.5	   100	   2.5	   1.2	   50	  k-­‐t	   accelerated	  b-­‐TFE	   Philips	   1.5	   100	   2.9	   1.5	   50	  TurboFLASH	   SIEMENS	   1.5	   255	   156	   1.13	   12	  
	  
Table	  4.1	  Scan	  parameters	  of	  the	  saturation-­‐recovery	  perfusion	  CMR	  sequences.	  	  
(TR=	  repetition	  time,	  TE=	  echo	  time,	  FA=	  flip	  angle,	  TFE=	  turbo	  field	  echo,	  b-­‐TFE=	  balanced	  
TFE,	  k-­‐t=	  k-­‐space	  and	  time,	  TurboFLASH=	  turbo	  fast	  low-­‐angle	  shot).	  	  In	   addition	   to	   these	   4	   different	   sequences,	   three	   different	   contrast	   agents	   (Gd-­‐DO3A-­‐butrol	   (Gadovist®,	   1mol/L,	   Bayer	   Healthcare,	   Leverkusen,	   Germany),	   Gd-­‐DTPA	   (Magnevist®,	   0.5mol/L,	   Bayer	   Healthcare,	   Leverkusen,	   Germany)	   and	   Gd-­‐DOTA	   (Dotarem®,	   0.5mol/L,	   Laboratoire	   Guerbet,	   France),	   4	   different	   doses	  (0.025mmol/kg,	  0.05mmol/kg,	  0.075mmol/kg,	  0.1mmol/kg),	  2	  different	   injectors	  (with	   and	   without	   “pause”	   function;	   Spectris®	   and	   Spectris	   Solaris®	   EP,	  respectively;	   MEDRAD,	   INC.,	   USA)	   and	   3	   different	   MR	   scanners	   from	   2	   different	  manufacturers	   (Philips	   Achieva	   and	   Intera;	   Siemens	   Avanto)	   were	   tested	   (Table	  4.2).	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   Gd-­‐DO3A-­‐butrol	  1.0mol/L	   Philips	  3.0T	  Dose	  (mmol/kg)	   TFE	   k-­‐t	  accelerated	  TFE	  0.025	   28	  (14)	   -­‐	  0.075	   -­‐	   1	  (1)	  0.1	   -­‐	   4	  (2)	  	  Gd-­‐DO3A-­‐butrol	  1.0mol/L	   Philips	  1.5T	  Dose	  (mmol/kg)	   TFE	   b-­‐TFE	   k-­‐t	  accelerated	  b-­‐TFE	  0.025	   4	  (2)	   -­‐	   -­‐	  0.075	   2	  (2)	   -­‐	   19	  (11)	  0.1	   -­‐	   -­‐	   37	  (19)	  0.1	   -­‐	   2	  (2)	   33	  (18)	  	  Gd-­‐DO3A-­‐butrol	  1.0mol/L	   SIEMENS	  1.5T	  Dose	  (mmol/kg)	   TurboFLASH	  0.05	   6	  (3)	  0.075	   3	  (2)	  	   Gd-­‐DTPA	  0.5mol/L	   Philips	  1.5T	  Dose	  (mmol/kg)	   b-­‐TFE	  0.05	   10	  (5)	  	   Gd-­‐DOTA	  0.5mol/L	   Philips	  1.5T	  Dose	  (mmol/kg)	   b-­‐TFE	  	  0.1	   12	  (6)	  	  
Table	   4.2	   Number	   of	   dual-­‐bolus	   perfusion	   scans	   (patients)	   in	   which	   different	   kinds	   and	  
doses	  of	  gadolinium	  CA,	  vendors	  and	  perfusion	  sequences	  were	  used.	  (TFE=	  turbo	  field	  echo,	  
b-­‐TFE=	  balanced	  TFE,	  k-­‐t=	  k-­‐space	  and	  time,	  TurboFLASH=	  turbo	  fast	  low-­‐angle	  shot).	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Dilution	  of	  the	  gadolinium	  CA	  was	  performed	  by	  a	  physician	  at	  each	  CMR	  session.	  The	  preparation	  time	  for	  the	  dual-­‐bolus	  set-­‐up	  and	  the	  heart	  rate	  at	  rest	  and	  during	  adenosine	   stress	   were	   recorded.	   Stroke	   volume	   (SV)	   and	   ejection	   fraction	   (EF)	  were	  determined	  from	  standard	  short-­‐axis	  cine	  MR	  images	  covering	  the	  entire	  left	  ventricle	   using	   a	   balanced	   steady	   state	   free	   precession	   (b-­‐SSFP)	   sequence	   (132).	  	  Cardiac	   output	   at	   rest	   and	   during	   stress	   was	   calculated	   as	   the	   stroke	   volume	  multiplied	  by	  the	  heart	  rate	  at	  rest	  and	  during	  stress	  respectively.	  To	   test	   the	   feasibility	  of	   the	  dual-­‐bolus	  set-­‐up,	  we	  sent	  a	  description	  of	   this	  dual-­‐bolus	   method	   (i.e.	   the	   subsection	   entitled	   	   “Set-­‐up	   for	   the	   universal	   dual-­‐bolus	  injection	   scheme”	   in	   this	   chapter)	   to	   3	   different	   sites	   in	   different	   countries	   and	  asked	   them	  to	  perform	  perfusion	  scans	   in	  5	  patients	  using	   these	  methods	  with	  a	  predefined	  pause	  of	  25	  seconds.	  
	  
	  
4.3.2 Data	  analysis	  Adenosine	   stress	   and	   rest	   perfusion	   CMR	   images	  were	   analysed	   using	   dedicated	  software	   (CMR	   42;	   Circle	   Cardiovascular	   Imaging	   Suite	   12,	   Calgary,	   Alberta,	  Canada).	   	   On	   a	   representative	   image	   from	   the	   dynamic	   series,	   an	   observer	  manually	  placed	  a	  circular	  region	  of	  interest	  (ROI)	  in	  the	  LV	  blood	  pool	  depicted	  on	  a	  basal	  slice	   to	  obtain	  the	  time-­‐SI	  plot	  of	   the	  arterial	   input	   function.	  The	  ROI	  was	  then	   copied	   to	   the	   other	   dynamic	   images	   of	   the	   same	   slice,	   the	   positions	   were	  reviewed	   and	   manually	   adjusted	   to	   correct	   for	   respiratory	   motion	   during	   data	  acquisition	   if	   required.	   	   In	   the	   time-­‐SI	   plot	   (Figure	   4.5),	  we	   defined	   several	   time	  points	  of	  interest	  on	  the	  arterial	  input	  function	  curve.	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Figure	  4.5	  The	  figure	  shows	  the	  time-­‐signal	   intensity	  (SI)	  plot	  of	  the	  arterial	   input	  function	  
(AIF)	   curve	   and	   indicates	   several	   time	   frames	   of	   interest:	   dilute	   start	   frame	   (T	   dilute	   start),	  
dilute	  peak	  frame	  (T	  dilute	  peak),	  dilute	  end	  frame	  (T	  dilute	  end),	  neat	  start	  frame	  (T	  neat	  start).	  	  T	  dilute	  
end	  was	   specified	   as	   the	   following	   time	   point:	   (T	   dilute	   peak-­‐	   T	   dilute	   start)	   +	   T	   dilute	   peak.	   The	   time	  
width	  of	  the	  dilute	  CA	  bolus	  curve	  (TW	  dilute)	  was	  defined	  as	  T	  dilute	  end	  -­‐	  T	  dilute	  start.	  	  Namely:	  dilute	  start	  point	  (T	  dilute	  start),	  dilute	  peak	  point	  (T	  dilute	  peak)	  and	  dilute	  end	  point	  (T	  dilute	  end).	  	  T	  dilute	  end	  was	  defined	  as	  follows:	  	  (T	  dilute	  peak-­‐	  T	  dilute	  start)	  +	  T	  dilute	  peak.	  	  The	  time	  width	  of	  dilute	  CA	  bolus	  curve	  (TW	  dilute)	  was	  defined	  as	  T	  dilute	  end	  -­‐	  T	  dilute	   start	   (Figure	   4.5).	   	   If	   TW	   dilute	  was	   longer	   than	   the	   predefined	  pause,	   this	  was	  regarded	   as	   an	   overlap	   between	   the	   AIF	   curves	   of	   the	   dilute	   and	   neat	   CA	   bolus.	  	  This	  would	   affect	   the	  quantitative	   analysis	   negatively.	   	   The	   relationship	  between	  TW	  dilute	  and	  cardiac	  output	  was	  obtained	  in	  36	  patients	  who	  underwent	  stress	  and	  rest	  dual-­‐bolus	  perfusion	  scan	  using	  0.1mmol/kg	  of	  Gd-­‐DO3A-­‐butrol	  (1mol/L).	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4.3.3 Statistics	  Linear	  regression	  analysis	  was	  performed	  in	  the	  36	  patients	  who	  underwent	  stress	  and	   rest	   dual-­‐bolus	   perfusion	   scans	   using	   0.1	   mmol/kg	   of	   Gd-­‐DO3A-­‐butrol	   (1	  mol/L)	   to	   evaluate	   the	   correlation	   of	   cardiac	   output	   and	  TW	   dilute	   (MedCalc	   11.4,	  Mariakerke,	   Belgium).	   	   For	   all	   continuous	   parameters,	   results	   are	   given	   as	   the	  mean	  ±	  standard	  deviation.	  	  A	  p	  value	  of	  less	  than	  0.05	  was	  considered	  statistically	  significant.	  	  
4.4 Results	  130	  dual-­‐bolus	   perfusion	   scans	  were	   performed	   in	   70	   patients	   in	   our	   institution	  (Guys	   and	   St	   Thomas’	   NHS	   foundation	   Trust)	  where	   the	   dual-­‐bolus	   scheme	  was	  devised.	   	   31	   scans	   in	   a	   further	   16	   patients	   were	   subsequently	   completed	   at	   3	  different	  sites.	  	  In	  total	  161	  dual-­‐bolus	  perfusion	  scans	  were	  performed,	  41	  (25%)	  of	  these	  were	  performed	  using	  a	  dual-­‐head	  power	  injector	  with	  a	  “pause”	  function.	  	  Three	  technical	  errors	  (1.9	  %)	  were	  observed	  in	  161	  perfusion	  scans.	  	  Two	  of	  three	  errors	  were	  observed	  at	   the	  original	   site.	   	   In	   these	   two	  cases,	   the	  dilute	   contrast	  was	  confused	  with	  the	  neat	  one	  resulting	  in	  the	  neat	  bolus	  being	  administered	  first.	  The	   remaining	   error	   was	   observed	   at	   a	   remote	   site,	   the	   most	   likely	   cause	   was	  related	   to	  manual	   injection	   of	   dilute	   contrast	   into	   the	   extension	   tube	   at	   a	  wrong	  time.	  	  No	  power	  injector	  related	  errors	  were	  observed.	  	  Apart	  from	  these	  3	  errors,	  all	  dual-­‐bolus	  perfusion	  scans	  were	  successfully	  completed.	  The	  preparation	  time	  for	  the	  dual-­‐bolus	  set-­‐up	  was	  6.9±1.5	  min.	  	  	  For	  all	  patients,	  EF	  and	  heart	  rate	  at	  rest	  and	  during	  stress	  were	  57±15	  %	  (range	  81-­‐16%),	   68±13	   beats	   per	   minute	   (bpm)	   (range	   43-­‐106	   bpm)	   and	   90±17	   bpm	  (range	  48-­‐	  167	  bpm),	  respectively.	   	  Cardiac	  output	  was	  5.6±1.5	  L/min	  (range	  9.6-­‐2.4	  L/min)	  at	  rest	  and	  7.4±2.1	  L/min	  (range	  3.4-­‐14.0	  L/min)	  during	  stress.	  	  	  Linear	   regression	   analysis	   showed	   a	  moderate	   correlation	   between	   TW	   dilute	   and	  cardiac	   output	   (y	   =	   -­‐1.2978x	   +	   22.559,	   r=0.511,	   p<0.001)	   (Figure	   4.6).	   This	   plot	  also	  indicated	  that	  25s	  is	  the	  optimal	  duration	  for	  the	  predefined	  pause	  despite	  one	  outlier	  who	  was	  a	  patient	  with	  low	  cardiac	  output.	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Figure	  4.6	  Linear	  regression	  analysis	  showed	  a	  moderate	  correlation	  between	  TW	  dilute	  and	  
cardiac	  output	  in	  the	  group	  A	  (0.1mmol/kg	  of	  Gd-­‐DO3A-­‐butrol,	  n=36)	  (y	  =	  -­‐1.2978x	  +	  22.559,	  
r=0.511,	   p<0.001).	   	   This	   graph	   also	   indicated	   that	   25s	   is	   the	   optimal	   duration	   for	   the	  
predefined	  pause	  despite	  of	  one	  outlier	  in	  the	  patient	  with	  low	  cardiac	  output.	  	  	  	  TW	  dilute	  at	  rest	  was	  significantly	   longer	  than	  TW	  dilute	  during	  stress	  (15.6±4.6s	  vs.	  11.8±4.2s,	   p<0.001).	   The	   dual-­‐bolus	   scheme	   worked	   well	   if	   the	   appropriate	  predefined	  pause	  was	  selected	  for	  any	  of	  the	  following	  conditions:	  three	  different	  contrast	   agents	   (Gd-­‐DO3A-­‐butrol,	   1mol/L;	   Gd-­‐DTPA,	   0.5mol/L;	   Gd-­‐DOTA	  0.5mol/L),	   4	   different	   doses	   (0.025mmol/kg,	   0.05mmol/kg,	   0.075mmol/kg,	  0.1mmol/kg),	   2	   different	   types	   of	   injectors	   (with	   and	   without	   “pause”	   function)	  and	  3	  different	  MR	  scanners	   from	  2	  different	  manufacturers	  (Philips	  Achieva	  and	  Intera;	  Siemens	  Avanto)	  (Figure	  4.7).	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Figure	   4.7	   Raw	   time-­‐signal	   intensity	   (SI)	   curves	   (LV	   blood	   pool)	   for	   dual-­‐bolus	   first-­‐pass	  
perfusion	  MR	  imaging	  are	  illustrated	  for	  different	  conditions.	  Field	  strength,	  CA	  type,	  pause	  
duration,	  sequence,	  vendor	  and	  rest	  or	  stress	  conditions	  are	  detailed	  below	  each	  perfusion	  
curve.	  Each	  curve	  shows	  two	  peaks:	  a	  lower	  peak	  after	  10%-­‐dilute	  contrast	  administration,	  
followed	  by	  a	  higher	  peak	  after	  neat	  contrast	  administration.	   	  Figure	  4.7	  E	  and	  4.7	  F,	  4.7	  H	  
and	  4.7	  I,	  4.7	  K	  and	  4.7	  L	  and	  4.7	  N	  and	  4.7	  O	  are	  the	  SI	  curves	  for	  rest	  and	  stress	  perfusion	  
obtained	  in	  the	  same	  session.	  	  There	  was	  1	  patient	  with	  hyper	  contractile	  LV	  function	  (EF	  >80%)	  and	  5	  patients	  with	  low	  LV	  function	  (EF	  <	  30%)	  in	  this	  study	  collective	  (Figure	  4.8).	  In	  all	  patients	  with	   an	  EF	  <	  30%	   the	   time-­‐SI	   curves	   showed	  an	  overlap	  between	   the	  dilute	   and	  neat	  CA	  bolus	  curves	  regardless	  of	  the	  duration	  of	  the	  predefined	  pause.	  In	  contrast	  there	  was	  excellent	  separation	  of	  the	  two	  curves	  in	  the	  case	  with	  hyper	  contractile	  LV	  function.	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Figure	  4.8	  The	  figure	  shows	  different	  time-­‐SI	  curves	  of	  different	  dual-­‐bolus	  perfusion	  scans	  
at	   rest.	   	   An	   example	   is	   given	   of	   a	   patient	  with	   hyper	   contractile	   LV	   EF	   (>80%)	   (a)	   and	   of	  
patients	  with	   low	   LV	   EF	   (<30%)	   (b,	   c,	   d,	   e,	   f).	   	   Each	   graph	   contains	   information	   about	   EF,	  
contrast	   agent,	   contrast	   agent	   dose,	   predefined	   pause	   and	   cardiac	   output	   (EF:	   ejection	  
fraction,	  CO:	  cardiac	  output).	  	  In	  the	  patient	  with	  hyper	  contractile	  LV	  EF	  the	  dilute	  and	  neat	  
CA	  bolus,	  are	  well	  separated.	  However,	  in	  the	  patients	  with	  low	  LV	  EF,	  these	  two	  curves	  are	  
overlapped	  with	  a	  various	  extent	  regardless	  of	  CA	  dose	  and	  predefined	  pause	  duration.	  	   	  
4.5 Discussion	  The	   universal	   dual-­‐bolus	   injection	   scheme	   described	   in	   this	   chapter	   has	   several	  advantages.	  Firstly,	  this	  method	  is	  not	  dependent	  on	  the	  latest	  double-­‐head	  power	  injectors	   and	   their	   functionality	   such	   as	   a	  multiple	   injections,	   a	   “pause”	   phase,	   a	  “hold”	   phase	   and	  many	   others.	  With	   some	  newer	   injectors,	   it	   is	   even	  possible	   to	  
Chapter	  4	  –	  A	  dual-­‐bolus	  scheme	  for	  quantitative	  perfusion	  CMR	   68	  
selectively	   inject	  gadolinium	  CA	  or	  saline	   interchangeably.	   	  However,	  most	  of	   the	  widely	  available	  power	  injectors	  in	  clinical	  CMR	  have	  only	  two	  injection	  phases	  for	  each	  injector	  head	  and	  no	  “pause”	  or	  “hold”	  phase.	  The	  order	  of	  contrast	  injection	  and	   saline	   injection	   cannot	   be	   programmed	   using	   these	   injectors.	   With	   these	  injectors,	  if	  the	  syringes	  on	  the	  injector	  heads	  are	  set	  up	  in	  the	  usual	  way	  and	  filled	  with	  contrast	  media	  for	  the	  first	   injection	  and	  saline	  for	  the	  second	  injection,	   it	   is	  complex	  to	  inject	  the	  dilute	  contrast	  medium	  and	  neat	  gadolinium	  CA	  serially	  and	  impossible	  to	  program	  the	  temporal	  delay	  needed	  to	  separate	  the	  boli.	  	  In	  the	  work	  detailed	   in	   this	   chapter	   two	   different	   double-­‐head	   injectors	   with	   and	   without	   a	  “pause”	  phase	  were	  used	  without	  observing	  any	  injector	  related	  errors.	  	  This	  dual-­‐bolus	   injection	   scheme	   provides	   a	   practical,	   straightforward	   and	   robust	   solution	  even	  for	  standard	  injectors.	  	  Secondly,	  using	  this	  method	  of	  manually	  injecting	  the	  contrast	  agent	  into	  the	  tube	  just	  before	  the	  injection,	  the	  dual-­‐bolus	  can	  easily	  and	  reliably	   be	   repeated	   in	   every	   CMR	  perfusion	   scan.	   	   Repeatability	   is	   important	   to	  assess	   ischemic	   heart	   disease,	   where	   two	   perfusion	   scans	   (during	   stress	   and	   at	  rest)	  are	  required	  in	  the	  same	  session.	  Importantly	  two	  remote	  and	  one	  local	  site	  demonstrated	   that	   this	  dual-­‐bolus	  scheme	   is	  easy	   to	  use	   in	  clinical	   routine.	   	  Both	  sites	   successfully	   completed	   dual-­‐bolus	   perfusion	   scans	   only	   following	   the	  instructions	   provided	   in	   this	   chapter.	   	   Although	   Christian	   et	   al.	   used	   a	   similar	  method	   in	   their	   animal	   study,	   they	  did	  not	   repeat	   the	  dual-­‐bolus	   injection	   in	   the	  same	   session	   (59).	  Ritter	   et	   al.	   quantified	   stress	   and	   rest	  MBF	  by	  perfusion	  CMR	  imaging	   in	   healthy	   volunteers	   with	   the	   pre-­‐bolus	   technique	   (133).	   However,	  practically	   the	   pre-­‐bolus	   technique	   requires	   a	   different	   set	   up	   because	   this	  technique	  uses	  1	  ml	  of	  undiluted	  contrast	  medium	  for	  the	  first	  bolus	  to	  determine	  the	   AIF.	   This	   pre-­‐bolus	   technique	   also	   requires	   different	   post	   processing	   to	  construct	  the	  AIF	  from	  the	  pre-­‐bolus	  time-­‐SI	  curve.	  	  There	  is	  only	  a	  single	  study	  by	  Utz	  et	  al.,	  which	  applied	  a	  dual-­‐bolus	  technique	  to	  stress	  and	  rest	  perfusion	  CMR	  in	  patients	   (130).	   However,	   although	   they	   demonstrated	   improved	   accuracy	   for	  absolute	   MBF	   values	   compared	   to	   the	   single-­‐bolus	   approach,	   the	   details	   of	   the	  dual-­‐bolus	   injection	   scheme	   are	   not	   provided.	   Thirdly,	   this	   dual-­‐bolus	   injection	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scheme	   can	   be	   performed	   without	   any	   new,	   unusual	   or	   expensive	   materials	   or	  techniques.	   	   The	   only	   material	   required	   in	   addition	   to	   the	   normal	   set-­‐up	   are	  extension	  tubes,	  3-­‐way	  stopcocks	  and	  syringes	  which	  are	  all	  widely	  available.	  The	   regression	   analysis	   obtained	   suggested	   that	   the	   optimal	   predefined	   pause	  duration	  between	  the	  dilute	  and	  neat	  gadolinium	  injection	  is	  25	  seconds	  or	  more	  if	  a	   contrast	   agent	  with	   high	   gadolinium	   concentration	   (1	  mol/L)	   is	   used.	   	   Cardiac	  output	   had	   a	   negative	   but	   only	  moderate	   correlation	  with	   the	   time	  width	   of	   the	  dilute	   CA	   curve,	   which	   was	   significantly	   longer	   in	   the	   resting	   state	   than	   during	  stress.	   	   These	   finding	   suggest	   that	   the	  predefined	  pause	   should	  be	  prolonged	   for	  the	   rest	   perfusion	   scan	   in	   case	   of	   overlap	   of	   the	   curves	   at	   stress.	   	   Theoretically,	  using	  a	   lower	  concentration	  of	  gadolinium	  CA	  (e.g.	  0.5	  mol/L	  with	  Gd-­‐DTPA),	   the	  bolus	   profile	   should	   be	   wider	   than	   in	   the	   case	   of	   a	   higher	   concentration	   of	  gadolinium	   contrast	   agent	   (e.g.	   1.0	   mol/L	   with	   Gd-­‐DO3A)	   because	   the	   weight	  dependent	   volume	   of	   contrast	   agent	   given	   to	   the	   patient	   is	   larger	   (e.g.	   if	   the	  patient’s	   body	   weight	   is	   60kg	   and	   the	   dose	   of	   the	   gadolinium	   contrast	   is	  0.1mmol/kg,	  6ml	  of	  Gd-­‐DO3A-­‐butrol	  is	  administered	  which	  is	  equivalent	  to	  12ml	  of	  Gd-­‐DTPA).	  	  Therefore,	  a	  longer	  pause	  between	  the	  two	  injections	  should	  be	  used.	  	  	  The	  current	  approach	  requires	  substantial	  “user”	  interaction.	  	  In	  the	  present	  study,	  there	  were	  3	  technical	  errors,	  in	  two	  cases	  the	  dilute	  gadolinium	  agent	  and	  the	  neat	  contrast	   agent	   syringes	   were	   accidentally	   interchanged.	   A	   repetition	   of	   these	  errors	   was	   avoided	   by	   carefully	   labelling	   each	   syringe.	   	   Another	   error	   was	  observed	  at	  a	  remote	  site	  and	  related	  to	  the	  manual	  contrast	  injection	  at	  a	  wrong	  time.	  This	  occurred	  during	  one	  of	   the	   first	  studies	  and	  might	  be	  explained	  by	   the	  relative	   inexperience	   with	   the	   new	   method.	   Undergoing	   some	   simple	   and	   brief	  training	   before	   applying	   our	   methods	   during	   clinical	   scanning	   should	   overcome	  such	   “user”	   related	  problems.	   	   This	  dual-­‐bolus	   injection	   scheme	   requires	  6.9±1.5	  minutes	  for	  the	  preparation	  of	  gadolinium	  CA	  and	  the	  set-­‐up	  for	  the	  power	  injector	  and	   lines.	   	   However,	   the	   perfusion	   scan	   is	   only	   extended	   by	   the	   duration	   of	   the	  predefined	  pause	   (i.e.	  ~25	   seconds	   in	   each	  perfusion	   scan).	   	   In	   our	   institute,	   the	  standard	   stress-­‐rest	   myocardial	   perfusion	   CMR	   set-­‐up	   preparation	   using	   the	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normal	   single	   bolus	   injection	   scheme	   requires	   3.2±1.8	   minutes.	   	   The	   dual-­‐bolus	  injection	  scheme	  just	  needs	  a	  few	  more	  minutes	  on	  top	  of	  the	  normal	  set-­‐up	  In	   patients	  with	   severely	   reduced	   LV	   function	   (EF	   <30%),	   the	   dual-­‐bolus	   curves	  tend	  to	  overlap	  due	  to	  the	  low	  cardiac	  output.	  In	  these	  cases,	  a	   longer	  predefined	  pause	  is	  required.	  Further	  research	  is	  required	  to	  ascertain	  whether	  the	  poor	  bolus	  profile	  in	  these	  patients	  still	  provides	  diagnostic	  and	  accurate	  MBF	  quantification.	  	  In	  contrast,	  our	  dual-­‐bolus	  scheme	  worked	  well	  in	  a	  patient	  with	  LV	  EF	  of	  >80%.	  	  	  
	  
4.5.1 Limitations	  Inevitably	   the	   use	   of	   a	   manual	   contrast	   injection	   necessitates	   the	   presence	   of	   a	  physician	   within	   the	   MR	   scanner	   room	   at	   the	   time	   of	   injection.	   	   However,	   the	  presence	  of	  a	  physician	  is	  reassuring	  for	  the	  patient	  particularly	  during	  the	  stress	  perfusion.	   In	   addition,	   in	   the	   current	   study,	   we	   didn’t	   perform	   a	   series	   of	  contiguous	  short	  axis	  cine	  MRI	  during	  adenosine	  stress.	  	  Instead,	  we	  used	  the	  rest	  left	   ventricular	   stroke	   volume	   (SV)	   to	   estimate	   the	   cardiac	   output	   (CO)	   during	  stress	   as;	   COstress	   =	   SVrest	   x	   HRstress,	   where	   HR	   is	   the	   heart	   rate.	   	   In	   this	   way,	   CO	  during	  stress	  may	  be	  overestimated.	  However,	  in	  terms	  of	  the	  purpose	  of	  this	  work	  to	   validate	   the	   dual-­‐bolus	  method	   setup,	   this	   over	   estimation	   of	   stress	   CO	   is	   not	  misleading	  because	  the	  delay	  time	  between	  pre-­‐bolus	  and	  neat	  bolus	  is	  always	  less	  during	  stress	  than	  in	  the	  resting	  state.	  	  
4.5.2 Conclusions	  We	  have	  devised	  a	  universal	  dual-­‐bolus	   injection	  scheme,	   to	  be	  used	   in	  a	   clinical	  setting,	  that	  is	  set-­‐up	  independent.	  The	  universal	  dual-­‐bolus	  injection	  scheme	  is	  a	  feasible	  technique	  to	  obtain	  a	  reasonable	  arterial	  input	  function	  curve	  to	  calculate	  absolute	  quantification	  of	  myocardial	  blood	  flow.	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An	  isolated	  perfused	  pig	  heart	  model	  for	  the	  
development,	  validation	  and	  translation	  of	  
novel	  magnetic	  resonance	  methodology	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5.1 Summary	  Novel	   cardiovascular	   magnetic	   resonance	   (CMR)	   techniques	   and	   imaging	  biomarkers	  are	  often	  validated	   in	  small	  animal	  models	  or	  empirically	   in	  patients.	  Direct	   translation	   of	   small	   animal	   CMR	   protocols	   to	   humans	   is	   rarely	   possible,	  while	  validation	  in	  humans	  is	  often	  difficult,	  slow	  and	  occasionally	  not	  possible	  due	  to	   ethical	   considerations.	   The	   aim	   of	   the	   work	   described	   in	   this	   chapter	   was	   to	  overcome	  these	  limitations	  by	  introducing	  a	  magnetic	  resonance	  (MR)	  compatible,	  free	   beating,	   blood-­‐perfused,	   isolated	   pig	   heart	   model	   for	   the	   development	   and	  validation	   of	   novel	   CMR	   methodology	   in	   general	   and	   particularly	   myocardial	  perfusion	  imaging.	  6	   hearts	  were	   perfused	   outside	   of	   the	  MR	   environment	   to	   establish	   preparation	  stability.	   Coronary	   perfusion	   pressure	   (CPP),	   coronary	   blood	   flow	   (CBF),	   left	  ventricular	   pressure	   (LVP),	   arterial	   blood	   gas	   and	   electrolyte	   composition	   were	  monitored	  over	  4	  hours.	  Further	  hearts	  were	  perfused	  within	  3T	   (n=3)	  and	  1.5T	  (n=3)	   clinical	   MR	   scanners,	   and	   characterised	   with	   functional	   (CINE),	   perfusion	  and	  late	  gadolinium	  enhancement	  (LGE)	  imaging	  using	  a	  system	  that	  required	  the	  electrical	  parts	  of	  the	  set-­‐up	  such	  as	  perfusion	  pumps	  to	  be	  within	  the	  safe	  part	  of	  the	  MR-­‐room.	  To	  further	  optimize	  the	  system,	  another	  4	  hearts	  were	  perfused	  in	  a	  3T	  XMR	  suite	  where	  all	  electrical	  parts	  remained	  outside	  of	  the	  scanner	  room	  and	  in	  the	  X-­‐Ray	  area.	  During	   the	   experiments	   all	   physiological	   parameters	   measured	   remained	   stable	  and	   within	   normal	   ranges.	   The	   model	   proved	   amenable	   to	   CMR	   at	   both	   field	  strengths	  using	  typical	  clinical	  acquisitions.	  Noise	  levels	  were	  least	  and	  comparable	  to	   background	  noise	   levels	  when	   operating	   all	   electrical	   parts	   outside	   of	   the	  MR	  scanner	  room.	  In	  conclusion	  this	  flexible	  model	  allows	  imaging	  of	  cardiac	  function	  in	  a	   controllable,	  beating,	  human-­‐sized	  heart	  using	  clinical	  MR	  systems.	   It	   should	  aid	   further	   development,	   validation	   and	   clinical	   translation	   of	   novel	   CMR	  methodologies,	  and	  imaging	  sequences.	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5.2 Introduction	  Cardiovascular	  magnetic	   resonance	   (CMR)	  perfusion	   imaging	   is	   a	  high-­‐resolution	  technique	  that	  has	  evolved	  rapidly	  over	  the	  past	  few	  years	  with	  the	  development	  of	  new	   hardware,	   contrast	   agents,	   acquisition	   sequences	   and	   new	   post-­‐processing	  tools.	   These	   recent	   and	   on-­‐going	   advances	   bring	   the	   promise	   of	   improved	  diagnostic	   accuracy	   and	   understanding	   of	   the	   pathophysiology	   and,	   most	  importantly,	   improved	  management	   of	   the	   disease.	  However	   these	   new	  methods	  have	  to	  be	  developed	  and	  validated	  before	  finally	  being	  translated	  to	  patients.	  	  Novel	  CMR	  techniques	  and	  imaging	  biomarkers	  are	  often	  validated	  in	  small	  animal	  models	  or	  empirically	  in	  patients.	  Direct	  translation	  of	  small	  animal	  CMR	  imaging	  protocols	   to	   humans	   is	   rarely	   possible.	   On	   the	   other	   hand,	   validation	   of	   novel	  imaging	   techniques	   in	   humans,	   for	   example	   quantitative	   perfusion,	   novel	  sequences,	  optimized	  contrast	  agent	  injection	  schemes	  or	  responses	  to	  alterations	  of	  blood	  flow	  requires	  large	  patient	  populations	  and	  is	  occasionally	  not	  possible	  for	  ethical	  reasons.	  	  In	  order	  to	  observe	  cardiovascular	  physiology	  and	  pathophysiology	  in	  a	  controlled	  fashion,	  complex	  experimental	  models	  are	  necessary	  to	  mimic	  the	  human	  situation	  as	  closely	  as	  possible.	  The	  porcine	  heart	  closely	  resembles	  the	  human	  heart	   from	  the	   point	   of	   view	   of	   size,	   physiology	   and	   anatomy	   and	   consequently	   pigs	   are	  frequently	  used	  for	  in	  vivo	  cardiovascular	  research	  (134).	  	  Oscar	   Langendorff	   introduced	   a	   model	   of	   retrograde	   perfusion	   of	   mammalian	  hearts	  via	  the	  Aorta	  with	  whole	  blood	  in	  1895	  (135).	  This	  preparation	  was	  refined	  by	  using	  a	  combination	  of	  whole	  blood	  and	  Krebs	  Henseleit	  solution	  as	  a	  perfusate	  and	   by	   either	   perfusing	   the	   coronary	   arteries	   directly	   or	   filling	   of	   the	   atria	   and	  chambers	  in	  a	  working	  heart	  mode	  in	  pigs	  (113,117,122).	  Explanted	  haemoperfused	  pig	  heart	  models	  have	  been	  developed	   to	   represent	   in	  
situ	  physiological	  cardiac	   function	  ex	  vivo	  (113).	  They	  have	  been	  used	  for	  various	  purposes	   including	   studies	   of	   cardiac	   physiology	   and	   comparison	   of	   different	  techniques	  of	  donor	  heart	  preservation	  (117),	  but	  have	  not	  yet	  been	  exploited	  for	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clinical	  CMR	  imaging,	  most	  likely	  due	  to	  practical	  difficulties	  such	  as	  perfusion	  rig	  design	  within	  the	  magnetic	  resonance	  (MR)	  environment.	  The	  purpose	  of	  the	  work	  described	  in	  this	  chapter	  was	  to	  design,	  build	  and	  test	  the	  feasibility	  of	  a	  novel	  MR	  compatible	  explanted,	  beating	  pig	  heart	  model	  that	  allows	  control	   of	   regional	   blood	   flow,	   oxygenation	   and	   nutrient	   delivery.	   Such	   a	  model	  would	  allow	  validation	  of	  CMR	  derived	  parameters	  against	  gold	  standards	  and	  easy	  translation	   of	   novel	   CMR	   methods	   to	   patients,	   using	   equipment	   and	   imaging	  sequences	   that	   mimic	   routine	   clinical	   practice.	   One	   main	   direction	   of	   this	   PhD	  thesis	  was	  to	  employ	  this	  model	   for	  quantitative	  perfusion	   imaging	  as	  detailed	   in	  the	  following	  chapters.	  	  
5.3 Methods	  	  The	  work	  was	  carried	  out	  in	  three	  phases.	  	  In	   phase	   1	   (n=	   6	   hearts)	   we	   validated	   the	   model	   against	   several	   in-­‐vivo	  physiological	   parameters,	   and	   characterised	   its	   stability	   outside	   of	   the	   MR	  environment.	  In	  phase	  2	  (n=	  6	  hearts)	  we	  tested	  a	  newly	  developed	  MR	  compatible	  version	  of	  the	  model	  and	  determined	  its	  feasibility	  at	  3	  Tesla	  (n=	  3	  hearts)	  and	  1.5	  Tesla	   (n=	   3	   hearts)	   clinical	   MR	   scanners.	   Finally	   in	   phase	   3	   (n=	   4	   hearts)	   we	  redeveloped	   the	   MR	   compatible	   model	   to	   be	   used	   in	   a	   3T	   XMR	   combined	  fluoroscopy	  and	  MR	  laboratory.	  Experiments	   were	   conducted	   after	   approval	   by	   the	   relevant	   authorities.	   All	  experiments	  were	   performed	   in	   compliance	  with	   the	  World	  Medical	   Association	  Declaration	  of	  Helsinki	  regarding	  ethical	  conduct	  of	  research	  involving	  animals.	  	  
5.3.1 Phase	  1	  
5.3.1.1 Heart	  removal	  and	  preparation	  Hearts	  were	  harvested	   from	  Large	  White	  Cross	   Landrace	  pigs	  weighing	  between	  40	  and	  60	  kg	  (average	  weight	  of	  51±6	  kg)	  as	  previously	  described	  (122).	  Pigs	  were	  premedicated	   with	   6	   mg/kg	   azaperone	   and	   0.05	   mg/kg	   atropine,	   and	   then	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anaesthetised	  with	  10	  mg/kg	  ketamine	  and	  ventilated	  with	  N2O	  at	  4.5	  l/min	  and	  O2	  at	  4	   l/min.	  General	  anaesthesia	  was	  maintained	  with	  0.8-­‐1.1	  vol.%	  isoflurane	  and	  1-­‐3	  µg/kg/h	  fentanyl.	  The	  animals	  were	  heparinised	  with	  5,000	  IU	  of	  heparin,	  the	  thorax	  was	   opened	   and	   1.8	   l	   of	   autologous	   blood	  was	   collected	   via	   the	   superior	  vena	   cava	   into	   1l	   plastic	   bottles	   containing	   10,000	   I.U.	   heparin.	   The	   pericardium	  was	  opened	  and	  the	  heart	  was	  removed	  after	  transection	  of	  the	  great	  heart	  vessels.	  The	   heart	   was	   immediately	   immersed	   in	   iced	   0.9%	   saline	   solution	   and	   the	  coronary	  arteries	  were	  perfused	  with	  cold	  (4ºC)	  Custudiol	  solution	  (HTK	  solution,	  Dr.	  Franz	  Köhler	  Chemie	  GmbH,	  Alsbach-­‐Hähnlein,	  Germany).	  Hearts	  were	  transported	  to	  the	   laboratory	  and	  prepared	  for	  perfusion	  as	   follows.	  The	  pulmonary	  artery	  was	  shortened	  to	  3–3.5	  cm	  and	  the	  aorta	  to	  approximately	  4	  cm.	  Both	  vessels	  were	  attached	  to	  an	  appropriate	  cannula.	  The	  remaining	  orifices	  were	  sewn	  closed.	  Warm	  ischaemic	  time	  from	  excision	  to	  beginning	  of	  cardioplegic	  infusion	  was	  less	  than	   one	   minute.	   Cold	   ischaemic	   time	   (from	   excision	   to	   reperfusion)	   ranged	  between	  83	  and	  146	  minutes	  (106±22,	  mean±SD).	  During	  the	  preparation,	  hearts	  were	  maintained	  in	  a	  cold	  cardioplegic	  solution	  to	  avoid	  rewarming.	  
	  
5.3.1.2 Perfusion	  system	  We	  performed	  the	  experiments	  in	  a	  system	  for	  direct	  coronary	  perfusion,	  in	  which	  the	   left	   and	   right	   coronary	   artery	   can	   be	   perfused	   independently	   of	   each	   other	  (Figure	  5.1).	   The	   heart	   was	   connected	   to	   the	   system	   with	   an	   aortic	   cannula	  inserted	   into	   the	   Aorta.	   The	   aortic	   cannula	   contained	   catheters	   to	   selectively	  perfuse	   right	   and	   left	   coronary	   arteries,	   to	   allow	   precise	   control	   of	   regional	  myocardial	  perfusion.	  	  The	   perfusion	   system	   consisted	   of	   two	   separate	   circuits	   –	   the	   haemoperfusate	  circuit	  to	  supply	  the	  heart	  with	  nutrients	  and	  oxygen	  and	  the	  dialysate	  circuit	   for	  the	  exchange	  of	  metabolites	  and	  clearance	  of	  contrast	  agent	  (Figure	  5.1).	  To	  avoid	  temperature	   loss	   the	  heart	  was	  suspended	   in	  whole	  blood	   in	  a	  purpose	  designed	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warm	   water-­‐jacketed	   heart	   chamber.	   Blood	   temperature	   and	   oxygenation	   were	  controlled	   by	   an	   oxygenator	   with	   an	   integrated	   heat	   exchanger	   (Dideco	   D	   100,	  Mirandola,	  Modena,	  Italy).	  The	  perfusate	  consisted	  of	  autologous	  whole	  blood	  (1.8	  litre),	  diluted	  with	  Krebs-­‐Henseleit	  solution	  (1	  litre,	  9.6	  g	  dry	  mass,	  Sigma,	  St.	  Louis,	  MO,	   USA,	   Krebs-­‐Henseleit	   buffer	   K-­‐3753).	   To	   adjust	   the	   pH,	   CO2	   was	   added	   if	  required.
	  
Figure	  5.1:	  Schematic	  view	  of	  the	  perfusion	  system:	  Starting	  from	  the	  perfusate	  reservoir	  (38	  
°C)	   the	   perfusate	   is	   first	   passed	   through	   roller	   pump	   2	   into	   a	   dialysis	   module	   and	   then	  
through	  a	  blood	  oxygenator	  with	   integrated	  heat	  exchanger.	  The	  oxygenated	  blood	   is	   then	  
pumped	  into	  the	  heart	  via	  roller	  pump	  1.	  Before	  entering	  the	  heart	  an	  air	  trap	  removes	  air	  
bubbles	   from	   the	   perfusate.	   The	   dialysate	   (38	   °C)	   is	   pumped	   through	   the	   dialysis	  module	  
with	  a	  centrifugal	  pump	  (pump	  3,	   flow	  of	  5	   l/min)	  to	  exchange	  metabolites	  (contrast	  agent	  
clearance)	  between	  the	  venous	  perfusate	  and	  the	  dialysate.	  The	  dialysate	  is	  re-­‐circulated	  in	  a	  
reservoir.	   T:	   sensor	   for	   dialysate	   temperature;	   O2	   and	   CO2:	   valves	   for	   oxygen	   and	   carbon	  
dioxide	   input.	  The	  perfusate	   reservoir	   and	   the	   venous	   and	  arterial	   blood	   circuits	   are	   fully	  
water-­‐jacketed.	  Temperature	  is	  controlled	  by	  an	  external	  heater.	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5.3.1.3 Connection	  to	  the	  perfusion	  system	  and	  reperfusion	  Following	   cannulation,	   hearts	   were	   connected	   to	   the	   perfusion	   apparatus	   and	  perfusion	  of	   the	  coronary	  arteries	  was	  started	  at	  an	   initial	  pressure	  of	  50	  mmHg.	  Approximately	  2	  minutes	  after	  the	  start	  of	  perfusion	  the	  pressure	  was	  increased	  to	  70	   mmHg.	   In	   the	   event	   of	   ventricular	   fibrillation	   electrical	   defibrillation	   was	  performed.	   After	   a	   stabilisation	   period	   of	   10	   to	   15	  minutes	   coronary	   blood	   flow	  (CBF)	   was	   adjusted	   to	   reach	   a	   CPP	   between	   60	   and	   80	   mmHg.	   All	   hearts	   were	  perfused	  for	  4	  hours.	  	  
5.3.1.4 Measurements	  on	  the	  isolated	  hearts	  Left	   ventricular	   pressure	   (LVP),	   right	   ventricular	   pressure	   (RVP),	   coronary	  perfusion	  pressure	  (CPP)	  and	  coronary	  blood	   flow	  (CBF)	  were	  assessed	  every	  30	  minutes.	   Arterial	   blood	   gas	   analysis	   and	   oximetry	   were	   performed	   every	   15	  minutes	   and	   included	   partial	   oxygen	   (pO2)	   and	   partial	   carbon	   dioxide	   (pCO2)	  pressure	   in	   addition	   to	   pH,	   haemoglobin,	   sodium,	   potassium,	   calcium,	   chloride,	  glucose	  and	  lactate.	  	  
5.3.2 Phase	  2	  Within	  phase	  2	  hearts	  were	  commercially	  purchased	  from	  Harlan	  Laboratories	  UK.	  Hearts	  were	  harvested	   from	  Large	  White	  Cross	   Landrace	  pigs	  weighing	  between	  40	  and	  60	  kg	  (average	  weight	  of	  49±5	  kg).	  Due	  to	  local	  requirements	  the	  protocol	  differed	  as	  follows:	  Pigs	  were	  sedated	  with	  10mg	  /	  kg	  i.m.	  ketamine	  and	  0.3	  mg/kg	  i.m.	   xylazine.	   General	   intravenous	   anaesthesia	   was	   achieved	   with	   1.5	   mg/kg	   i.v.	  alphaxolone.	   Coronary	   arteries	  were	   perfused	  with	   20	  ml	   sterile	   concentrate	   for	  cardioplegia	   infusion	   (Martindale	   Pharmaceuticals,	   Romford,	   Essex,	   UK)	   diluted	  immediately	  before	  use	  in	  1	  litre	  of	  Ringer’s	  Solution.	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5.3.2.1 Modified	  MR-­‐Compatible	  Perfusion	  System	  We	   tested	   a	   newly	   developed	   MR	   compatible	   version	   of	   the	   original	   set-­‐up	  described	  in	  phase	  1.	  The	  setup	  consisted	  of	  MR	  safe	  and	  MR	  compatible	  parts.	  All	  equipment	  in	  the	  scanner	  was	  made	  of	  MR	  safe	  materials	  (136),	  i.e.	  not	  influencing	  the	   MR-­‐homogeneity	   of	   the	   main	   magnetic	   field.	   Electrical	   and	   magnetic	   parts	  (control-­‐unit,	   power-­‐supply,	   pumps,	   pacer	   etc.)	   were	   made	   MR	   compatible	   by	  placing	   them	  approximately	  6	  metres	  away	   from	  the	  magnet	  outside	   the	  5	  Gauss	  line	   (Figure	   5.2).	   They	   were	   also	   shielded	   with	   aluminium	   foil	   wrapped	   around	  them.	  The	  pump	  engines	  were	   connected	   to	   the	   custom-­‐made	  pump	  heads	  using	  polycarbon	  drive	  shafts.	  The	  cylindrical	  chamber	  for	  the	  perfused	  heart	  was	  made	  of	  perspex,	  which	  has	  a	  magnetic	  susceptibility	  close	  to	  water	  and	  therefore	  these	  materials	   do	   not	   affect	   the	   B0-­‐homogeneity	   and	   image	   quality	   as	   described	   by	  Schenck	  (137).	  ECG-­‐triggering	  was	  performed	  by	  means	  of	  a	  small	  animal	  MR	  ECG	  system	  (SA	   Instruments,	  Stony	  Brook,	  NY,	  USA).	  Pacing	  wires	  were	  custom	  made	  from	  copper	  and	  connected	  to	  a	  clinical	  pacing	  system	  (Biotronik	  EDP	  20,	  Berlin,	  Germany).	  Temperature	  was	  monitored	  by	  an	  MR	  compatible	  thermocouple.	  This	  set-­‐up	  allowed	  us	  to	  run	  the	  same	  system	  within	  the	  MR	  scanner	  as	  the	  one	  we	  had	  developed	  for	  the	  non-­‐MR	  environment.	  	  
	  
	  
Figure	   5.2	  MR	   compatible	   model:	   Column	   A,	   B	   and	   C	   show	   the	   technical	   setup	   of	   the	   MR	  
compatible	   perfusion	   system	   in	   detail.	   A	   and	   B	   All	   electrical	   parts	   (control-­‐unit,	   power-­‐
supply,	   pumps	   etc.)	   are	   shielded	   with	   aluminium	   foil	   and	   placed	   approximately	   6	  metres	  
away	   from	  the	  magnet.	  The	  pump	  engines	  were	   then	  connected	   to	   the	  custom	  made	  pump	  
heads	   using	   polycarbon	   drive	   shafts.	   	   C	   Detail	   of	   the	   trolley	   containing	   dialysis	   unit	   and	  
oxygenator	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5.3.2.2 Measurement	   of	   Interference	   with	   Image	   Quality	   of	   the	   Perfusion	  
System	  Designing	   the	  perfusion	  system	  to	  be	  MR-­‐compatible	  ensures	   that	   the	  equipment	  does	  not	  adversely	  affect	   the	   function	  of	   the	  MR	  scanner,	   i.e.	  no	  significant	   image	  artefacts	  or	  noise.	  Since	  all	  equipment	  inside	  the	  MR	  scanner	  was	  made	  of	  MR	  safe	  material	   the	   main	   source	   of	   potential	   image	   degradation	   would	   be	   due	   to	  radiofrequency	   (rf)-­‐interference	   of	   equipment	   (e.g.	   control-­‐unit,	   power-­‐supply,	  pumps,	   pacer	   etc.)	   with	   the	   MR	   scanner.	   In	   order	   to	   test	   the	   potential	   rf-­‐interference,	  MR	  images	  without	  rf-­‐excitation	  were	  acquired	  with	  a	  perfused	  heart	  inside	   the	  MR	   scanner.	   The	   resulting	   noise	   images	   allowed	   for	   detecting	   any	   rf-­‐signal	   within	   the	   bandwidth	   used	   by	   the	   MR	   image	   acquisition.	   In	   particular,	  images	   with	   a	   bandwidth	   of	   185kHz	   were	   acquired	   at	   three	   different	   centre	  frequencies	  ensuring	  an	  rf	  sweep	  across	  a	  550kHz	  range	  around	  the	  MR	  resonance	  frequency.	  This	  range	  covers	  the	  range	  of	  frequencies	  that	  can	  be	  acquired	  in	  CMR.	  To	   compare	   this	   to	   the	  background	   level	  of	  noise,	   the	   same	  experiment	  was	  also	  acquired	   with	   all	   equipment	   switched	   off	   as	   well	   as	   without	   equipment	   in	   the	  room.	  	  	  
5.3.2.3 Cardiovascular	  Magnetic	  Resonance	  MR	  imaging	  was	  carried	  out	  on	  a	  clinical	  3	  Tesla	  MR	  scanner	  (Achieva,	  Philips,	  Best,	  The	  Netherlands)	  and	  on	  a	  clinical	  1.5	  Tesla	  MR	  scanner	  (Intera	  CV,	  Philips,	  Best,	  The	   Netherlands).	   For	   signal	   reception,	   a	   clinical	   32-­‐channel	   coil	   array	   was	  positioned	  around	  the	  heart	  chamber,	  which	  was	  then	  placed	  in	  the	  magnet.	  MR	  data	  were	  acquired	  in	  short	  axis	  and	  long	  axis	  (2-­‐chamber,	  3-­‐chamber	  and	  4-­‐chamber	  view)	  of	  the	  LV.	  We	  used	  a	  balanced	  steady	  state	  free	  precession	  (SSFP)	  sequence	  with	  a	  repetition	  time	  of	  3	  ms,	  echo	  time	  of	  1.5	  ms,	  flip	  angle	  40°,	  spatial	  resolution	  at	  2	  x!1.6	  x	  8	  mm3	  for	  CINE	  imaging.	  For	  perfusion	  MR	  imaging	  we	  used	  a	   saturation	   recovery	   gradient	   echo	   pulse	   sequence	   accelerated	   with	   k–t	   SENSE	  with	   a	   repetition	   time	   of	   2.4	   ms,	   echo	   time	   of	   0.8	   ms,	   flip	   angle	   20°,	   spatial	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resolution	   at	   1.3	   x!1.3	   x	   8	   mm3.	   Contrast	   administration	   was	   performed	   with	  gadobutrolum	   (Gadovist,	   Bayer	   Healthcare,	   Leverkusen,	   Germany)	   using	   a	   dual-­‐bolus	  scheme	  (5	  ml	  of	  neat	  at	  0.07	  mmol/ml	  and	  5	  ml	  of	  dilute	  at	  0.007	  mmol/ml)	  (138).	   Contrast	   was	   administered	   either	   into	   the	   common	   arterial	   inflow	   line	  supplying	   both	   coronary	   arteries	   or	   selectively	   into	   the	  RCA	   or	   LCA	   through	   the	  aortic	   cannula	   for	   selective	   first	   pass	   perfusion	   imaging.	   Late	   gadolinium	  enhancement	   (LGE)	   CMR	   was	   performed	   in	   identical	   slice	   orientations	   using	  conventional	  methods	  with	   a	   repetition	   time	   of	   4.9	  ms,	   echo	   time	   of	   2.4	  ms,	   flip	  angle	  15°,	  spatial	  resolution	  at	  1.7	  x	  1.7	  x	  8	  mm3.	  	  	  Three	  hearts	  at	  3	  T	   (n=3)	  and	   three	  hearts	  at	  1.5	  T	   (n=3)	  were	  perfused	   for	  240	  minutes	  with	  constant	  blood	  flow	  and	  oxygenation.	  In	  one	  heart	  at	  3	  T	  (n=1)	  blood	  flow	  was	  kept	   constant	   for	  60	  minutes	  with	   subsequent	  occlusion	  of	   the	  RCA	   for	  180	  minutes.	  All	  hearts	  underwent	  CINE	  imaging,	  selective	  first-­‐pass	  perfusion	  and	  LGE	  imaging.	  	  
5.3.3 Phase	  3	  
5.3.3.1 Adaption	  of	  the	  Perfusion	  System	  to	  be	  used	  in	  3T	  XMR	  laboratory	  In	   order	   to	   develop	   a	   system	   that	   is	   free	   from	   any	   electrical	   interference	   we	  redeveloped	  the	  system,	  described	   in	  phase	  2,	   to	  be	   fully	  operational	   in	  a	  clinical	  3T	   XMR	   suite.	   All	   electrical	   and	   magnetic	   parts	   and	   thus	   potentially	   interfering	  equipment	   remained	   in	   the	   X-­‐Ray	   room	   of	   a	   combined	   3T	   XMR	   suite.	   We	   used	  wave-­‐guides	  to	  operate	  the	  system	  from	  a	  room	  next	  to	  the	  scanner	  room	  (in	  our	  case	   the	   X-­‐Ray	   room)	   (Figure	   5.3).	   The	   pump	   engines	   in	   the	   X-­‐Ray	   room	   were	  connected	   to	   the	   custom-­‐made	  MR	   compatible	   pump	  heads	   in	   the	   scanner	   room	  using	  polycarbon	  drive	  shafts	  and	  custom	  made	  connectors	  that	  were	  fitted	  in	  the	  wave-­‐guides	  (Figure	  5.3).	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Figure	  5.3	  The	  modified	  set-­‐up	  allows	  the	  operation	  of	  the	  system	  through	  wave-­‐guides	  from	  
the	  X-­‐Ray	  room	  (Cath	  lab)	  of	  the	  XMR	  suite.	  All	  electrical	  and	  magnetic	  parts	  remain	  in	  the	  X-­‐
Ray	  room.	  The	  pump	  engines	  are	  connected	  to	  the	  custom-­‐made	  MR	  compatible	  pump	  heads	  
using	  polycarbon	  drive	  shafts	  through	  custom	  made	  connectors	  fitted	  in	  the	  wave-­‐guides.	  	  
	  
5.3.3.2 Cardiovascular	  Magnetic	  Resonance	  MR	   imaging	   was	   performed	   in	   4	   additional	   hearts	   in	   a	   state	   of	   the	   art	   hybrid	  clinical	   3	   Tesla	   XMR	   suite.	   Similarly	   to	   phase	   2	   Large	  White	   Cross	   Landrace	   pig	  hearts	  were	  commercially	  purchased	   from	  Harlan	  Laboratories	  UK	  with	  a	  weight	  between	  40	  and	  55	  kg	  (average	  weight	  of	  47±7	  kg).	  The	  3T	  scanner	  used	  in	  phase	  2	  (Achieva,	   Philips,	   Best,	   The	  Netherlands)	  was	   integrated	   in	   the	   newly	   build	   XMR	  laboratory	   related	   to	   a	   local	   project	   at	   King’s	   College	   London.	   Cine	   imaging,	  perfusion	   imaging	   and	   late	   gadolinium	   enhanced	   imaging	   scanning	   parameters	  were	  therefore	   identical	   to	   the	  ones	  used	   in	  phase	  2	  at	  3	  Tesla.	  Measurements	  of	  interference	   with	   image	   quality	   were	   also	   performed.	   The	   noise	   scans	   were	  obtained	   with	   the	   novel	   set-­‐up	   running	   and	   compared	   to	   the	   background	   noise	  with	  the	  set-­‐up	  described	  in	  phase	  2	  as	  well	  as	  an	  unshielded	  pump	  engine	  running	  inside	  the	  Faraday	  cage	  (but	  outside	  the	  5	  Gauss	  line).	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5.4 Results	  	  
5.4.1 Phase	  1	  Haemoperfusion	  of	  six	  hearts	  was	  performed	  in	  a	  direct	  coronary	  perfusion	  mode.	  Hearts	  were	  defibrillated	  2-­‐5	  times	  with	  30	  Joule	  to	  reach	  stable	  electrical	  activity	  with	  synchronous	  ventricular	  contraction.	  Successful	  recovery	  occurred	  in	  6	  out	  of	  6	  hearts.	  Heart	  rate	  ranged	  between	  60	  and	  110	  beats	  per	  minute.	  Arterial	  blood	  gas	   analysis	   revealed	   stable	   metabolism	   (Table	   5.1)	   at	   a	   controlled	   level	   of	  coronary	  perfusion	  within	  a	  near	  normal	  physiological	  range.	  Normal	  values	  of	  CBF	  and	  CPP	  were	  maintained	  throughout	  the	  experiments	  (Figure	  5.4).	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Perfusion	  	  
Time	  [min]	  
0	   15	   30	   60	   90	   120	   150	   180	   210	   240	  
pH	   7,66	  ±	  0,15	   7,55	  ±	  0,1	   7,51	  ±	  0,14	   7,45	  ±	  0,04	   7,42	  ±	  0,04	   7,4	  ±	  0,03	   7,39	  ±	  0,02	   7,38	  ±	  0,04	   7,41	  ±	  0,03	   7,43	  ±	  0,04	  
pO2	  [mmHg]	   299	  ±	  49	   265	  ±	  146	   273	  ±	  86	   252	  ±	  28	   215	  ±	  50	   230	  ±	  40	   271	  ±	  40	   282	  ±	  50	   273	  ±	  55	   280	  ±	  38	  
pCO2	  [mmHg]	   20	  ±	  7	   26	  ±	  6	   27	  ±	  5	   32	  ±	  4	   34	  ±	  4	   35	  ±	  3	   36	  ±	  4	   36	  ±	  5	   33	  ±	  5	   32	  ±	  5	  
tHb	  [g/dl]	   5,7	  ±	  0,8	   4,9	  ±	  0,4	   5,3	  ±	  0,6	   4,5	  ±	  0,6	   4,5	  ±	  0,4	   4,9	  ±	  0,8	   4,7	  ±	  0,4	   5,2	  ±	  0,6	   4,7	  ±	  0,6	   4,5	  ±	  0,4	  
Calcium	  	  [mmol/L]	   0,45	  ±	  0,02	   1,16	  ±	  0,12	   1,23	  ±	  0,1	   1,28	  ±	  0,11	   1,28	  ±	  0,11	   1,27	  ±	  0,11	   1,28	  ±	  0,11	   1,28	  ±	  0,12	   1,27	  ±	  0,11	   1,26	  ±	  0,11	  
Potassium	  	  [mmol/L]	   5	  ±	  0,1	   5,1	  ±	  0,1	   5,1	  ±	  0,1	   5,1	  ±	  0,2	   5,1	  ±	  0,2	   5,1	  ±	  0,2	   5,2	  ±	  0,2	   5,3	  ±	  0,2	   5,3	  ±	  0,2	   5,3	  ±	  0,2	  
Sodium	  [mmol/L]	   132	  ±	  6	   131	  ±	  5	   131	  ±	  4	   132	  ±	  4	   132	  ±	  4	   132	  ±	  4	   132	  ±	  4	   132	  ±	  4	   133	  ±	  4	   133	  ±	  4	  
Chloride	  [mmol/L]	   111	  ±	  3	   110	  ±	  4	   111	  ±	  5	   110	  ±	  5	   110	  ±	  4	   110	  ±	  4	   111	  ±	  4	   110	  ±	  4	   111	  ±	  4	   111	  ±	  5	  
Glucose	  [mmol/L]	   8,7	  ±	  0,3	   8,5	  ±	  0,1	   8,4	  ±	  0,1	   8	  ±	  0,2	   7,8	  ±	  0,2	   7,5	  ±	  0,1	   7,1	  ±	  0,2	   6,7	  ±	  0,2	   6,6	  ±	  0,2	   6,3	  ±	  0,2	  
Lactate	  [mmol/L]	   0,5	  ±	  0,2	   0,7	  ±	  0,2	   0,9	  ±	  0,2	   1,1	  ±	  0,2	   1,3	  ±	  0,2	   1,5	  ±	  0,2	   1,7	  ±	  0,2	   2	  ±	  0,3	   2,3	  ±	  0,3	   2,6	  ±	  0,4	  
	  
Table	  5.1	  Arterial	  Blood	  Gas	  Analysis	  and	  Oximetry	  (average	  and	  standard	  deviation	  for	  n=6	  pigs).	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Figure	  5.4	  Average	  coronary	  blood	  flow	  and	  perfusion	  pressure	  during	  phase	  1	  
Coronary	  Perfusion	  Pressure	  (CPP,	  [mmHg])	  and	  Coronary	  Blood	  Flow	  (CBF	  [ml/min/100g])	  
during	  240	  minutes	  of	  direct	  coronary	  perfusion.	  
	  
5.4.2 Phase	  2	  
5.4.2.1 Interference	  with	  Image	  Quality	  of	  the	  Perfusion	  System	  The	  acquired	  noise	  images	  showed	  no	  significant	  rf-­‐interference	  of	  the	  equipment	  inside	  the	  MR	  room	  with	  the	  MR	  scanner.	  In	  particular,	  no	  additional	  high	  rf-­‐signals	  were	  observed	  over	  the	  complete	  frequency	  range	  of	  550	  kHz,	  which	  would	  result	  in	  strong	  image	  artefacts.	  However,	  a	  small	   increase	  (15%)	  of	  the	  noise	  level	  was	  found	  when	  the	  electrical	  equipment	  inside	  the	  MR-­‐room	  was	  switched	  on.	  
	  
5.4.2.2 Cardiovascular	  Magnetic	  Resonance	  Hearts	  were	   defibrillated	  with	   30	   Joule	   3	   times	   on	   average.	  We	   performed	   CINE	  imaging,	   first	   pass	   perfusion	   imaging	   and	   LGE	   imaging.	   The	   image	   quality	   was	  comparable	  to	  clinical	  scanning	  (Figure	  5.5,	  5.6	  and	  5.7).	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Signal	  intensity	  (SI)	  curves	  during	  first	  pass	  perfusion	  imaging	  were	  obtained	  in	  a	  view	   perpendicular	   to	   the	   heart	   chamber.	   The	   image	   plane	   contained	   a	  perpendicular	  cut	  through	  the	  arterial	  inflow	  tubing	  (arterial	  input	  function)	  and	  a	  short	  axis	  view	  of	  the	  myocardium	  (myocardial	  response	  curve)	  (Figure	  5.5).	  By	   selective	   injection	   of	   gadolinium	   contrast	   agent	   into	  RCA	   and	   LCA	   the	   spatial	  extent	  of	  the	  respective	  territories	  was	  determined	  (Figure	  5.6).	  In	   one	   heart	   at	   3	   T	   blood	   flow	  was	   kept	   constant	   for	   the	   first	   60	  minutes.	   After	  standard	  assessment	  of	  ventricular	  function	  the	  perfusion	  territory	  of	  the	  RCA	  was	  mapped	  by	  first	  pass	  perfusion	  (Figure	  5.7	  B).	  The	  RCA	  was	  subsequently	  occluded	  for	   180	   minutes.	   We	   found	   good	   agreement	   between	   the	   left	   ventricular	  myocardium	   in	   the	   RCA	   territory	   identified	   by	   first	   pass	   perfusion	   prior	   to	   RCA	  occlusion	  and	  the	  left	  ventricular	  territory	  identified	  by	  LGE	  (Figure	  5.7	  C)	  imaged	  180	  minutes	  after	  RCA	  occlusion.	  The	  RCA	  territory	  measured	  using	  the	  short	  axis	  RCA	  first	  pass	  perfusion	  stack	  was	  96	  g	  representing	  37%	  of	  the	  total	  (258	  g)	  left	  ventricular	   myocardial	   mass.	   The	   RCA	   territory	   measured	   using	   LGE	   imaging,	  which	  represents	  infarction,	  was	  95	  g	  or	  36%	  of	  the	  total	  LV	  mass	  (Figure	  5.6).	  
	  
Figure	   5.5	  The	   figure	   shows	   the	   determination	   of	   time	   signal	   intensity	   (SI)	   curves	   during	  
first	  pass	  perfusion.	  The	   image	  plane	  contains	  a	  cut	   through	   the	  arterial	   inflow	  tubing	  and	  
through	   the	   myocardium	   in	   short-­‐axis	   orientation.	   The	   arterial	   input	   function	   including	  
prebolus	   can	   be	   obtained	   from	   the	   blood	   pool	   during	   first	   pass	   of	   gadolinium.	   The	  
myocardial	   response	   curve	   can	   be	   obtained	   shortly	   afterwards	   during	  wash-­‐in	   of	   contrast	  
agent	  into	  the	  myocardium.	  The	  images	  have	  been	  segmented	  to	  improve	  visibility.	  




Figure	  5.6	  The	   figure	  shows	   two	  short	  axis	  slices	  during	   first	  pass	  perfusion	  of	  gadolinium	  
imaged	   at	   3	   Tesla	   after	   selective	   injection	   into	   the	   right	   and	   left	   coronary	   artery,	  
respectively.	   	  A	  Anatomic	  reference	  plane	  (basal	  slice);	  B	  k-­‐t	  SENSE	  selective	  RCA	  first	  pass	  
perfusion;	  C	  k-­‐t	  SENSE	  selective	  LCA	  first	  pass	  perfusion.	  The	  images	  have	  been	  segmented	  to	  





Figure	  5.7	  Perfusion	  territory	  and	  Size	  of	  Infarction:	  The	  perfusion	  territory	  of	  the	  RCA	  was	  
mapped	  at	  3	  Tesla	  by	  first	  pass	  perfusion	  with	  direct	  injection	  of	  the	  contrast	  agent	  into	  the	  
RCA	   (central	   image).	   The	   perfusion	   territory	  was	   96g	   (36%	   of	   left	   ventricular	  myocardial	  
mass).	   Then	   the	   RCA	   was	   occluded	   for	   180	   minutes.	   Late	   gadolinium	   enhancement	   (LGE,	  
image	   on	   the	   right)	   resulted	   in	   95g	   myocardial	   infarction	   (36	   %	   of	   LV	   mass).	   The	   close	  
agreement	   of	   LGE	   and	   selective	   RCA	   perfusion	   highlights	   the	   almost	   complete	   absence	   of	  
collaterals	  in	  pigs.	  	  A	  Anatomic	  reference	  plane	  (midmyocardial	  slice);	  B	  k-­‐t	  SENSE	  selective	  
RCA	  first	  pass	  perfusion;	  C	  LGE	  image	  after	  180	  minutes	  of	  RCA	  occlusion.	  The	  images	  have	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5.4.3 Phase	  3	  Imaging	  quality	  of	   the	  clinical	  sequences	  was	  good	  and	  qualitatively	  not	  different	  from	   the	   quality	   obtained	   in	   phase	   2.	   The	   acquired	   noise	   images	   showed	   no	  increase	  of	  noise	  levels	  with	  the	  modified	  set-­‐up	  running	  as	  compared	  to	  the	  set-­‐up	  used	   in	   phase	   2.	  With	   the	   unshielded	   pump	   engine	   running	   in	   the	   room	   overall	  noise	  levels	  increased	  significantly	  by	  a	  factor	  of	  8.	  In	  addition,	  a	  high	  rf-­‐signal	  was	  observed	   at	   330	   kHz	   above	   the	   MR-­‐resonance	   frequency	   that	   would	   potentially	  result	   in	   strong	   image	   artefacts.	   The	   noise	   level	   and	   the	   additional	   spurious	   rf-­‐signal	  can	  be	  significantly	  reduced	  to	  the	  original	  values	  (reference	  measurement	  without	  any	   instruments)	  when	   the	  pump	  motor	   is	   installed	  outside	   the	  Faraday	  cage	  driving	  the	  mechanical	  component	  of	  the	  pump	  at	  the	  scanner	  through	  wave-­‐guides.	  Using	  sufficient	  aluminium	  shielding	  as	  described	  in	  phase	  2	  prevents	  the	  additional	   spurious	   rf-­‐signal	   and	   reduces	   the	   background	   noise	   to	   a	   level	   that	   is	  approximately	  15%	  higher	  than	  the	  original	  values.	  	  	  
5.5 Discussion	  The	  data	  presented	  in	  this	  chapter	  demonstrate	  the	  potential	  of	  an	  isolated,	  blood-­‐perfused	   pig	   heart	   preparation	   as	   an	   experimental	   tool	   to	   validate	   newly	  developed	  CMR	  techniques	  and	  assess	  numerous	  physiological	  parameters.	  Our	  study	  demonstrates	  that	  1.)	  stable	  near	  physiological	  conditions	  are	  obtained	  during	  normal	  perfusion	  and	  oxygenation	  of	  the	  heart,	  2.)	  the	  model	  can	  be	  safely	  run	  in	  a	  clinical	  MR	  scanner,	  3.)	   interventions	  such	  as	  down-­‐regulation	  of	   flow	  or	  occlusion	   of	   a	   coronary	   artery	   can	   be	   easily	   performed	   and	   4.)	   good	   quality	  imaging	   of	   the	   beating,	   isolated,	   blood-­‐perfused	   pig	   heart	   system	   is	   feasible	   in	   a	  clinical	   system	   using	   imaging	   sequences	   identical	   to	   those	   used	   for	   patient	  examinations.	  	  The	   isolated	   pig	   heart	  model	   represents	   an	   experimental	   platform	   that	   is	   stable	  over	  a	  period	  of	  at	  least	  4	  hours	  that	  can	  be	  used	  for	  imaging	  experiments.	  Whilst	  it	  is	   not	   as	   physiological	   as	   intact	   animals	   it	   offers	   much	   greater	   control	   and	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reproducibility.	  While	  we	  used	  it	  in	  a	  coronary	  perfusion	  mode	  it	  can	  also	  be	  used	  in	   a	  working	  heart	  mode	   and	   can	   either	   be	  perfused	  with	   crystalloid	   solution	   or	  with	  whole	  blood	  as	  in	  the	  current	  set-­‐up.	  	  The	   present	   study	   to	   the	   best	   of	   our	   knowledge	   is	   the	   first	   to	   demonstrate	   the	  feasibility	  of	  perfusing	  a	  beating	  heart	  system	  in	  a	  clinical	  MR	  scanner.	  Our	  current	  model	  has	  several	  important	  advantages	  over	  other	  experimental	  designs,	  but	  also	  some	  limitations,	  which	  need	  to	  be	  considered.	  The	  main	  advantage	  is	  the	  model’s	  precision	   allowing	   accurate	   control	   of	   regional	   and	   global	   perfusion	   and	  oxygenation,	  as	  well	  as	  controlled	  nutrient	  delivery.	  In	  fact	  as	  a	  consequence	  others	  have	   implemented	   similar	   models	   to	   create	   realistic	   interventional	   training	  scenarios	   for	   transcatheter	   pulmonary	   and	   aortic	   valve	   implantation	   (123,124).	  Generally	  and	  similarly	  to	  our	  work	  there	  is	  good	  performance	  of	  these	  models	  in	  the	   near-­‐physiological	   range	   over	   several	   hours	   (113,120,122,125,135).	   Whole	  heart	   or	   regional	   ischaemia	   can	   easily	   be	   induced	   and	   adjusting	   perfusion	   can	  control	   the	   severity	   of	   ischaemia.	   Pig	   hearts	   are	   well	   suited	   for	   studies	   of	  myocardial	   blood	   flow	   as	   they	   have	   virtually	   no	   anastamoses	   between	   adjacent	  coronary	  perfusion	  beds	  (Figure	  5.6	  and	  5.7)	  (134).	  This	  anatomical	  homogeneity	  means	  that	  studies	  are	  much	  more	  reliable	  and	  reproducible.	  The	  model	  is	  also	  free	  from	  external	  influences	  such	  as	  neuro-­‐humoral	  activation-­‐	  the	  effects	  of	  which	  are	  difficult	   to	   quantify.	   In	   addition	   in	   contrast	   to	   in	   vivo	   preparations	   the	   isolated	  heart	   preparation	   allows	   experiments	   to	   be	   continued	   after	   fatal	   events	   (e.g.	  infarction	  induced	  cardiac	  arrest	  or	  arrhythmias),	  which	  can	  frequently	  terminate	  an	  in	  vivo	  experiment.	  Despite	  making	  the	  system	  MR	  compatible	  we	  were	  able	  to	  keep	  the	  tubing	  short	  and	  the	  volume	  of	  the	  circuit	  small.	  This	  is	  a	  particular	  advantage	  over	  the	  model	  that	  has	  been	  recently	  introduced	  by	  Eggen	  et	  al.	  (128).	  Their	  perfusion	  system	  for	  isolated	   human	   hearts,	   that	   are	   unsuitable	   for	   transplantation,	   operates	   via	   long	  plastic	  tubes	  from	  an	  adjacent	  room	  outside	  of	  the	  MR	  environment.	  The	  utilisation	  of	   the	   polycarbon	   drive	   shafts	   in	   the	   set-­‐ups	   described	   in	   phase	   2	   and	   phase	   3	  allowed	  to	  have	  very	  short	  tubing	  just	  next	  to	  the	  MR	  scanner.	  This	  is	  important	  as	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it	  allows	  the	  use	  of	  a	  mixture	  of	  autologous	  blood	  and	  crystalloid	  solution	  with	  near	  normal	   haematocrit	   and	   haemoglobin	   without	   the	   need	   for	   donor	   or	   support	  animals.	   	   Perfusion	   with	   blood	   leads	   to	   more	   stable	   function	   and	   less	   oedema	  compared	  to	  crystalloid	  solution	  perfusion	  (134).	  	  Furthermore	  the	  image	  quality	  achieved	  is	  sufficient	  using	  adequate	  shielding	  of	  all	  electrical	   parts	   with	   aluminium	   foil.	   The	   associated	   small	   increase	   in	   noise	   can	  however	  be	  reduced	  further	  to	  a	   level	  that	   is	  comparable	  to	  background	  noise	  by	  operating	   the	   system	   in	   the	   3T	   XMR	   suite	   located	   in	   the	   Rayne	   Institute	   at	   St	  Thomas’	   Hospital.	   Elimination	   of	   this	   small	   excess	   noise	   will	   potentially	   deliver	  more	   reliable	   and	   reproducible	   results.	   Finally	   during	   myocardial	   perfusion	  imaging	  generation	  of	  high	  quality	   time	  SI	  curves	  (Figure	  5.5)	   including	  prebolus	  and	   main	   bolus	   was	   feasible.	   This	   is	   of	   particular	   importance	   as	   the	   dual-­‐bolus	  approach	   has	   been	   shown	   to	   be	   very	   accurate	   for	   quantitative	   MR	   perfusion	  assessment	  (59).	  	  	  
5.5.1 Limitations	  The	   main	   disadvantages	   of	   this	   model	   are	   the	   less	   physiological	   environment	  compared	   to	   in	   vivo	   experiments	   and	   the	   relatively	   high	   associated	   costs.	   For	  studies	  of	  myocardial	  perfusion	  rapid	  recirculation	  of	  contrast	  is	  prevented	  in	  the	  current	   model.	   This	   is	   an	   oversimplification	   of	   in	   vivo	   conditions	   but	   allows	  immediately	   repeated	  perfusion	   scans.	  Gadolinium	  accumulation	   in	   the	  perfusate	  cannot	  entirely	  be	  prevented	  despite	   the	  dialysis	  unit	  suggesting	  that	   the	  dialysis	  unit	   with	   its	   increased	   extracellular	   volume	   cannot	   entirely	   replace	   a	   fully	  functioning	   kidney	   in	   in-­‐vivo	   experiments.	   In	   addition	   contrast	   arrival	   time	  was	  longer	  compared	  with	  in	  vivo	  as	  a	  consequence	  of	  distribution	  and	  dilution	  in	  the	  inflow	   tubing.	  Whether	   this	   influences	   quantitative	   perfusion	   analysis	   with	   CMR	  needs	  to	  be	  investigated.	  	  As	  this	  was	  a	  feasibility	  study	  we	  did	  not	  perform	  metabolic	  assessment	  of	  the	  10	  hearts	   we	   perfused	   in	   the	   magnets.	   Therefore	   stable	   physiological	   function	   was	  assumed	   on	   the	   basis	   of	   the	   previously	   performed	   validation	   experiments.	   We	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performed	  a	  proof	  of	  concept	  study	  to	  demonstrate	  the	  feasibility	  of	  the	  model	  in	  the	  MR	  environment	  and	  thus	  we	  did	  not	  perform	  systematic	  statistical	  analysis.	  	  	  
5.5.2 Conclusions	  The	  current	  work	  demonstrates	   for	   the	   first	   time	   the	   feasibility	  of	  operating	  and	  imaging	  an	  isolated	  beating	  porcine	  heart	  preparation	  in	  a	  clinical	  MR	  scanner.	  The	  technical	   design	   of	   this	   isolated	   pig	   heart	   model	   allows	   ex	   vivo	   simulation	   and	  imaging	   of	   cardiac	   function.	   This	   novel	   system	   provides	   excellent	   control	   of	  physiological	   parameters	   and	   allows	   validation	   of	   novel	   techniques	   against	   gold	  standards	   and	   easy	   translation	   of	   the	   methods	   to	   patients	   using	   identical	  equipment	  and	  imaging	  sequences.	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6.1 Summary	  Cardiovascular	  Magnetic	  Resonance	  (CMR)	  myocardial	  perfusion	  imaging	  has	  the	  promise	   to	   evolve	   into	   a	   method	   allowing	   for	   full	   quantification	   of	   myocardial	  blood	   flow	   (MBF).	  Multiple	   quantification	   pathways	   exist,	   however	   at	   present	   it	  remains	   unclear	   which	   algorithm	   is	   the	   most	   accurate.	   The	   aim	   of	   the	   work	  described	  in	  this	  chapter	  was	  to	  investigate	  which	  methodology	  is	  most	  suited	  for	  quantification	  of	  myocardial	  perfusion	  in	  myocardial	  standard	  segments	  at	  1.5	  and	  3	  Tesla	  using	  state	  of	  the	  art	  perfusion	  techniques	  and	  quantification	  algorithms.	  	  First-­‐pass	  CMR	  perfusion	  was	  performed	  in	  the	  MR	  compatible	  blood	  perfused	  pig	  heart	   model.	   Perfusion	   imaging	   was	   acquired	   at	   rest,	   low	   flow	   and	   during	  adenosine	   induced	  hyperemia	   in	  control	  and	  coronary	  occlusion	  conditions.	  CMR	  myocardial	   perfusion	   imaging	   was	   performed	   at	   1.5	   Tesla	   (n=4)	   and	   at	   3	   Tesla	  (n=6).	  Fluorescent-­‐labelled	  microspheres	  and	  externally	  controlled	  coronary	  blood	  flow	   served	   as	   reference	   standards	   for	   comparison	   of	   different	   quantification	  strategies,	   namely	   Fermi	   function	   constrained	   deconvolution,	   autoregressive	  moving	   average	   modeling	   (ARMA),	   deconvolution	   using	   exponential	   basis	   and	  deconvolution	  using	  B-­‐spline	  basis.	  All	  CMR	  derived	  MBF	  estimates	  correlated	  with	  microsphere	   results.	   	   The	   best	   correlation	   was	   achieved	   with	   Fermi	   function	  constrained	   deconvolution	   both	   at	   1.5	   Tesla	   (r2=0.86,	   p<0.001)	   and	   at	   3	   Tesla	  (r2=0.81,	  p<0.001).	  The	  weakest	  correlation	  at	  1.5	  Tesla	  was	  found	  using	  B-­‐spline	  deconvolution	  (r2=0.55,	  p<0.001)	  and	  at	  3	  Tesla	  using	  exponential	  deconvolution	  (r2=0.24,	  p<0.001).	  In	   conclusion	  CMR	  derived	  quantitative	  blood	   flow	  estimates	   correlate	  with	   true	  myocardial	   blood	   flow	   in	   a	   controlled	   animal	   model.	   Different	   quantitative	  methods	  deliver	  results	  that	  strongly	  correlate	  with	  the	  gold	  standard	  at	  1.5	  Tesla	  and	   range	   from	  moderate	   to	   strong	   correlation	   at	   3	  Tesla.	  Amongst	   these	  Fermi	  function	   constrained	   deconvolution	   qualifies	   as	   the	   most	   accurate	   technique	   at	  both	   field	   strengths.	   CMR	  perfusion	  based	  on	  Fermi	   function	  deconvolution	  may	  therefore	   emerge	   as	   a	   useful	   clinical	   tool	   providing	   accurate	   quantitative	   blood	  flow	  assessment.	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6.2 Introduction	  Myocardial	   ischaemia	   due	   to	   coronary	   artery	   disease	   (CAD)	   represents	   a	   major	  cause	   of	   negative	   outcome	   after	   revascularization	   therapy	   (139).	   Cardiovascular	  magnetic	   resonance	   (CMR)	   myocardial	   perfusion	   imaging	   can	   accurately	  determine	   myocardial	   ischaemia	   and	   detect	   the	   physiological	   significance	   of	   a	  coronary	   artery	   narrowing	   which	   is	   not	   possible	   with	   luminal	   angiography	  (31,35).	   Myocardial	   perfusion	   imaging	   with	   CMR	   compares	   favourably	   to	   other	  non-­‐invasive	   techniques	   (7,8,32,42,140)	   and	   is	   increasingly	   used	   for	   patient	  management	   and	   clinical	   decision	  making	   (11,16,141).	   CMR	   perfusion	   has	   been	  validated	   against	   invasive	   hemodynamic	   measurements	   such	   as	   coronary	   flow	  reserve	   (CFR)	   and	   fractional	   flow	   reserve	   (FFR)	   (8,44,46,47,102,142-­‐144).	   The	  feasibility	   of	   full	   quantification	   of	   myocardial	   blood	   flow	   (MBF)	   with	   CMR	  perfusion	   has	   been	   demonstrated	   (72,84,145)	   which	   may	   develop	   as	   clinically	  useful	  diagnostic	  test	  for	  non-­‐invasive	  assessment	  of	  MBF	  (72).	  However	  there	  are	  several	   points	   that	   need	   to	   be	   considered:	   1.)	   full	   quantification	   of	   myocardial	  perfusion	  is	  estimated	  from	  signal	   intensity	  (SI)	  time	  curves	  and	  the	  relationship	  between	  arterial	   input	   function	   (AIF)	  and	  myocardial	   response	  curves.	  Both	   rely	  on	  heart	  rate,	  cardiac	  output,	  ejection	  fraction	  and	  coronary	  anatomy	  and	  may	  not	  necessarily	   be	   the	   same	   for	   a	   given	   sequence	   or	   field	   strength.	   2.)	   There	   are	  several	   mathematical	   algorithms	   available	   for	   quantification	   of	   CMR	   derived	   SI-­‐time	   curves	   such	   as	   Fermi	   function	   constrained	   deconvolution,	   autoregressive	  moving	   average	   modeling	   (ARMA),	   deconvolution	   using	   exponential	   basis	   and	  deconvolution	  using	  B-­‐spline	  basis	  (for	  further	  detail	  please	  also	  refer	  to	  chapter	  3).	  At	  present	  it	  is	  unknown	  which	  is	  most	  accurate.	  The	   novel	   magnetic	   resonance	   (MR)	   compatible	   explanted	   pig	   heart	   model	  introduced	   in	   chapter	   5	   allows	   accurate	   control	   of	   regional	   blood	   flow	   and	  therefore	  represents	  an	  ideal	  vehicle	  for	  quantitative	  perfusion	  validation	  (146).	  It	  is	  also	  free	  of	  many	  of	  the	  influences	  mentioned	  above	  which	  make	  quantification	  strategies	   difficult	   in	   living	   animals	   or	   patients.	   Furthermore,	   combining	   the	  advantage	  of	  known,	  precisely	  controlled	  blood	   flow	  rates	  with	  a	  state	  of	   the	  art	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imaging	   cryomicrotome	   assessment	   of	   fluorescent-­‐labelled	   microspheres	   (147)	  provides	  an	  unprecedented	  true	  gold	  standard	  for	  perfusion	  validation.	  The	  aim	  of	  the	   work	   described	   in	   this	   chapter	   was	   therefore	   to	   perform	   a	   head	   to	   head	  comparison	   of	   different	   quantitative	   perfusion	   algorithms	   using	   this	   unique	  imaging	   set-­‐up	   and	   to	   perform	   a	   small	   feasibility	   study	   in	   patients	   with	  functionally	   significant	   CAD	   using	   the	   most	   accurate	   perfusion	   algorithm	   and	  identical	  acquisition	  sequences	  and	  MR	  scanners.	  	  	  
6.3 Methods	  
6.3.1 Experimental	  design	  of	  the	  study	  All	  animal	  experiments	  were	  conducted	  after	  approval	  by	  the	  U.K.	  Home	  Office	  in	  accordance	   with	   the	   U.K.	   Animals	   (Scientific	   Procedures)	   Act	   of	   1986	   and	   in	  compliance	  with	  the	  World	  Medical	  Association	  Declaration	  of	  Helsinki	  regarding	  ethical	   conduct	   of	   research	   involving	   animals.	   Ten	   healthy	   Large	   White	   Cross	  Landrace	  pigs	  weighing	  between	  41	  and	  54	  kg	  were	  included	  in	  this	  study	  (Harlan	  Laboratories,	  UK).	  Hearts	  were	  harvested	  as	  previously	  described	  (146).	  Sedation	  was	  performed	  with	  ketamine	   (10mg	  /	   kg	   i.m.)	   and	   xylazine	   (0.3	  mg/kg	   i.m.)	   in	  combination	   with	   alphaxolone	   for	   general	   intravenous	   anaesthesia	   (1.5	   mg/kg	  i.v.).	  Heparin	  was	  administered	  (5,000	  IU)	  and	  exsanguination	  started	  through	  the	  superior	  vena	  cava.	  The	  hearts	  were	  removed	  after	  transection	  of	  the	  great	  heart	  vessels	  and	  intra-­‐coronary	  infusion	  of	  cold	  (4ºC)	  cardioplegic	  solution	  (Martindale	  Pharmaceuticals,	   Romford,	   Essex,	   UK)	   was	   performed.	   Catheters	   were	   inserted	  into	  the	  coronary	  arteries	  for	  reperfusion.	  To	  create	  left	  ventricular	  (LV)	  preload	  a	  pressure	  balloon	  was	  inserted	  through	  the	  aortic	  valve	  into	  the	  left	  ventricle	  and	  inflated	   to	   a	   systolic	   pressure	   of	   50	   mmHg.	   After	   the	   hearts	   were	   cannulated,	  pressure	   controlled	  perfusion	  of	   the	   coronary	   arteries	  was	   started	   at	   around	  50	  mmHg.	  Over	  approximately	  5	  minutes	  pressure	  was	  slowly	  increased	  to	  a	  constant	  perfusion	  mode	  of	  0.8	  ml/min/g.	  In	  the	  event	  of	  ventricular	  fibrillation,	  electrical	  defibrillation	   was	   performed.	   After	   preparation	   stability	   was	   achieved	   the	   left	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anterior	  descending	  (LAD)	  coronary	  artery	  was	  occluded	  to	  create	  a	  territory	  with	  a	  perfusion	  defect	  and	  a	  normally	  perfused	  remote	  territory	  and	  CMR	  imaging	  was	  started.	   Perfusion-­‐CMR	   was	   performed	   at	   rest,	   with	   50%	   flow	   reduction	   and	  during	   pharmacological	   vasodilation	   with	   adenosine	   (Figure	   6.1).	   During	  adenosine	  infusion	  the	  flow	  was	  altered	  to	  maintain	  the	  same	  coronary	  perfusion	  pressure	  as	  during	  the	  resting	  state.	  	  
	  
Figure	  6.1	  The	  figure	  describes	  the	  time	  course	  of	  the	  CMR	  examination.	  After	  preparation	  
stability	   was	   achieved	   CMR	   imaging	   was	   started	   with	   the	   acquisition	   of	   rest	   perfusion	  
images.	   Microspheres	  were	   injected	   after	   the	   gadolinium	   injection	   for	   perfusion	   imaging.	  
This	  process	  was	   repeated	  with	  50%	  of	   the	   flow	  and	  during	  pharmacological	   vasodilation	  
with	  adenosine	  with	  coronary	  perfusion	  pressure	  controlled	  increase	  in	  MBF.	  	  
6.3.2 Cardiovascular	  magnetic	  resonance	  perfusion	  imaging	  The	   animal	   studies	   were	   performed	   on	   1.5	   Tesla	   (Intera	   CV,	   Philips,	   Best,	   The	  Netherlands),	   (n=4)	   and	   3	   Tesla	   (Achieva	   TX,	   Philips,	   Best,	   The	   Netherlands),	  (n=6)	   clinical	   MR	   scanners.	   For	   signal	   reception,	   a	   clinical	   interventional	   L	   flex	  receiver	   coil	   array	  was	   tightly	   positioned	   around	   the	   heart	   chamber,	  which	  was	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then	  placed	  in	  the	   isocenter	  of	   the	  magnet.	  CMR	  perfusion	  data	  were	  acquired	  in	  short	  axis	  orientation	  of	  the	  LV	  following	  a	  recognized	  standard	  model	  (60).	  Image	   parameters	   at	   1.5	   Tesla	   were	   as	   follows:	   CMR-­‐perfusion	   imaging	   was	  performed	  with	  a	  5	  fold	  k-­‐t	  broad	  linear	  speed	  up	  technique	  (BLAST)	  accelerated	  balanced	   turbo	  gradient	  echo	  pulse	  sequence	  with	  11	   training	  profiles	  yielding	  a	  typical	   spatial	   resolution	   of	   1.9x2x10	  mm.	   TE/TR	  was	   1.35/2.71;	   50°	   flip	   angle;	  90°	  prepulse	  and	  100	  ms	  prepulse	  delay.	  At	  3	  Tesla	  we	  used	  a	  saturation	  recovery	  gradient	  echo	  pulse	  sequence	  accelerated	  with	  k–t	  BLAST	  (k-­‐t	  factor	  5	  and	  11	  training	  profiles)	  with	  a	  repetition	  time	  of	  2.7	  ms,	  echo	  time	  of	  0.9	  ms,	  flip	  angle	  20°,	  spatial	  resolution	  at	  1.3	  x	  1.3	  x	  8	  mm.	  	  Perfusion-­‐CMR	  was	  performed	  using	  a	  dual-­‐bolus	  scheme	  with	  5	  ml	  of	  neat	  (0.07	  mmol/ml)	   and	   5	   ml	   of	   dilute	   (0.007	   mmol/ml)	   gadobutrolum	   bolus	   injections	  (Gadovist,	   Bayer	   Healthcare,	   Leverkusen,	   Germany)	   (138).	   Post-­‐processing	   of	  perfusion	   images	   was	   performed	   with	   a	   dedicated	   software	   prototype	   (Philips	  Healthcare,	  Best,	  The	  Netherlands).	  	  
6.3.3 Quantitative	  analysis	  of	  magnetic	  resonance	  perfusion	  imaging	  The	  LV	  was	  divided	   into	  standard	  segments	   (60).	  The	  SI-­‐time	  curves	  of	   the	  CMR	  perfusion	  images	  were	  incorporated	  into	  MATLAB	  (Natick,	  MA,	  USA)	  and	  different	  algorithms	   for	   quantification	   were	   applied,	   namely	   Fermi	   function	   constrained	  deconvolution,	   ARMA,	   deconvolution	   using	   exponential	   basis	   and	   deconvolution	  using	  B-­‐spline	  basis	   (70,72).	  Prior	   to	  deconvolution	  analysis,	  baseline	  correction,	  spatial	  and	  temporal	   filtering	  and	  homogeneity	  correction	  was	  performed	  on	  the	  extracted	  SI	  curves.	  	  
6.3.4 Quantitative	  microsphere	  analysis	  	  Immediately	  after	  the	  gadolinium	  injection	  a	  total	  of	  100,000	  microspheres	  were	  injected	  into	  the	  circulation	  at	  the	  same	  site	  used	  for	  gadolinium	  injection.	  Up	  to	  3	  different	  colours	  of	  microspheres	  were	  used	  during	  the	  experiments.	  Quantitative	  analysis	  of	  the	  microtome	  images	  was	  performed	  in	  the	  same	  standard	  segments	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Nt 	  where	   Ns	   is	   the	   number	   of	   microspheres	   counted	   in	   a	   segment,	   Nt	   is	   the	   total	  number	  of	  microspheres	  injected,	  Ft	  is	  the	  total	  arterial	  input	  flow	  rate	  in	  mL/min,	  and	   Ms	   is	   the	   mass	   of	   a	   segment	   in	   grams.	   Segment	   mass	   was	   derived	   from	  segment	   volume,	  which	  was	   calculated	   from	   a	   fine	   3D	   binarised	   left	   ventricular	  mesh.	  	  To	  quantify	  microspheres	  circumferentially	  in	  the	  same	  standard	  segments	  used	   for	   quantitative	   CMR	   perfusion	   analysis,	   the	   LV	   centroid	   and	   anterior	   RV	  insertion	   point	   were	   identified	   in	   each	   perfusion	   slice,	   with	   circumferential	  segments	   then	   defined	   every	   60	   degrees	   around	   the	   centroid	   allowing	   very	  accurate	  alignment	  of	  the	  perfusion	  and	  cryomicrotome	  slices	  (Figure	  6.2).	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Figure	   6.2	   The	   figure	   shows	   a	   single	   time	   frame	   of	   a	   perfusion	   study	   at	   3	   Tesla	   after	  
occlusion	  of	   the	  LAD	  (upper	   left).	  The	  middle	   image	   (top	  row)	  shows	   the	  overlay	  with	   the	  
microsphere	   distribution	   after	   registration	   of	   the	   cryomicrotome	   images	   and	   the	   MR	  
images.	  Segmental	  microsphere	  quantification	  reveals	  the	  perfusion	  defect	  and	  the	  normal	  
perfusion	   in	  remote	  myocardium	  (upper	  right	  corner).	   In	   the	  middle	  row	  segmentation	  of	  
the	   perfusion	   image	   is	   displayed	   (left),	   as	   well	   as	   segmental	   signal	   intensity	   (SI)	   curves	  
during	   first	   pass	   of	   gadolinium	   (middle).	   Using	   the	   SI-­‐curves	  with	   different	   quantification	  
algorithms	  delivers	  CMR	  based	  quantitative	  results	  [ml/min/g]	  depending	  on	  the	  algorithm	  
used.	   In	   this	   example	   Fermi	   function	   constrained	   deconvolution	   shows	   the	   closest	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6.3.5 Patient	  studies	  Six	  patient	  studies	  were	  performed	  (three	  at	  each	  field	  strength)	  according	  to	  our	  local,	   clinical	   perfusion	   protocol,	   approved	   by	   the	   local	   ethics	   committee.	   All	  patients	  gave	  written	   informed	  consent.	  All	  patients	  had	  significant	   flow	   limiting	  CAD	  as	  determined	  by	  FFR	  (<0.8).	  The	  patients	  underwent	  myocardial	  perfusion	  imaging	  using	  a	  rest/stress	  adenosine	  protocol	  on	  the	  same	  MR	  scanners	  used	  for	  the	  animal	  studies.	  The	  CMR	  perfusion	  sequences	  were	  similar	  to	  the	  ones	  used	  in	  the	   explanted	   hearts	   and	   contrast	   administration	  was	   performed	  with	   the	   dual-­‐bolus	   scheme	   using	   gadobutrolum	   (Gadovist,	   Bayer	   Healthcare,	   Leverkusen,	  Germany)	  (138).	  
	  
6.3.6 Statistics	  Data	   analysis	  was	   performed	  with	   IBM	   SPSS	   statistics	   for	  Mac	   20.0.0	   (SPSS	   Inc.,	  Chicago,	   Illinois,	   USA).	   Continuous	   data	   are	   expressed	   as	   the	   mean	   ±	   standard	  deviation	   (SD).	   The	   paired	   samples	   t-­‐test	   was	   used	   to	   compare	   perfusion	  measurements	   at	   rest	   with	   stress	   and	   low	   flow	   within	   individual	   hearts,	   and	  between	  rest	  and	  stress	  in	  the	  patients.	  To	  compare	  perfusion	  measurements	  with	  CMR	   and	   microspheres	   linear	   regression	   analysis	   and	   the	   method	   proposed	   by	  Bland	  and	  Altman	  were	  used	  (148).	   Intra-­‐observer	  variability	  was	  assessed	  using	  the	  coefficient	  of	  variation	   (CV)	  defined	  as	   the	  ratio	  of	   the	  SD	   to	   the	  mean	  of	   the	  differences	   between	   the	   measurements.	   A	   p-­‐value	   of	   <0.05	   was	   considered	  statistically	  significant.	  	  	  	  
6.4 Results	  All	  the	  explanted	  hearts	  recovered	  electrical	  function	  upon	  reperfusion.	  In	  case	  of	  reperfusion	   arrhythmias	   defibrillation	   was	   performed	   to	   achieve	   sinus	   rhythm.	  Hearts	   were	   shocked	   for	   3±2	   times	   on	   average.	   All	   hearts	   remained	   reasonably	  stable	   throughout	   the	   perfusion	   experiments.	   Heart	   Rate	   was	   71±15.	   The	   heart	  weight	   was	   272±19	   g.	   The	   external	   roller	   pump	   blood	   flow	   was	   set	   to	   238±46	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ml/min.	  Further	  measurements	  were	  taken	  during	  reduced	  flow	  at	  118±20	  ml/min	  and	  during	  adenosine	   induced	  hyperemia	  with	  392±47	  ml/min.	  These	   flow	  rates	  constituted	  an	  overall	  LV	  flow	  of	  0.89±0.18,	  0.45±0.1	  and	  1.47±0.16	  ml/min/g	  LV	  (p<0.001),	   respectively.	   On	   a	   segmental	   level	   perfusion	   values	   derived	   from	   the	  different	   techniques	   based	   on	   CMR	   SI-­‐time	   curves	   were	   compared	   to	   the	  microspheres.	   Figure	   6.3	   shows	   the	   relation	   between	   microspheres	   and	   CMR	  derived	  perfusion	   for	   1.5	  Tesla	   and	  Figure	  6.4	   for	   3	  Tesla.	   All	   CMR	  derived	  MBF	  estimates	   correlated	   with	   the	   microspheres.	   The	   best	   correlation	   was	   achieved	  with	   Fermi	   function	   constrained	   deconvolution	   both	   at	   1.5	   Tesla	   (r2=0.86,	  p<0.001)	   and	  at	  3	  Tesla	   (r2=0.81,	  p<0.001).	  The	  weakest	   correlation	  at	  1.5	  Tesla	  was	  found	  using	  B-­‐spline	  deconvolution	  (r2=0.55,	  p<0.001).	  At	  3	  Tesla	  exponential	  deconvolution	   showed	   the	   weakest	   correlation	   (r2=0.24,	   p<0.001).	   Generally	  correlation	   was	   stronger	   at	   1.5	   Tesla	   with	   strong	   correlation	   coefficients	   for	   all	  algorithms	   (r2=0.55-­‐0.86).	   At	   3	   Tesla	   correlations	   was	   slightly	   lower	   (r2=0.24-­‐0.81).	  This	  was	  particularly	  true	  for	  ARMA,	  exponential	  deconvolution	  and	  B-­‐spline	  deconvolution	   that	   were	   only	   moderately	   correlated	   with	   microspheres	   as	  opposed	  to	  Fermi,	  that	  showed	  comparable	  results	  to	  1.5	  Tesla	  (Table	  6.1).	  	  	   	  	   1.5	  Tesla	   3	  Tesla	   p-­‐value	  	  Algorithm	   	  r	   	  r2	   	  r	   	  r2	   	  <0.001	  	  Fermi	   	  0.93	   	  0.86	   	  0.9	   	  0.81	   	  <0.001	  	  ARMA	   	  0.88	   	  0.77	   	  0.59	   	  0.35	   	  <0.001	  	  Exponential	   	  0.92	   	  0.85	   	  0.49	   	  0.24	   	  <0.001	  	  B-­‐spline	   	  0.74	   	  0.55	   	  0.64	   	  0.41	   	  <0.001	  	  
Table	  6.1	  The	  table	  shows	  the	  correlation	  strength	  of	  the	  individual	  algorithms	  with	  the	  gold	  
standard	  of	  microspheres.	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The	  Bland	  Altman	  analysis	  and	  95%	  confidence	  intervals	  of	  the	  difference	  showed	  excellent	   results	   for	   Fermi	   deconvolution	   with	   minimal	   overestimation	   of	  perfusion	   at	   3	   Tesla.	   ARMA	   showed	  minimal	   underestimation	   of	   perfusion	   at	   3	  Tesla	   and	   moderate	   underestimation	   at	   1.5	   Tesla.	   Exponential	   deconvolution	  showed	   excellent	   results	   at	   1.5	   Tesla,	   however	   moderate	   overestimation	   of	  perfusion	  at	  3	  Tesla.	  B-­‐spline	  deconvolution	  showed	  moderate	  overestimation	  of	  flow	  at	  both	  field	  strengths	  (Figure	  6.3	  and	  6.4,	  Table	  6.2).	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Figure	  6.3	  The	  figure	  shows	  the	  correlation	  of	  quantitative	  perfusion	  analysis	  using	  different	  algorithms	  with	  the	  gold	  standard	  of	  microsphere	  derived	  
quantitative	   perfusion	   at	   1.5	   Tesla	   (top	   row).	   The	   bottom	   row	   shows	   the	   agreement	   between	   CMR	   derived	   perfusion	   and	   the	   gold	   standard	   of	  
microsphere	  derived	  perfusion	  using	   the	  Bland	  Altman	  analysis.	  There	  was	  good	  correlation	  with	  minimal	  error	  between	  CMR	  derived	  quantitative	  
perfusion	  analysis	  and	  microspheres,	  which	  was	  most	  significant	  for	  Fermi	  function	  constrained	  deconvolution	  (left	  hand	  side).	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Figure	  6.4	  The	  figure	  shows	  the	  correlation	  of	  quantitative	  perfusion	  analysis	  using	  different	  algorithms	  with	  the	  gold	  standard	  of	  microsphere	  derived	  
quantitative	   perfusion	   at	   3	   Tesla	   (top	   row).	   The	   bottom	   row	   shows	   the	   agreement	   between	   CMR	   derived	   perfusion	   and	   the	   gold	   standard	   of	  
microsphere	  derived	  perfusion	  using	  the	  Bland	  Altman	  analysis.	  There	  was	  excellent	  correlation	  with	  minimal	  error	  between	  CMR	  derived	  quantitative	  
perfusion	  analysis	  and	  microspheres	  using	  Fermi	  deconvolution	  (left	  hand	  side)	  as	  opposed	  to	  moderate	  correlation	  using	  the	  other	  algorithms.	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Field	  
Strength	  
Modality	   Mean	   CI	   (95%)	   of	   the	  
Difference	  	  
p-­‐value	  
1.5	  Tesla	   Microspheres	  	   1.17±1.05	   	   	  Fermi	   1.15±0.96	   -­‐0.28-­‐0.31	   0.93	  ARMA	   0.99±0.62	   -­‐0.07-­‐0.43	   0.16	  Exponential	   1.22±0.83	   -­‐0.33-­‐0.22	   0.7	  B-­‐spline	   1.39±1.17	   -­‐0.55-­‐0.1	   0.17	  3	  Tesla	   Microspheres	   0.9±0.72	   	   	  Fermi	   0.97±0.66	   -­‐0.28-­‐0.14	   0.51	  ARMA	   0.85±0.88	   -­‐0.19-­‐0.3	   0.66	  Exponential	   1.21±0.74	   -­‐0.52-­‐(-­‐0.08)	   0.007	  B-­‐spline	   1.34±0.86	   -­‐0.67-­‐(-­‐0.2)	   <0.001	  	  
Table	  6.2	  The	   table	  shows	   the	  mean	  perfusion	  values	  based	  on	  microspheres	  and	  CMR	  for	  
both	   field	   strengths.	   Data	   is	   presented	   as	   mean	   ±	   standard	   deviation	   (SD)	   along	   with	   p-­‐
values	   indicating	   statistical	   significance	   based	   on	   the	   paired	   t-­‐test.	   (CI)-­‐	   Confidence	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Field	  Strength	   	   CV	  1.5	  Tesla	   Fermi	   6%	  ARMA	   27%	  Exponential	   14%	  B-­‐spline	   3%	  3	  Tesla	   Fermi	   19%	  ARMA	   32%	  Exponential	   10%	  B-­‐spline	   7%	  
	  
Table	  6.3:	  Intra-­‐observer	  variability	  of	  CMR	  quantitative	  perfusion	  analysis	  as	  expressed	  by	  
the	  coefficient	  of	  variation	  (CV).	  	  	  
6.4.1 Patient	  Studies	  In	  all	   six	  patient	  studies	  stress	  perfusion	  CMR	  was	  successfully	  completed.	  Table	  6.4	  shows	  the	  patient	  demographics	  and	  results.	  The	  segmental	  blood	  flow	  is	  given	  per	   coronary	   artery	   territory	   in	   ml/min/g.	   Significant	   CAD	   was	   detected	   in	   all	  cases	   using	   quantitative	   CMR.	   Whilst	   MBF	   values	   were	   significantly	   different	  during	   adenosine	   stress	   between	   ischemic	   and	   remote	   areas	   both	   at	   1.5	   Tesla	  (p=0.007)	   and	  3	  Tesla	   (p=0.01)	   they	  were	  not	   at	   rest	   (1.5	  Tesla	   p=0.54;	   3	  Tesla	  p=0.44).	  MBF	  did	  not	  significantly	  increase	  in	  ischemic	  areas	  (1.5	  Tesla	  p=0.06;	  3	  Tesla	  p=0.42)	  during	  adenosine	  stress	  whereas	  it	  did	  in	  remote	  areas	  (1.5	  Tesla	  p=	  0.02;	  3	  Tesla	  p=0.04).	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Variable	   1.5	  Tesla	   3	  Tesla	  Patients	  	   (n=3)	   (n=3)	  Age	  (years)	   61±6	   65±10	  Male	  sex	  (%)	   100	   100	  1/2/3	  vessel	  disease	  	   1/1/1	   3/0/0	  MBF	   ischemic	   area	   stress/rest	  [ml/min/g]	   1.46±0.17	  /	  0.94±0.47	   1.59±0.1	  /	  1.2±0.7	  MBF	   remote	   area	   stress/rest	  [ml/min/g]	   3.18±0.12	  /	  1.41	  ±0.51	   2.21±0.57	  /	  0.86±0.1	  	  
Table	   6.4.	   Results	   of	   the	   quantitative	   perfusion	   analysis	   using	   Fermi	   function	   constrained	  
deconvolution	  in	  six	  patients.	  	  
6.5 Discussion	  This	   work	   has	   several	   important	   findings.	   Firstly,	   it	   demonstrates	   that	   Fermi	  function	   constrained	   deconvolution	   quantitative	   magnetic	   resonance	   perfusion	  analysis	   very	   accurately	   assesses	   true	  myocardial	   blood	   flow	   at	   1.5	   and	   3	   Tesla	  using	  state	  of	  the	  art	  CMR	  perfusion	  acquisitions.	  Secondly,	  it	  demonstrates	  better	  performance	  of	  CMR	  based	  quantification	  at	  1.5	  Tesla	  versus	  3	  Tesla.	  Thirdly,	  the	  accuracy	  of	  four	  different	  quantification	  algorithms	  and	  their	  relationship	  with	  the	  true	  perfusion	  values	  are	  reported.	  Lastly,	  using	   the	  most	  accurate	  quantification	  algorithm	   namely	   Fermi	   function	   constrained	   deconvolution	   allows	   accurate	  detection	  of	  significant	  CAD	  in	  small	  patient	  groups	  at	  1.5	  Tesla	  and	  3	  Tesla.	  	  The	   interesting	   part	   of	   this	   study	   is	   the	   utilisation	   of	   a	   very	   controlled	   animal	  environment	   where	   myocardial	   blood	   flow	   to	   the	   heart	   is	   known	   and	   its	  distribution	   over	   time	   within	   the	   myocardium	   is	   quantified	   with	   CMR	   and	  validated	   versus	   microspheres.	   The	   availability	   of	   this	   gold	   standard	   allows	   the	  identification	   of	   any	   underestimation	   or	   overestimation	   of	   perfusion	   by	   a	   given	  CMR	  quantification	  algorithm.	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The	  results	  outlined	  in	  this	  chapter	  show	  that	  CMR	  derived	  quantitative	  perfusion	  imaging	  assessed	  with	  either	  Fermi,	  ARMA,	  Exponential	  or	  B-­‐spline	  deconvolution	  correlates	  with	  fluorescent-­‐labelled	  microspheres	  both	  at	  1.5	  and	  3	  Tesla.	  There	  is	  however	  a	   stronger	  correlation	  and	  a	  more	  accurate	  assessment	  of	  blood	   flow	  at	  1.5	   Tesla	   as	   compared	   to	   3	   Tesla.	   Interestingly	   Fermi	   function	   constrained	  deconvolution	   shows	   very	   good	   correlation	   at	   both	   field	   strengths,	   which	   is	   in	  agreement	  with	  a	  recent	  publication	  showing	  excellent	  accuracy	  for	  the	  detection	  of	  significant	  CAD	  (compared	  to	  FFR)	  using	  Fermi	  function	  quantification	  at	  3	  Tesla	  and	  a	  similar	  sequence	  as	  the	  one	  used	  in	  this	  chapter	  (44).	  The	  other	  algorithms	  are	   clearly	   inferior	   at	   3	   Tesla	   with	   lower	   correlation	   coefficients	   and	  overestimation	  of	  flow	  for	  exponential	  and	  B-­‐spline	  methods	  and	  underestimation	  for	  ARMA.	  Whilst	  correlation	  coefficients	  are	  better	  at	  1.5	  Tesla	  for	  all	  3	  methods	  there	   is	   still	   significant	   overestimation	   with	   B-­‐spline	   and	   underestimation	   with	  ARMA.	  Only	   exponential	   basis	   deconvolution	  has	   a	   similar	   correlation	   coefficient	  and	  estimation	  of	  perfusion	  as	  Fermi	  function	  constrained	  deconvolution	  and	  may	  therefore	   represent	   an	   alternative	   method	   at	   1.5	   Tesla.	   Based	   on	   these	  observations	   we	   performed	   a	   small	   feasibility	   study	   in	   patients	   using	   Fermi	  deconvolution.	   We	   were	   able	   to	   demonstrate	   that	   a	   technique	   developed	   in	   the	  explanted	  heart	  can	  be	  translated	  to	  patients	  and	  potentially	  be	  utilized	  for	  clinical	  decision-­‐making.	  	  The	   crucial	   question	   is	   whether	   higher	   spatial	   resolutions	   allow	   improved	  detection	   of	   subendocardial	   ischaemia	   (149).	   Hsu	   et	   al.	   recently,	   very	   elegantly	  demonstrated	  that	  perfusion	  gradients	  can	  be	  detected	  using	  low	  spatial	  resolution	  techniques	  and	  pixel-­‐wise	  quantification	  strategies	  in	  patients	  (111).	  However	  this	  technique	  has	  also	  been	  developed	  for	  3	  Tesla	  and	  its	  feasibility	  was	  demonstrated	  in	   a	  novel	   hardware	  perfusion	  phantom	   (101)	   and	   in	  patients	   (70).	   Interestingly	  Fermi	  function	  constrained	  deconvolution	  also	  showed	  the	  best	  results	  using	  pixel-­‐wise	  analysis	  at	  3	  Tesla	  (70).	  There	   is	   very	   recent	   evidence	   from	   our	   group	   demonstrating	   that	   standard	   kt-­‐BTFE	  based	  CMR	  perfusion	  imaging	  at	  1.5	  Tesla	  has	  similar	  diagnostic	  accuracy	  for	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quantitative	  myocardial	  perfusion	  reserve	  analysis	  as	  compared	  to	  the	  clinical	  gold	  standard	   of	   quantification	   positron	   emission	   tomography	   (PET)	   in	   patients	  with	  CAD	  (77).	  This	  is	  in	  line	  with	  the	  results	  presented	  in	  this	  chapter	  indicating	  that	  quantitative	  analysis	   strategies	  are	   feasible	  both	  at	  1.5	  and	  3	  Tesla.	  The	  kt-­‐BTFE	  sequence	   mentioned	   above	   has	   also	   been	   selected	   in	   a	   major	   ongoing	   CMR	  perfusion	   clinical	   trial	   (MR-­‐INFORM,	   clinicaltrials.gov	   NCT01236807).	   Our	   study	  shows	   that	   it	   may	   also	   allow	   precise	   quantitative	   perfusion	   analysis	   and	   sub-­‐studies	  of	   the	  MR-­‐INFORM	  trial	  aiming	   to	   investigate	   its	  diagnostic	  accuracy	  and	  prognostic	  implications	  will	  certainly	  be	  of	  interest.	  	  It	   is	   important	   to	   bear	   in	  mind	   that	   the	  detected	  differences	   in	   the	   animal	  work	  described	   in	   this	   chapter	   are	   likely	   to	   be	   real	   because	   some	   unknown	   variables	  that	  exist	  in	  patient	  studies	  or	  in	  the	  living	  animal	  such	  as	  the	  true	  intracoronary	  blood	  flow	  do	  not	  exist	  in	  the	  current	  model.	  The	  fact	  that	  the	  AIF	  is	  directly	  taken	  from	  the	  tubing	  connecting	  to	  the	  coronaries	  makes	  it	  less	  susceptible	  to	  external	  influences	   such	   as	   heart	   rate,	   ejection	   fraction	   or	   cardiac	   output.	   In	   fact	   in	   the	  current	   model	   we	   actually	   measure	   the	   AIF	   of	   the	   bolus	   that	   directly	   and	  completely	   washes	   into	   the	   myocardium.	   The	   current	   model	   may	   therefore	   be	  useful	  as	  a	  new	  reference	  standard	  for	  quantitative	  perfusion	  validation	  using	  CMR	  especially	  given	  the	  fact	  that	  results	  are	  very	  easily	  translatable	  to	  patients.	  	  Given	  the	  accumulating	  evidence	  of	   the	  use	  of	  quantitative	  perfusion	  analysis	   for	  various	   diseases	   and	   to	   detect	   early	   and	   subtle	   changes	   we	   believe	   that	   Fermi	  function	  constrained	  deconvolution	  represents	  a	  very	  accurate,	  precise	  and	  robust	  technique	  that	  can	  be	  recommended	  at	  1.5	  and	  3	  Tesla	  using	  current	  state	  of	  the	  art	  perfusion	  sequences.	  Whether	  this	  approach	  or	  recently	  introduced	  novel	  CMR	  based	  perfusion	  methodology	  such	  as	  the	  gradientogram	  method	  (150)	  or	  pixel	  or	  voxel-­‐wise	  assessment	  of	  perfusion	  are	  most	  accurate	  will	  need	  to	  be	  clarified	   in	  future	  studies	  (70,111).	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6.5.1 Limitations	  The	   fact	   that	   the	   explanted	   heart	   is	   less	   physiological	   and	   free	   from	   external	  influences	   such	   as	   heart	   rate	   and	   cardiac	   output	   makes	   it	   an	   ideal	   validation	  platform	   for	   quantitative	   perfusion.	   However	   this	   model	   oversimplifies	   in	   vivo	  physiological	   conditions	   with	   complex	   nervous	   cardiac	   regulation,	   breathing	  motion	  during	  stress	  and	  dilution	  of	  contrast	  in	  the	  LV	  and	  aorta.	  This	  is	  important	  to	  consider	  when	  translating	  the	  results	  to	  a	  more	  realistic	  scenario	  such	  as	  living	  animals	  or	  patients.	  	  	  
6.5.2 Conclusions	  CMR	   derived	   quantitative	   blood	   flow	   estimates	   very	   accurately	   resemble	   true	  myocardial	   blood	   flow	   in	   a	   controlled	   animal	   model.	   There	   are	   inherent	  differences	  between	  the	  algorithms	  with	  Fermi	  deconvolution	  being	  most	  accurate.	  Exponential	  deconvolution	  is	  very	  accurate	  at	  1.5	  Tesla	  but	  less	  accurate	  at	  3	  Tesla	  due	   to	   overestimation	  of	   perfusion.	  Whilst	  B-­‐spline	  deconvolution	  overestimates	  perfusion,	  ARMA	  underestimates	  perfusion	  at	  both	  field	  strengths.	  When	  accurate	  quantification	  is	  required	  Fermi	  function	  constrained	  deconvolution	  should	  be	  the	  method	   of	   choice	   at	   3	   Tesla.	   At	   1.5	   Tesla	   exponential	   deconvolution	   has	   similar	  performance	   and	   both	   techniques	   can	   be	   recommended.	   	   Using	   accurate	  quantification	   algorithms	   is	   essential	   to	   allow	   CMR	   perfusion	   quantification	   to	  develop	  into	  a	  useful	  clinical	  tool.	  	  	  	  
This	  chapter	  will	  be	  submitted	  for	  publication	  as	  a	  manuscript.	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7.1 Summary	  The	  purpose	  of	  this	  study	  was	  to	  test	  the	  feasibility	  and	  validate	  full	  quantification	  of	  myocardial	  perfusion	  using	  cardiovascular	  magnetic	   resonance	   (CMR)	   imaging	  at	   a	   voxel	   level.	   Magnetic	   resonance	   (MR)	   myocardial	   perfusion	   imaging	   was	  performed	   in	  explanted	  blood	  perfused	  pig	  hearts	  at	  1.5	  Tesla	   (n=4)	  and	  3	  Tesla	  (n=4).	   Images	   were	   acquired	   at	   rest,	   low	   flow	   and	   during	   adenosine	   induced	  hyperemia	   in	   control	   and	   coronary	   occlusion	   conditions.	   Fluorescent-­‐labelled	  microspheres	   and	   known	   coronary	   blood	   flow	   were	   the	   reference	   standard	   for	  myocardial	   blood	   flow	   (MBF)	   validation.	   MBF	   quantification	   of	   the	   time-­‐signal	  intensity	   curves	   was	   performed	   using	   a	   Fermi	   function	   approximation	   basis	   for	  deconvolution.	  CMR	  derived	  MBF	  estimates	  correlated	  well	  with	  the	  microspheres	  both	  at	  1.5	  Tesla	  (r2=0.88,	  p<0.001)	  and	  3	  Tesla	  (r2=0.91,	  p<0.001).	  There	  was	  also	  a	  strong	  correlation	  at	  the	  subendocardial,	  midmyocardial	  and	  subepicardial	  level	  at	   1.5	   Tesla	   (r2=0.86,	   r2=0.81,	   r2=0.77,	   p<0.001	   respectively)	   and	   at	   3	   Tesla	  (r2=0.83,	   r2=0.9,	   r2=0.71,	   p<0.001	   respectively).	   CMR	   derived	   quantitative	   blood	  flow	  at	  the	  voxel	  level	  is	  feasible	  and	  very	  accurate	  as	  compared	  to	  microspheres.	  This	  technique	  is	  suitable	  to	  both	  clinically	  used	  field	  strengths	  and	  may	  provide	  a	  novel	  useful	  clinical	  assessment	  for	  high	  resolution	  MBF	  quantification	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7.2 Introduction	  Myocardial	   ischaemia	  due	  to	  coronary	  artery	  disease	  (CAD)	  can	  be	  detected	  with	  cardiovascular	   magnetic	   resonance	   (CMR)	   perfusion	   imaging	   (11,16,61,71)	   that	  provides	   an	   accurate	   assessment	   of	   the	   functional	   severity	   of	   a	   given	   anatomic	  coronary	  artery	  narrowing	   (16,44).	  CMR	  perfusion	   imaging	  has	  established	   itself	  as	  an	   important	  non-­‐invasive	  clinical	   test	   to	  guide	  patient	  management	  (16,141).	  Furthermore	   it	   provides	   fully	   quantitative	   estimates	   of	   myocardial	   blood	   flow	  (MBF)	  (72,84,145)	  and	   initial	  validation	  studies	  have	  shown	  excellent	  agreement	  with	  microspheres	   (59,66,68,75).	   The	   initial	   validation	   of	   quantitative	   perfusion	  techniques	   has	   however	   been	   restricted	   to	   larger	   areas	   such	   as	   myocardial	  segments	  to	  increase	  signal	  to	  noise.	  There	  is	  recent	  evidence	  from	  our	  group	  (70)	  and	   others	   (111)	   that	   quantification	   of	   MBF	  may	   be	   feasible	   at	   a	   voxel-­‐wise	   or	  pixel-­‐wise	  level	  both	  at	  1.5	  Tesla	  	  and	  3	  Tesla.	  	  The	   introduced	   novel	   magnetic	   resonance	   (MR)	   compatible	   explanted	   pig	   heart	  model	   is	   a	  well-­‐suited	   vehicle	   for	   quantitative	   perfusion	   validation	   (chapter	   5,	   6	  and	   7)	   (146).	   The	   aim	   of	   the	   current	   work	   outlined	   in	   the	   current	   chapter	  was	  therefore	   to	   assess	   the	   feasibility	   of	   quantitative	   voxel-­‐wise	   CMR	   perfusion	  imaging	  and	  to	  validate	  it	  using	  fluorescent-­‐labelled	  microspheres	  in	  combination	  with	  a	  state	  of	  the	  art	  imaging	  cryomicrotome	  (147).	  	  	  
7.3 Methods	  	  
7.3.1 Experimental	  design	  of	  the	  study	  All	  animal	  experiments	  were	  conducted	  after	  approval	  by	  the	  U.K.	  Home	  Office	  in	  accordance	   with	   the	   U.K.	   Animals	   (Scientific	   Procedures)	   Act	   of	   1986	   and	   in	  compliance	  with	  the	  World	  Medical	  Association	  Declaration	  of	  Helsinki	  regarding	  ethical	   conduct	   of	   research	   involving	   animals.	   Eight	   healthy	   Large	   White	   Cross	  Landrace	  pigs	  weighing	  between	  43	  and	  54	  kg	  were	  included	  in	  this	  study	  (Harlan	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Laboratories,	  UK).	  Hearts	  were	  harvested	  as	  previously	  described	  (146).	  Sedation	  was	  performed	  with	   ketamine	   (10mg	  /	   kg	   i.m.)	   and	   xylazine	   (0.3	  mg/kg	   i.m.)	   in	  combination	   with	   alphaxolone	   for	   general	   intravenous	   anaesthesia	   (1.5	   mg/kg	  i.v.).	  Heparin	  was	  administered	  (5,000	  IU)	  and	  exsanguination	  started	  through	  the	  superior	  vena	  cava.	  The	  hearts	  were	  removed	  after	  transection	  of	  the	  great	  heart	  vessels	  and	  intra-­‐coronary	  infusion	  of	  cold	  (4ºC)	  cardioplegic	  solution	  (Martindale	  Pharmaceuticals,	   Romford,	   Essex,	   UK)	   was	   performed.	   Catheters	   were	   inserted	  into	   the	   coronary	   arteries	   before	   reperfusion.	   To	   simulate	   left	   ventricular	   (LV)	  preload	   a	   pressure	   balloon	   was	   inserted	   through	   the	   aortic	   valve	   into	   the	   left	  ventricle	   and	   inflated	   to	   a	   systolic	   pressure	   of	   50	  mmHg.	   After	   the	   hearts	  were	  cannulated,	  pressure	  controlled	  perfusion	  of	   the	  coronary	  arteries	  was	  started	  at	  around	  50	  mmHg.	  Over	  approximately	  5	  minutes	  pressure	  was	  slowly	  increased	  to	  a	  constant	  perfusion	  mode	  of	  0.8	  ml/min/g.	  In	  the	  event	  of	  ventricular	  fibrillation,	  electrical	   defibrillation	   was	   performed.	   In	   case	   of	   persisting	   bradycardia	   right	  atrial	   pacing	   was	   performed.	   After	   preparation	   stability	   was	   achieved	   the	   left	  anterior	  descending	  (LAD)	  coronary	  artery	  was	  occluded	  to	  create	  a	  territory	  with	  a	  perfusion	  defect	  and	  CMR	  imaging	  was	  started.	  Perfusion-­‐CMR	  was	  performed	  at	  rest,	   with	   50%	   flow	   reduction	   and	   during	   pharmacological	   vasodilation	   with	  adenosine	  (Figure	  7.1).	  During	  adenosine	  infusion	  the	  flow	  was	  altered	  to	  maintain	  the	  same	  coronary	  perfusion	  pressure	  as	  during	  the	  resting	  state.	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Figure	   7.1	   The	   figure	   shows	   a	   flow	   chart	   of	   the	   time	   course	   of	   the	   experiments.	   After	  
preparation	   stability	   was	   achieved,	   CMR	   imaging	   was	   started	   with	   the	   acquisition	   of	   rest	  
perfusion	   images.	  Microspheres	  were	   injected	  after	   the	  gadolinium	   injection	   for	  perfusion	  
imaging.	  This	  process	  was	   repeated	  with	  50%	  of	   the	   flow	  and	  during	  adenosine-­‐mediated	  
pharmacological	  vasodilation	  in	  a	  constant-­‐pressure	  perfusion	  mode.	  	  
7.3.2 Cardiovascular	  magnetic	  resonance	  perfusion	  imaging	  The	   animal	   studies	   were	   performed	   on	   1.5	   Tesla	   (Intera	   CV,	   Philips,	   Best,	   The	  Netherlands),	  (n=4)	  and	  3	  Tesla	  (Achieva	  TX,	  Philips,	  Best,	  The	  Netherlands),	  (n=4)	  clinical	  MR	  scanners.	  For	  signal	  reception,	  a	  clinical	   interventional	  L	  flex	  receiver	  coil	  array	  was	  tightly	  positioned	  around	  the	  heart	  chamber,	  which	  was	  then	  placed	  in	   the	   isocenter	   of	   the	  magnet.	   CMR	   perfusion	   data	  were	   acquired	   in	   short	   axis	  orientation	  of	  the	  LV	  following	  a	  recognized	  standard	  model	  (60).	  Image	   parameters	   at	   1.5	   Tesla	   were	   as	   follows:	   CMR-­‐perfusion	   imaging	   was	  performed	  with	  a	  balanced	  turbo	  gradient	  echo	  pulse	  sequence	  accelerated	  with	  a	  5-­‐fold	   k-­‐t	   broad	   linear	   speed	   up	   technique	   (BLAST)	   using	   11	   training	   profiles	  yielding	  a	   typical	   spatial	   resolution	  of	  1.9x2x10	  mm.	  TE/TR	  were	  1.35/2.71;	  50°	  flip	  angle;	  90°	  prepulse	  and	  100	  ms	  prepulse	  delay.	  At	   3	   Tesla	   a	   saturation	   recovery	   gradient	   echo	   pulse	   sequence	   was	   used	  accelerated	  with	  k–t	  BLAST	  (k-­‐t	  factor	  5	  and	  11	  training	  profiles)	  with	  a	  repetition	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time	  of	  2.7	  ms,	  echo	  time	  of	  0.9	  ms,	  flip	  angle	  20°,	  spatial	  resolution	  at	  1.3	  x	  1.3	  x	  8	  mm.	  	  Perfusion-­‐CMR	  was	  performed	  using	  a	  dual-­‐bolus	  scheme	  with	  5	  ml	  of	  neat	  (0.07	   mmol/ml)	   and	   5	   ml	   of	   dilute	   (0.007	   mmol/ml)	   gadobutrolum	   bolus	  injections	   (Gadovist,	   Bayer	   Healthcare,	   Leverkusen,	   Germany)	   (138).	   Post-­‐processing	   of	   perfusion	   images	   was	   performed	   with	   a	   dedicated	   software	  prototype	  (Viewforum,	  Philips	  Healthcare,	  Best,	  The	  Netherlands).	  	  
7.3.3 Quantitative	  analysis	  of	  magnetic	  resonance	  perfusion	  imaging	  The	   signal	   intensity	   (SI)	   curves	   of	   the	   CMR	  perfusion	   images	  were	   incorporated	  into	   a	   Fermi	   function	   deconvolution	   algorithm	   to	   perform	   quantitative	   analysis	  (64).	  The	  LV	  was	  divided	  into	  standard	  segments	  (60).	  Each	  segment	  was	  further	  divided	   into	   10	   transmural	   positions	   starting	   from	   the	   subendocardium	   to	   the	  subepicardium	  and	  10	  angular	  positions	  resulting	  in	  100	  regions	  of	  interest	  (ROI)	  per	   segment	   (150).	   	   SI-­‐time	  curves	  were	  extracted	   for	  each	  ROI.	  For	  comparison	  with	  microspheres	  each	  transmural	  segment	  was	  subdivided	  into	  subendocardial,	  midmyocardial	   and	   subepicardial	   sub-­‐segments	   to	   allow	   validation	   of	   regional	  quantitative	   perfusion	   values	   based	   on	   voxel-­‐wise	   quantification.	   Prior	   to	  deconvolution	   analysis,	   baseline	   correction,	   spatial	   and	   temporal	   filtering	   and	  homogeneity	  correction	  was	  performed	  on	  the	  extracted	  SI	  curves.	  	  	  
7.3.4 Quantitative	  microsphere	  analysis	  	  Immediately	   after	   the	   gadobutrolum	   injection	   a	   total	   of	   100,000	   microspheres	  were	   injected	   into	   the	   circulation	  at	   the	   same	   site	  used	   for	   gadolinium	   injection.	  Three	   different	   colours	   of	   microspheres	   were	   used	   during	   the	   experiments.	  Quantitative	  analysis	  of	  the	  microtome	  images	  was	  performed	  in	  similar	  segments	  used	   for	   perfusion	   quantification	   according	   to	   previously	   described	   methods	  (147).	   To	   assess	   microsphere	   deposition	   cryomicrotome	   and	   CMR	   images	   were	  registered	   to	   the	   same	   coordinate	   space	   and	   microsphere	   flow	   quantified	   in	  segments	   as	   a	   function	   of	   segment	   volume,	   arterial	   flow	   rate,	   and	   microsphere	  count	  fraction	  (147).	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Nt 	  where	   Ns	   is	   the	   number	   of	   microspheres	   counted	   in	   a	   segment,	   Nt	   is	   the	   total	  number	  of	  microspheres	  injected,	  Ft	  is	  the	  total	  arterial	  input	  flow	  rate	  in	  mL/min,	  and	  Ms	  is	  the	  mass	  of	  a	  segment	  in	  grams.	  Segment	  volumes	  were	  calculated	  from	  a	  3D	   binarised	   left	   ventricular	   mesh,	   for	   which	   a	   local	   transmural	   coordinate	  direction	  was	   defined,	   allowing	   the	   partitioning	   of	   the	   LV	  wall	   into	   segments	   of	  equal	   transmural	   width.	   	   To	   quantify	   microspheres	   circumferentially,	   the	   LV	  centroid	   and	   anterior	   RV	   insertion	   point	  were	   identified	   in	   each	   perfusion	   slice,	  with	  circumferential	  segments	  then	  defined	  every	  60	  degrees	  around	  the	  centroid	  allowing	   very	   accurate	   alignment	   of	   the	   perfusion	   and	   cryomicrotome	   slices	  (Figure	   7.2).	   Transmural	   segments	   were	   subdivided	   into	   subendocardial,	  midmyocardial	   and	   subepicardial	   sub-­‐segments	   to	   allow	   validation	   of	   pixel-­‐wise	  quantification	  at	  this	  level.	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Figure	   7.2	   The	   figure	   shows	   a	   still	   image	   of	   a	   perfusion	   study	   at	   3	   Tesla	   after	   selective	  
occlusion	   of	   the	   LAD	   (middle	   image).	   The	   image	   on	   the	   right	   shows	   the	   overlay	   with	   the	  
microsphere	  distribution	  after	  transfer	  of	  the	  cryomicrotome	  images	  in	  the	  same	  coordinate	  
space.	  Transmural	  microsphere	  quantification	  reveals	  the	  perfusion	  defect	  and	  the	  normal	  
perfusion	   in	  remote	  myocardium	  (lower	  right	  corner).	  A	  more	  detailed	  relationship	  of	   the	  
regional	  flow	  patterns	  can	  be	  appreciated	  from	  the	  quantitative	  microsphere	  images	  based	  
on	   the	   subdivided	   images	   into	   subendocardial,	   midmyocardial	   and	   subendocardial	   sub-­‐
segments	  (upper	  right	  corner).	  In	  the	  middle	  row	  the	  segmentation	  of	  the	  perfusion	  image	  is	  
displayed	  (middle	  left).	  On	  the	  lower	  left	  the	  transmural	  quantitative	  perfusion	  values	  based	  
on	  averaged	  voxel-­‐wise	  Fermi	  function	  constrained	  deconvolution	  can	  be	  appreciated.	  The	  
upper	   left	   shows	   the	   same	   images	   with	   quantitative	   values	   for	   subendocardial,	  
midmyocardial	   and	   subepicardial	   sub-­‐segments.	   Using	   voxel-­‐wise	   SI-­‐curves	   for	   Fermi	  
function	  constrained	  deconvolution	  delivers	  CMR	  based	  quantitative	  results	  [ml/min/g]	  that	  
match	  the	  microsphere-­‐based	  results.	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7.3.5 Statistics	  Data	   analysis	  was	   performed	  with	   IBM	   SPSS	   statistics	   for	  Mac	   20.0.0	   (SPSS	   Inc.,	  Chicago,	   Illinois,	   USA).	   Continuous	   data	   are	   expressed	   as	   the	   mean	   ±	   standard	  deviation	   (SD).	   The	   paired	   samples	   t-­‐test	   was	   used	   to	   compare	   perfusion	  measurements	  at	  rest	  and	  with	  stress	  and	  low	  flow	  within	  one	  heart.	  To	  compare	  perfusion	  measurements	  with	   CMR	   and	  microspheres	  we	   used	   linear	   regression	  analysis	   and	   the	   method	   proposed	   by	   Bland	   and	   Altman	   (148).	   Intra-­‐observer	  variability	  was	  assessed	  using	  the	  coefficient	  of	  variation	  (CV)	  defined	  as	  the	  ratio	  of	  the	  SD	  to	  the	  mean	  of	  the	  differences	  between	  the	  measurements.	  A	  p-­‐value	  of	  <0.05	  was	  considered	  statistically	  significant.	  	  	  	  
7.4 Results	  All	   hearts	   recovered	   electrical	   function	   upon	   reperfusion.	   In	   case	   of	   reperfusion	  arrhythmias	   defibrillation	   was	   performed	   to	   achieve	   sinus	   rhythm.	   Hearts	   were	  shocked	   for	   3±2	   times	   on	   average.	   All	   hearts	   remained	   reasonably	   stable	  throughout	   the	   perfusion	   experiments.	   Heart	   rate	   was	   73±17	   beats	   per	   minute.	  The	  heart	  weight	  was	  269±20	  g.	  The	  external	   roller	  pump	  blood	   flow	  was	   set	   to	  245±40	   ml/min.	   Further	   measurements	   were	   taken	   during	   reduced	   flow	   at	  123±18	  ml/min	   and	   during	   adenosine	   induced	   hyperemia	  with	   401±43	  ml/min.	  These	   flow	   rates	   constituted	   an	   overall	   LV	   flow	   of	   0.91±0.17,	   0.47±0.09	   and	  1.52±0.1	  ml/min/g	  LV	  (p<0.001),	  respectively.	  For	  quantitative	  comparison	  Figure	  7.3	  shows	  the	  relation	  between	  microspheres	  and	  CMR	  derived	  perfusion	  at	  both	  field	  strengths.	  Essentially	  there	  was	  an	  excellent	  correlation	  at	  both	  field	  strengths	  considering	  an	  average	  value	  on	  a	  transmural	  basis,	  which	  was	  slightly	  higher	  at	  3	  Tesla	   (r2=0.91;	  p<0.001)	  as	  compared	   to	  1.5	  Tesla	   (r2=0.88;	  p<0.001).	  There	  was	  also	   an	   excellent	   agreement	   after	   subdivision	   of	   the	   segments	   at	   both	   field	  strengths	  (Table	  7.1,	  Figure	  7.3	  and	  7.4).	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   1.5	  Tesla	   3	  Tesla	   p-­‐value	  Spatial	  Location	   	  r	   	  r2	   	  r	   	  r2	   	  <0.001	  	  Transmural	   	  0.94	   	  0.88	   	  0.96	   	  0.91	   	  <0.001	  	  Subendocardial	   	  0.93	   	  0.86	   	  0.91	   	  0.83	   	  <0.001	  	  Midmyocardial	   	  0.9	   	  0.81	   	  0.95	   	  0.9	   	  <0.001	  	  Subepicardial	   	  0.88	   	  0.77	   	  0.84	   	  0.71	   	  <0.001	  
	  
Table	   7.1	   The	   table	   shows	   the	   correlation	   strength	   at	   the	   individual	   field-­‐strength	   and	  
spatial	  location	  with	  the	  gold	  standard	  of	  microspheres.	  	  	  	  Bland	  Altman	  analysis	  showed	  good	  agreement	  between	  CMR	  derived	  quantitative	  perfusion	  and	  the	  microsphere	  gold	  standard	  as	  shown	  in	  Figure	  7.3	  and	  7.4	  and	  Table	  7.2.	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  Field	  Strength	   Spatial	  Location	   Modality	   Mean	   CI	  (95%)	  of	   the	  Difference	   p-­‐value	  
1.5	  Tesla	   Transmural	   CMR	   1.1±0.82	   -­‐0.24-­‐0.31	   0.82	  Microspheres	   1.07±0.98	  Subendocardial	   CMR	   1.28±1.11	   -­‐0.34-­‐0.38	   0.9	  Microspheres	   1.25±1.25	  Midmyocardial	   CMR	   1.08±0.78	   -­‐0.38-­‐0.22	   0.61	  Microspheres	   1.16±1.16	  Subepicardial	   CMR	   0.94±0.71	   -­‐0.16-­‐0.29	   0.58	  Microspheres	   0.88±0.77	  
3	  Tesla	   Transmural	   CMR	   1±0.79	   -­‐0.17-­‐0.31	   0.58	  Microspheres	   0.94±0.75	  Subendocardial	   CMR	   1.11±1.04	   -­‐0.36-­‐0.32	   0.92	  Microspheres	   1.12±1.11	  Midmyocardial	   CMR	   1.08±0.89	   -­‐0.23-­‐0.33	   0.73	  Microspheres	   1.03±0.9	  Subepicardial	   CMR	   0.93±0.76	   -­‐0.04-­‐0.39	   0.11	  Microspheres	   0.75±0.56	  	  
Table	  7.2	  The	   table	   shows	   the	  mean	  perfusion	  values	  based	  on	  microspheres	  and	  CMR	   for	  
both	   field	   strengths.	   Data	   is	   presented	   as	   mean	   ±	   standard	   deviation	   (SD)	   along	   with	   p-­‐
values	  indicating	  statistical	  significance	  based	  on	  the	  paired	  t-­‐test.	  (CI)-­‐	  Confidence	  Intervals;	  
(CMR)-­‐cardiac	  magnetic	  resonance.	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Figure	  7.3	  The	  figure	  shows	  the	  correlation	  of	  CMR	  derived	  quantitative	  perfusion	  analysis	  with	  the	  gold	  standard	  of	  microsphere	  derived	  quantitative	  
perfusion	  at	  1.5	  Tesla	  (top	  row).	  The	  bottom	  row	  shows	  the	  agreement	  between	  CMR	  derived	  perfusion	  and	  the	  gold	  standard	  using	  the	  Bland	  Altman	  
analysis.	  Results	  are	  shown	  for	  transmural	  segments	  and	  sub-­‐segments	  (subendocardial,	  midmyocardial	  and	  subepicardial)	  from	  left	  to	  right.	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Figure	  7.4	  The	  figure	  shows	  the	  correlation	  of	  CMR	  derived	  quantitative	  perfusion	  analysis	  with	  the	  gold	  standard	  of	  microsphere	  derived	  quantitative	  
perfusion	  at	  3	  Tesla	  (top	  row).	  The	  bottom	  row	  shows	  the	  agreement	  between	  CMR	  derived	  perfusion	  and	  the	  gold	  standard	  using	  the	  Bland	  Altman	  
analysis.	  Results	  are	  shown	  for	  transmural	  segments	  and	  sub-­‐segments	  (subendocardial,	  midmyocardial	  and	  subepicardial)	  from	  left	  to	  right.	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There	   was	   little	   intra-­‐observer	   variability	   for	   all	   spatial	   locations	   at	   both	   field	  strengths.	   In	   comparison	   there	  was	   less	   variability	   at	   1.5	   Tesla	   as	   opposed	   to	   3	  Tesla	  (Table	  7.3).	  
	   Field	  Strength	   1.5	  Tesla	   3	  Tesla	  	  Spatial	  Location	   	  CV	   	  CV	  	  Transmural	   	  9%	   	  14%	  	  Subendocardial	   	  9%	   	  13%	  	  Midmyocardial	   	  10%	   	  18%	  	  Subepicardial	   	  9%	   	  15%	  
	  
Table	  7.3:	  Intra-­‐observer	  variability	  of	  CMR	  quantitative	  perfusion	  analysis	  as	  expressed	  by	  
the	  coefficient	  of	  variation	  (CV).	  
	  
	  
7.5 Discussion	  The	  current	  work	  described	  in	  this	  chapter	  has	  several	  important	  findings.	  Firstly,	  it	   demonstrates	   that	   Fermi	   function	   constrained	   deconvolution	   quantitative	  magnetic	  resonance	  perfusion	  analysis	  at	   the	  voxel-­‐level	  very	  accurately	  assesses	  true	  myocardial	  blood	  flow	  at	  1.5	  and	  3	  Tesla	  using	  state	  of	  the	  art	  MR	  perfusion	  acquisitions.	   Secondly,	   it	   demonstrates	   that	   this	   regional	   assessment	   of	  quantitative	   blood	   flow	   can	   be	   utilized	   to	   assess	   differences	   throughout	   the	  myocardial	  wall	  at	  3	  Tesla	  but	  also	  with	  lower	  spatial	  resolution	  at	  1.5	  Tesla.	  	  The	  utilisation	  of	   a	   very	   controlled	   environment	  where	  myocardial	   blood	   flow	   is	  known	   and	   its	   distribution	   over	   time	   within	   the	   myocardium	   is	   quantified	   with	  microspheres	  provides	  a	  very	  accurate	  validation	  of	  this	  novel	  technique.	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Recently	  Motwani	  et	  al.	  suggested	  that	  higher	  spatial	  resolutions	  allow	  improved	  visual	  detection	  of	  subendocardial	  ischaemia	  (149).	  However	  in	  the	  current	  work	  assessment	   of	   subendocardial	   quantitative	   voxel-­‐wise	   perfusion	   assessment	  showed	   similar	   performance	  with	   excellent	   correlations	   at	   both	  1.5	   and	  3	  Tesla.	  This	  was	  irrespective	  of	  the	  higher	  spatial	  resolution	  obtained	  at	  3	  Tesla	  compared	  to	  1.5	  Tesla.	  The	  feasibility	  of	  the	  voxel-­‐wise	  technique	  had	  initially	  been	  described	  and	  validated	  in	  non-­‐beating	  isolated	  perfused	  pig	  hearts	  at	  1.5	  Tesla	  (65).	  Hsu	  et	  al.	   demonstrated	   that	  perfusion	  gradients	  based	  on	  pixel-­‐wise	  quantification	   can	  be	  detected	  at	  1.5	  Tesla	  in	  patients	  (111).	  They	  furthermore	  showed	  very	  accurate	  assessment	   of	   quantitative	   perfusion	   in	   canines	   compared	   to	   microspheres.	  However	  there	  are	  assumptions	  inherent	  to	  the	  quantitative	  methodology	  involved	  such	  as	  estimation	  of	  myocardial	  blood	   flow	   from	  the	  relationship	  of	   the	  arterial	  input	   function	   and	   the	   myocardial	   response	   curve.	   The	   latter	   are	   heavily	  influenced	  by	  cardiac	  output,	  ejection	  fraction	  and	  heart	  rate.	  In	  validation	  studies	  it	  is	  therefore	  difficult	  to	  provide	  a	  true	  gold	  standard	  when	  myocardial	  blood	  flow	  rates	   are	   unknown.	   In	   our	   study	  we	   have	   overcome	   these	   limitations	   and	  were	  able	  to	  confirm	  the	  finding	  of	  Hsu	  et	  al.	  at	  1.5	  Tesla	  and	  furthermore	  validate	  the	  voxel-­‐wise	   quantification	   approach	   we	   had	   developed	   at	   3	   Tesla	   in	   a	   perfusion	  hardware	  phantom	  and	  in	  patients	  (70,101).	  We	  used	  Fermi	  function	  constrained	  deconvolution	  that	  showed	  the	  best	  results	  for	  voxel-­‐wise	  quantitative	  analysis	  in	  patients	   at	   3	   Tesla	   (70).	   Furthermore	   there	   is	   similar	   excellent	   correlation	  with	  microspheres	  at	  1.5	  Tesla.	  This	  is	  important	  and	  in	  line	  with	  recent	  evidence	  from	  our	  group	  that	  demonstrates	  that	  standard	  kt-­‐BTFE	  based	  CMR	  perfusion	  imaging	  at	  1.5	  Tesla	  has	  similar	  diagnostic	  accuracy	  for	  quantitative	  myocardial	  perfusion	  reserve	   analysis	   as	   the	   clinical	   gold	   standard	  of	  quantification	  positron	  emission	  tomography	  	  (PET)	  in	  patients	  with	  CAD	  (77).	  Most	  clinical	  CMR	  examinations	  are	  performed	  at	  1.5	  Tesla	  and	  it	  is	  therefore	  crucial	  to	  have	  a	  working	  methodology	  in	  this	  scenario.	  The	  sequence	  used	  in	  this	  work	  at	  1.5	  Tesla	  has	  also	  been	  selected	  in	  a	   major	   ongoing	   CMR	   perfusion	   clinical	   trial	   (MR-­‐INFORM,	   clinicaltrials.gov	  NCT01236807).	  The	  work	  described	   in	  this	  chapter	  shows	  that	   it	  may	  also	  allow	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precise	   quantitative	   perfusion	   analysis	   based	   on	   voxel-­‐wise	   SI-­‐time	   curves	   and	  sub-­‐studies	  of	  the	  MR-­‐INFORM	  trial	  will	  aim	  to	  investigate	  the	  diagnostic	  accuracy	  and	  prognostic	  implications	  of	  this	  novel	  technique.	  	  There	   is	   accumulating	   evidence	   of	   the	   use	   of	   quantitative	   perfusion	   analysis	   for	  various	  diseases	  bringing	  the	  promise	  to	  detect	  early	  and	  subtle	  changes.	  A	  robust	  assessment	   of	   the	   spatial	   extent	   of	   blood	   flow	   alterations	   based	   on	   voxel-­‐wise	  quantification	   may	   expand	   the	   clinical	   applications	   of	   quantitative	   perfusion	  assessment	  and	  could	  add	  onto	  the	  diagnostic	  accuracy	  of	  the	  methodology.	  	  	  
7.5.1 Limitations	  The	   fact	   that	   the	   explanted	   heart	   is	   less	   physiological	   and	   free	   from	   external	  influences	   such	   as	   heart	   rate	   and	   cardiac	   output	   makes	   it	   an	   ideal	   validation	  platform	   for	   quantitative	   perfusion.	   However	   this	   model	   oversimplifies	   in	   vivo	  physiological	   conditions	  with	   complex	   nervous	   cardiac	   regulation	   and	   breathing	  motion	   during	   stress.	   Thus,	   the	   techniques	   described	   in	   this	   chapter	   need	   to	   be	  investigated	   in	   specific	   patient	   populations	   before	   clinical	   use	   can	   be	  recommended.	  Future	  studies	  need	  to	  especially	  aim	  at	  determining	  the	  diagnostic	  accuracy	  of	  this	  technique	  to	  detect	  functionally	  significant	  CAD	  in	  patients.	  	  	  
7.5.2 Conclusions	  CMR	   derived	   voxel-­‐wise	   quantitative	   blood	   flow	   estimates	   very	   accurately	  resemble	  true	  myocardial	  blood	  flow	  in	  a	  controlled	  animal	  model.	  This	  holds	  true	  irrespective	   of	   spatial	   location	   or	   field	   strength.	   Using	   state	   of	   the	   art	   perfusion	  sequences	  and	  quantification	  algorithms	  is	  essential	  to	  allow	  CMR	  perfusion	  to	  be	  quantified	  at	  the	  voxel	  level,	  which	  may	  develop	  into	  a	  useful	  clinical	  tool.	  	  	  
This	  chapter	  will	  be	  submitted	  for	  publication	  as	  a	  manuscript.	  
	   	  	   	   	  	  
Chapter	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The	   aim	   of	   this	   thesis	   was	   first	   to	   develop	   a	   novel	   magnetic	   resonance	   (MR)	  compatible	   explanted	   pig	   heart	   model	   that	   allows	   excellent	   control	   of	   regional	  blood	   flow.	  The	   second	  aim	  was	   to	  use	   it	   for	   validation	  of	  quantitative	  perfusion	  imaging	   at	   the	   segmental	   and	   at	   the	   voxel-­‐level	   against	   the	   gold	   standard	   of	  fluorescent-­‐labelled	   microspheres	   using	   standard	   clinical	   perfusion	   acquisitions	  and	  MR	  scanners.	  	  There	   are	   several	   important	   outcomes	   of	   this	   thesis.	   Firstly	   and	   importantly	   the	  thesis	  resulted	  in	  a	  novel	  animal	  platform	  for	  validation	  of	  quantitative	  perfusion.	  The	   model	   described	   can	   be	   very	   accurately	   controlled	   in	   terms	   of	   global	   and	  regional	  blood	  flow	  and	  seems	  optimally	  suited	  for	  validation	  work	  in	  combination	  with	  microsphere	  quantification.	  This	  thesis	  therefore	  introduces	  a	  new	  reference	  standard	   for	   quantitative	   perfusion	   validation	   using	   cardiovascular	   magnetic	  resonance	   (CMR).	   Furthermore,	   the	   fact	   that	   the	   animal	  model	   can	   be	   used	  with	  clinical	   MR	   scanners	   allows	   for	   easy	   and	   efficient	   translation	   of	   the	   results	   to	  patients.	  Secondly	  in	  order	  to	  be	  able	  to	  accurately	  quantify	  myocardial	  perfusion	  a	  dual-­‐bolus	  technique	  has	  been	  developed	  that	  is	  universal	  and	  can	  be	  easily	  used	  in	  any	  clinical	  setting.	  This	   is	   important	   to	  allow	  quantification	  strategies	  to	  emerge	  from	  a	  complicated	  research	  tool	  into	  an	  every	  day	  clinical	  application.	  Thirdly	  we	  have	  tested	  several	  quantification	  algorithms	  and	  can	  recommend	  Fermi	   function	  constrained	   deconvolution	   to	   be	   used	   with	   current	   clinical	   sequences	   and	   MR	  scanners.	   Lastly	   voxel-­‐wise	   quantification	   seems	   an	   attractive	   method	   that	   may	  carry	   even	  more	   information	   by	   looking	   at	   very	   localized	   blood	   flow	   alterations.	  Future	   research	  needs	   to	   translate	   this	  validated	  methodology	   to	  patients	  and	   to	  define	   quantitative	   thresholds	   in	   order	   to	   make	   clinical	   decisions	   based	   on	   the	  severity	   of	   ischaemia,	   rather	   than	   the	   pure	   presence	   or	   absence	   of	   perfusion	  defects.	  The	  ability	  to	  detect	  very	  early	  stages	  of	  the	  ischaemic	  cascade	  is	  expected	  to	   increase	   the	   sensitivity	   of	   functional	   testing	   when	   managing	   coronary	   artery	  disease	  (CAD)	  in	  clinical	  practice.	  	  CMR	  perfusion	  imaging	  already	  plays	  an	  important	  role	  in	  the	  clinical	  management	  of	  patients	  with	  CAD.	  The	  qualitative	  visual	  assessment	  of	  pure	  perfusion	  defects	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has	  been	  shown	  to	  be	  very	  accurate	  and	  at	  present	  CMR	  perfusion	  is	  regarded	  as	  one	   of	   the	   best	   diagnostic	   techniques.	   In	   a	   recent	   meta-­‐analysis	   only	   positron	  emission	   tomography	   (PET)	   reached	   similar	   diagnostic	   accuracy	   (151).	  However	  PET	  is	  less	  available	  and	  expertise	  in	  this	  methodology	  is	  not	  present	  in	  all	  cardiac	  centres.	  It	  is	  important	  to	  acknowledge	  that	  quantitative	  analysis	  of	  CMR	  perfusion	  images	  deliver	  similar	  information	  as	  the	  quantitative	  analysis	  of	  PET	  images	  (77).	  It	   may	   well	   be	   that	   CMR	   will	   emerge	   as	   the	   gold	   standard	   for	   non-­‐invasive	  assessment	  of	  myocardial	  blood	  flow	  (MBF).	  Also	  there	  is	  data	  expected	  in	  2015	  to	  report	   the	   value	   of	   CMR	   perfusion	   in	   regard	   to	   the	   invasive	   gold	   standard	   of	  fractional	   flow	   reserve	   (FFR).	  MR	   INFORM	   (clinicaltrials.gov	  NCT01236807)	  will	  assess	   whether	   an	   initial	   strategy	   of	   CMR	   perfusion	   is	   non-­‐inferior	   to	   invasive	  angiography	   supplemented	   by	   FFR	   measurements	   to	   guide	   the	   management	   of	  patients	   with	   stable	   coronary	   artery	   disease.	   Non-­‐inferiority	   of	   CMR	   perfusion	  imaging	   to	   the	   current	   invasive	   reference	   standard	   (FFR)	   would	   establish	   CMR	  perfusion	   imaging	   as	   an	   attractive	   non-­‐invasive	   alternative	   to	   current	   diagnostic	  pathways.	  	  CMR	   perfusion	   imaging	   however	   is	   evolving	   further	   and	   ischaemia	   assessment	  with	   full	   heart	   coverage	   using	   3D	   perfusion	   acquisitions	   shows	   excellent	  agreement	  with	  FFR	  (152).	  Whether	  or	  not	  using	  quantification	  strategies	  with	  this	  novel	  technique	  could	  even	  further	  enhance	  the	  accuracy	  of	  CMR	  perfusion	  imaging	  can	  only	  be	  speculated.	  The	  field	  of	  CMR	  imaging	  is	  moving	  towards	  full	  quantification.	  This	  does	  not	  only	  apply	   to	   myocardial	   perfusion	   imaging	   but	   also	   to	   other	   areas	   including	   tissue	  characterisation	   with	   T1	   and	   T2	   mapping	   strategies	   (153,154).	   Extensive	  controlled	   validation	   is	   a	   prerequisite	   to	   establish	   these	   novel	   strategies.	   The	  described	   animal	   platform	   may	   have	   utility	   beyond	   the	   scope	   of	   perfusion	  quantification.	  Future	  developments	  of	  the	  model	  may	  involve	  a	  full	  working	  heart	  setup	  allowing	  regional	  wall	  motion	  to	  be	  studied	  and	  quantified.	  It	  may	  serve	  as	  a	  useful	  tool	  when	  validation	  of	  different	  CMR	  methodology	  is	  required	  in	  the	  future.	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